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Asthma is an increasing health problem among the working age 
population and may already start at a young age. The aim was 
to study the asthma prognosis and the work ability of men with 
asthma since youth.
We used the Finnish Defence Force registers to select the study 
populations. Military aggravated asthma had a good 2-year and 
20-year prognosis. Both mild and more severe asthma at the age 
of around 20 seems to be associated with reduced work ability 
among middle-aged men. Furthermore, current occupational ex-
posure may be associated with asthma exacerbations among men 
with relatively severe asthma in youth. 
Health care providers should therefore carefully follow men with 
asthma that began in youth, support their work ability and pay 
close attention to their work environment.
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7AbstRACt
Asthma is a significant and increasing health problem among the working 
aged population and is associated with decreased work ability. The worsen-
ing of asthma due to conditions at work has been shown to be a common 
occurrence. The aim was to study the asthma prognosis and the work 
ability of men with asthma since youth. The first objective was to analyse 
the impact of individual characteristics and lung function tests at the age 
of around 20 as risk factors for current persistent asthma. The second aim 
was to assess work ability of men with asthma at 40 years of age and risk 
factors for decreased work ability. Finally, we investigated whether current 
work and workplace exposure is associated with asthma severity, asthma 
control and the occurrence of exacerbations at the age of 40. 
We used the Finnish Defence Force registers to select the two dif-
ferent study populations. As our study populations consisted mainly of 
men with early-onset atopic asthma the results cannot be generalised to 
other types of asthma. Initially, in 2007 a postal questionnaire was sent 
to all 216 men with verified asthma from the 2004–2005 Central Mili-
tary Hospital register. All study subjects included in our second study 
population were men currently aged at approximately 40 years old. The 
Recruits with asthma (Asthma Group 1, n=505) consisted of all asthmat-
ics who were referred to the Central Military Hospital during the period 
1987–1990 and who had relatively mild asthma in youth. The Asthmatics 
exempted from service (Asthma Group 2, n=393) included men who were 
exempted from military service during the period 1986–1989 due to 
asthma and had more severe asthma in youth. The Controls (n=1500) 
had performed their military service without asthma. A postal question-
naire including validated questions about asthma and work ability was 
sent out approximately twenty years after military service or exemption 
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at call-up. Thereafter, a total of 119 respondents from the recruits with 
asthma group attended the clinical tests.
Asthma was significantly less severe at the two-year follow-up than 
during military service (p=0.036) and allergic sensitisation was the most 
important determinant of more severe asthma. Approximately half of 
those men who belonged to our second study population and attended 
the clinical visit approximately twenty years after their military service 
had current persistent asthma. A positive exercise test and obstructive 
spirometry at baseline were associated with asthma persistence at the 
twenty-year follow-up. The self-assessed current work ability compared 
with life time best for recruits with asthma and asthmatics exempted from 
service was significantly reduced when compared with the controls (the 
adjusted odds ratio, (OR) 1.5, 95% confidence interval (95%CI) 1.0–2.2 
and 1.6, 95%CI 1.0–2.5, respectively). Among the asthmatics being a 
current smoker, having only basic education, being a manual worker or 
being self-employed and suffering from current severe asthma were associ-
ated most strongly with decreased self-assessed work ability. In asthmatics 
exempted from service, being a manual worker or self-employed were also 
associated significantly with the occurrence of asthma exacerbations dur-
ing past 12 months (adjusted OR 4.5, 95%CI 1.2–16.3).
Conclusions: Military aggravated asthma has a good short-term and long-
term prognosis. A positive exercise test and obstructive spirometry might 
be clinically meaningful prognostic measures in males with asthma that 
began at a young age. Both mild and more severe asthma at the age of 
around 20 seems to be associated with reduced self-assessed work abil-
ity in 40-year-old men. Current work and occupational exposure may 
be associated with the occurrence of asthma exacerbations in middle-
aged men who had relatively severe asthma at around 20 years of age. 
Occupational health care professionals and other health care providers 
should, therefore, follow carefully men with asthma that began in youth, 
supporting their work ability and paying close attention to their work 
environment.
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Astma on yleinen sairaus työikäisessä väestössä, ja sen on osoitettu liitty-
vän alentuneeseen työkykyyn. Työn arvioidaan vaikeuttavan astmaoireita 
merkittävällä osalla työssä käyvistä astmaa sairastavista. Tämän väitös-
kirjatyön tarkoituksena oli selvittää astman ennustetta ja sairauden vai-
kutusta työkykyyn miehillä, jotka ovat sairastaneet astmaa nuoruudesta 
alkaen. Tarkempina tavoitteina oli tutkia keuhkojen toimintakokeiden ja 
allergiatutkimusten tulosten merkitystä pysyvän astman kehittymiseen. 
Toisena tavoitteena oli arvioida astmaa sairastavien miesten työkykyä 
noin 40 vuoden iässä ja riskitekijöitä, jotka liittyivät heikentyneeseen 
työkykyyn. Kolmanneksi selvitimme nykyisen työn ja työssä tapahtuvan 
altistumisen yhteyttä tämänhetkiseen astman vaikeusasteeseen, hoitota-
sapainoon ja pahenemisvaiheiden esiintymiseen.
Käytimme tutkimuksessamme kahta eri tutkimusaineistoa, jotka 
valittiin Puolustusvoimien rekistereistä. Koska tutkimusaineistoomme 
kuului lähinnä miehiä, joilla oli varhaisessa iässä alkava allerginen ast-
ma, tuloksiamme ei voi yleistää koskemaan muita astman fenotyyppejä. 
Aluksi selvitimme astman 2-vuotisennustetta varusmiespalveluksen 
jälkeen postikyselyn avulla ja valitsimme tähän tutkimukseen kaikki ne 
miehet, joita oli hoidettu Keskussotilassairaalassa astman vuoksi vuosina 
2004–2005. Selvitimme astman pidempiaikaista ennustetta käyttäen 
toista tutkimusaineistoa. Siihen kuului kolme eri ryhmää ja kaikki tutki-
mukseen valitut miehet olivat parhaillaan noin 40 vuoden iässä. Astmaa 
sairastavien varusmiesten ryhmään (astma ryhmä 1, n = 505) valittiin 
kaikki varusmiehet, joita oli hoidettu Keskussotilassairaalassa vuosina 
1987–1990 astman vuoksi. Nämä miehet edustivat nuoruudessaan lievää 
tai keskivaikeaa astmaa sairastavia. Palveluksesta vapautettujen ryhmään 
(astma ryhmä 2, n = 393) valittiin ne miehet, jotka oli vapautettu va-
rusmiespalveluksesta astman vuoksi vuosina 1986–1989, ja tämä ryhmä 
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edusti nuoruudessaan melko vaikeaa astmaa sairastavia. Verrokkiryhmään 
(n = 1 500) valittiin satunnaisotoksella miehiä, jotka eivät sairastaneet 
astmaa varusmiespalveluksen aikana. Noin 20 vuotta varusmiespalveluksen 
jälkeen lähetimme postikyselyn, jossa esitettiin astmaa ja työkykyä koskevia 
kysymyksiä. Tämän jälkeen tehtyihin kliinisiin tutkimuksiin osallistui 119 
miestä, jotka kuuluivat astmaa sairastavien varusmiesten ryhmään. 
Kyselyn perusteella astma oli merkitsevästi lievempi kaksi vuotta 
varusmiespalveluksen jälkeen kuin sen aikana (p = 0.036), ja allergia oli 
tärkein vaikeampaa astmaa ennustava tekijä. Astman pidempiaikaista 
ennustetta selvittävässä tutkimuksessa noin puolet kliinisiin tutkimuksiin 
osallistuneista miehistä sairasti pysyvää astmaa 20 vuotta varusmiespal-
veluksen jälkeen. Positiivinen juoksurasituskoe ja obstruktiivinen spiro-
metria varusmiesiässä liittyivät pysyvään astmaan 20 vuoden kuluttua. 
Tutkittavien omaan arvioon perustuva työkyky verrattuna elinaikaiseen 
parhaimpaan oli alentunut sekä astmaa sairastavien varusmiesten ryhmässä 
että palveluksesta vapautettujen ryhmässä verrattuna verrokkeihin (vakioi-
tu odds ratio (OR) 1.5, 95 %:n luottamusväli, confidence interval (CI) 
1.0–2.2 ja OR 1.6, 95 %CI 1.0–2.5, vastaavasti). Astmaa sairastavilla 
nykyinen tupakointi, ainoastaan peruskoulutus, työntekijänä (käsittää 
lähinnä tuotanto- ja palvelutyöntekijät) tai yrittäjänä toimiminen sekä 
tämänhetkinen vaikea astma liittyivät kaikkein selvimmin alentunee-
seen työkykyyn. Palveluksesta vapautettujen ryhmässä työntekijänä tai 
yrittäjänä toimiminen liittyivät astman pahenemisvaiheen esiintymiseen 
viimeisen vuoden aikana (vakioitu OR 4.5, 95%CI 1.2–16.3).
Johtopäätökset: Varusmiespalveluksen aikana vaikeutuneella astmalla 
on hyvä lyhyt- ja pitkäaikaisennuste. Positiivinen juoksurasituskoe ja 
obstruktiivinen spirometria nuoruudessa saattavat olla kliinisesti mer-
kittäviä astman ennusteeseen vaikuttavia tekijöitä. Sekä lievää ja että 
vaikeampaa astmaa nuoruudessaan sairastavien miesten omaan arvioon 
perustuva työkyky on alentunut noin 40 vuoden iässä. Nykyinen työ ja 
työperäinen altistuminen saattavat liittyä astman pahenemisvaiheiden 
esiintymiseen keski-ikäisillä miehillä, joilla oli ollut suhteellisen vaikea 
astma nuoruudessaan. Tämän vuoksi työterveyshuollossa ja muualla 
terveydenhuollossa olisi tärkeää seurata erityisen hyvin nuorena astmaan 
sairastuneita, tukea heidän työkykyään ja kiinnittää huomiota heidän 
työympäristöönsä.
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1  IntRoduCtIon
Asthma is a significant health problem in the working-age population. 
Asthma incidence has been increasing during recent decades and no 
clear signs of levelling off can yet be detected (Anandan et al. 2010). 
The prevalence of asthma and asthma symptoms has increased especially 
in children and adolescents (Lai et al. 2009). A recent Finnish study 
reported a 9.4% asthma prevalence in adult Finnish population (Pal-
lasaho et al. 2011). Thus one can conclude that currently and in future 
a significant proportion of workers have asthma and need to cope with 
asthma during their career.
Over the past decades, work-related asthma has increasingly been 
recognised as a public health concern due to its high prevalence. Ac-
cording to the most recent systematic analysis approximately 18% of 
adult-onset asthma is estimated to be caused by occupational exposures 
(Toren et al. 2009a). In addition to being a cause of asthma, work can 
also aggravate pre-existing or new-onset asthma and approximately 20% 
of working asthmatics are suggested to have work aggravated asthma 
(Henneberger et al. 2011). Based on several earlier studies, there seems 
to be consensus that asthma is associated with decreased work ability. 
However, only a few longitudinal studies exist regarding the effect of 
asthma on work ability (Toren et al. 2009b).
Identifying several clinically and inflammatory different asthma 
phenotypes and their presentations in different population groups 
has recently increased the awareness of the variable characteristics of 
asthma (Pavord 2012). At population level most asthmatics have mild 
form of the disease, although an estimation of 5–10% proportion of 
severe asthma exists (Holgate et al. 2006). The distribution of asthma 
severity is, however, dependent on the population studied. Additionally, 
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the treatment options for asthma have evolved markedly during recent 
decades. In Finland inhaled corticosteroids have been extensively used as 
first line therapy for persistent asthma since the 1980’s and the National 
Asthma Programme has the aim of teaching primary care providers in 
the diagnosis and treatment of asthma (Haahtela et al. 2006). 
It can be assumed that most asthmatics currently have a relatively mild 
form of the disease with good treatment options which might only have 
a minor effect on work ability. Additionally asthma treatment can poten-
tially keep the disease stable in most cases despite exposure to irritants or 
asthmogens at work. This is likely to be especially true for asthma starting 
in childhood, because it is usually the atopic phenotype and generally 
milder than non-atopic adult-onset asthma (Moore et al. 2010). The 
Finnish Allergy Program encourages young people with severe asthma 
to avoid occupations with exposure to respiratory irritants, but gener-
ally, work as a fire fighter is the only explicit career restriction to those 
with mild asthma (Haahtela et al. 2012).There is a need for longitudinal 
studies about the effects of work on asthma starting at a young age in 
order to achieve evidence for vocational guidance for young asthmatics.
The present series of studies aimed to examine the prognosis and 
prognostic factors of asthma in men with asthma since childhood or 
early adulthood presenting mostly the early onset atopic asthma -phe-
notype. The more specific goals were to investigate work ability and the 
risk factors for decreased work ability as well as the associations between 
occupational exposure and asthma outcome. Recognising the modifi-
able risk factors of poor asthma outcome is important for decreasing the 
burden of asthma.
15
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2.1  Asthma
2.1.1	Definition
Asthma is a complex disorder with many distinct clinical phenotypes, 
which manifest in interaction of genetic predisposition and environ-
mental exposures. Until the 1980s bronchospasm was considered to 
be a key feature of asthma, but after that the increasing knowledge of 
airway inflammation has changed the definition of asthma. The current 
Global Initiative for Asthma (GINA) –report states that “Asthma is a 
chronic inflammatory disorder of the airways in which many cells and 
cellular elements play a role. The chronic inflammation is associated with 
airway hyperresponsiveness that leads to recurrent episodes of wheezing, 
breathlessness, chest tightness and coughing, particularly at night or in 
the early morning. These episodes are usually associated with widespread, 
but variable airflow obstruction within the lung that is often reversible 
either spontaneously or with treatment” (GINA 2012).
2.1.2 Pathogenesis of asthma
The key feature in asthma is a variable airway inflammation includ-
ing many different types of inflammatory cells and mediators (GINA 
2012). Cytokines, chemokines, cysteinyl leukotrienes, histamine, nitric 
oxide and prostaglandinD2 are identified to be important mediators of 
asthmatic inflammation. Airway inflammation leads to several patho-
physiological changes in airways typical for asthma, like thickening of 
the basement membrane, hypertrophy and hyperplasia of smooth muscle 
cells, blood vessel proliferation and increased number of goblet cells. 
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These changes are usually described as airway remodelling and can result 
to irreversible narrowing of the airways.
Asthmatic airway inflammation has been referred to be as eosinophilic 
inflammation, but during last two decades the awareness of the complex 
and variable nature of this inflammation has increased (Gibson 2009). 
Recently asthmatic inflammation has often been studied non-invasively 
using induced sputum samples. In healthy subjects, the cell count of 
these samples consists of approximately 2/3 of macrophages and 1/3 
neutrophils without the presence of significant numbers of eosinophils 
or lymphocytes. In asthmatics the following inflammatory cell profiles 
have been identified: 1) eosinophilic, 2) neutrophilic or non-eosinophilic, 
3) mixed granulocytic, and 4) paucigranulocytic; with normal levels of 
neutrophils and absent eosinophils (Haldar et al. 2007). As many as 25% 
of untreated symptomatic asthmatics (Green et al. 2002a) and 50% of 
those treated with high-dose inhaled corticosteroids (ICS) had a normal 
sputum eosinophil count (Gibson et al. 2001). In a recent study of 508 
asthmatics from the University Asthma Clinic 42% had eosinophilic, 
16% neutrophilic, 3% mixed granulocytic and 40% paucigranulocytic 
inflammation and use of ICS showed not significant effect on the inflam-
mation types (Schleich et al. 2013).
Eosinophilia is typically found in a classic atopic type of asthma 
with IgE-mediated sensitisation and most of these patients have a good 
response to ICS therapy (Pavord 2012). Neutrophilic inflammation in 
asthmatics has been connected to obesity (Haldar et al. 2007), smoking 
(Chalmers et al. 2001) and exposure to occupational low-molecular-
weight sensitizers (Anees et al. 2002), as well as to older age, female gender 
and poor response to ICS (Green et al. 2002a). Asthmatic patients with 
mixed granulocytic inflammation have been shown to have lowest lung 
function, increased daily symptoms and increased health care use (Hastie 
et al. 2010), while those with paucigranulocytic inflammation typically 
have well-controlled or intermittent disease (Haldar et al. 2007). The 
clinical phenotypes taking account inflammatory profiles from cluster 
approaches are described in chapter 2.1.4. 
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2.1.3  Clinical examinations in asthma
symptoms and clinical signs
The typical asthma symptoms are intermittent wheezing, chest tightness, 
shortness of breath, coughing and mucus production. The variability of 
these symptoms, their precipitation by factors such as exercise, cold air, 
allergens, viral respiratory infections or specific agents such as aspirin, 
form the basis of the clinical diagnosis of asthma. Furthermore the 
symptom relief using bronchodilators and ICS is characteristic to asthma 
(Asthma: Current Care guideline, 2012), although phenotypes with a 
poor response to conventional asthma therapies have been identified 
(Haldar et al. 2008). Patients with cough-variant asthma have a cough 
as the principal, if not only, asthma symptom and have typically more 
symptoms at night (Johnson et al. 1991).
Due to the variable characteristics of asthma, a physical examination 
of the respiratory system may be normal. The most usual abnormal 
finding is expiratory wheezing on lung auscultation, which however 
is sometimes detected only in forced expiration. In severe obstruction 
wheezing is sometimes missing, because of severely reduced air flow and 
ventilation (GINA 2012). 
Measurements of lung function
Spirometry is a physical test that measures how an individual inhales or 
exhales volumes of air as a function of time (Miller et al. 2005). The 
primary signal measured in spirometry may be volume or flow and several 
international guidelines have been created for conducting the measure-
ments (American Thoracic Society (ATS) 1987; ATS 1995; Miller et 
al. 2005). The variation of normal values in spirometry is large and the 
predicted values appropriate to the patient’s ethnic group, sex, age and 
height should be used. The predicted values of Viljanen are used for the 
adult subjects of Finnish origin (Viljanen 1982).
The most important parameters used and expressed in litres are: 1) 
forced vital capacity (FVC), the maximum volume of air exhaled with 
maximum forced effort from maximum inhalation and 2) forced expira-
tory volume in 1 second (FEV1), the maximum volume of air exhaled in 
the first second of forced expiration from a position of full inhalation. 
18
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The most useful assessment of airflow limitation is the ratio of FEV1 to 
FVC, which is normally 0.75–0.80 and can be 0.90 in children. The 
spirometric parameters mentioned above are usually expressed as absolute 
values and as a percentage of the predictive values. Spirometry is the 
recommended method of measuring airflow limitation and reversibility 
to establish a diagnosis of asthma (GINA 2012, Asthma: Current Care 
guideline, 2012). The term reversibility is generally applied to rapid 
improvements in FEV1 measured within minutes after inhalation of 
rapid-acting bronchodilatator for example salbutamol 200–400µg.
Mean forced expiratory flow between 25 and 75% of the FVC 
(FEF25–75%) and forced expiratory flow rate at 50% of vital capacity 
(FEF50%) are the spirometric variables most commonly cited as indicators 
of small airways obstruction, although they have been criticised as hav-
ing a marked measurement variability and poor correlation with other 
measures of air trapping (Sorkness et al. 2008), which is an important 
feature observed in small airway disease. The other methods used to detect 
small airways obstruction include impulse oscillometry, nitrogen wash-
out test, bronchoscopy, sputum induction, fractional exhaled nitric oxide 
and high-resolution computed tomography (van der Wiel et al. 2013). 
Peak Expiratory Flow (PEF)-monitoring is performed by using a port-
able meter in a home setting in order to measure day-to-day variability of 
airflow limitation. The measurements are done first after waking in the 
morning, when values are typically at their lowest, and in the evening. 
Usually the measurements are also taken before and few minutes after 
bronchodilatator medication. The diurnal variation can be defined as 
the difference between daily maximum and minimum values expressed 
as % of the daily mean value (GINA 2012).
Airway hyperresponsiveness
Airway hyperresponsiveness is a major pathophysiological feature of 
asthma and can be defined as “an increase in the ease and degree of air-
way narrowing to inhaled bronchoconstrictor stimuli of chemical and 
physical origin, leading to variability in airway obstruction” (Sterk et al. 
1993). Bronchoconstrictor stimuli are classified according to the main 
mechanism through which they induce airway limitation. Direct stimuli 
such as histamine and methacholine act directly on bronchial smooth 
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muscle, while indirect stimuli such as exercise, mannitol or eucapnic 
hyperventilation induce the release of bronchoconstriction mediators 
from inflammatory cells (Sterk et al. 1993). The pathophysiology of 
airways hyperresponsiveness measured with these two methods differs. 
In the direct bronchial provocation test the response is suggested to be 
dependent on both underlying inflammation and/or presence of airway 
remodelling; while in the indirect bronchial provocation test the pres-
ence of inflammation (e.g. eosinophils, mast cells) is a key feature for 
the response (Brannan et al. 2012). In steroid-naïve asthma patients 
the response to indirect stimuli has been connected to markers of eo-
sinophilic inflammation; increased levels of sputum eosinophilia and 
fractional exhaled nitric oxide measurements (FENO) (Porsbjerg et al. 
2008). Therefore it has been postulated that airway hyperresponsiveness 
to indirect stimuli could be used to identify asthma patients benefitting 
from ICS therapy (Brannan et al. 2012). This has been supported by the 
impairment of mannitol induced hyperreactivity and asthma symptoms 
during ICS therapy (Brannan et al. 2002; Koskela et al. 2003).
The direct challenge test has been shown to be more sensitive and 
less specific in diagnosing asthma when compared with the indirect 
challenge test (Cockcroft 2010). Additionally the positive predictive 
value of metacholine challenge in diagnosing asthma has been shown to 
increase as the degree of airways hyperresponsiveness is greater (e.g. the 
provocative dose of metacholine causing a 20% fall in FEV1 is lower). 
However airway hyperresponsiveness is not specific to asthma and up 
to 70% of subjects with airway hyperresponsiveness have been found to 
be without respiratory symptoms (Kolnaar et al. 1997). 
Measuring	airway	inflammation
The non-invasive methods used to measure airway inflammation in asthma 
are FENO and examination of spontaneously produced or hypertonic-
saline induced sputum analysis. Levels of exhaled nitric oxide have shown 
to be elevated in people with untreated asthma compared to non-asthmatic 
subjects and sputum analyses have shown eosinophilic or neutrophilic 
inflammation in asthmatics. Although these findings are not specific to 
asthma both FENO and sputum analysis can be useful in evaluating the 
optimal treatment for asthma (Green et al. 2002b; Smith et al. 2005).
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establishing asthma diagnosis
Despite the important role of airway inflammation in asthma patho-
genesis and treatment, according to current international (GINA 2012) 
and the Finnish national guidelines (Asthma: Current Care guideline, 
2012) the diagnosis of asthma is based on observing reversible airflow 
obstruction. According to GINA guidelines the diagnosis of asthma can 
be confirmed in patients having typical symptoms by demonstrating: 
1) the improvement of ≥ 12% and 200ml in FEV1 in response to bro-
chodilator in spirometry, 2) the improvement of ≥ 20% and 60l/min in 
PEF in response to bronchodilator or diurnal variation ≥ 20% in PEF or 
3) showing hyperresponsiveness in direct or indirect airway challenges. 
2.1.4		Classification
Phenotypes
There is increasing awareness of heterogeneity of asthma and also the 
overlapping of asthma with chronic bronchitis and emphysema (Weath-
erall et al. 2009). Recent reviews have highlighted the importance of 
different asthma phenotypes, their natural history and varying treat-
ment responses (Wenzel 2006). Allergic and non-allergic asthma are 
probably the most common discussed phenotypes. The former means 
asthma related to atopy e.g. presence of positive skin prick tests or the 
clinical response to common environmental allergens, while nonallergic 
asthma manifests without atopy. Other phenotypes have been defined 
by clinical or physiological categories (i.e. severity, age of onset and 
chronic airflow obstruction), asthma triggers (i.e. exercise, allergens, 
occupational allergens and irritants) or the type of inflammation (eo-
sinophilic or neutrophilic asthma) (Wenzel 2006). Due to the variability 
of asthma, these phenotypes may not be enough to classify asthma. In a 
recent adult study the populations of two large epidemiological studies 
were included and using a clustering approach four different phenotypes 
were identified “active treated allergic childhood-onset asthma”, “active 
treated adult-onset asthma”, “inactive/mild untreated allergic asthma” 
and “inactive/mild untreated non-allergic asthma” (Siroux et al. 2011). 
The pattern of granulocyte inflammation in induced sputum samples 
combined with clinical features can be used to identify different inflam-
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matory phenotypes of asthma (Pavord 2012). This type of characteri-
zation seems to be relevant due to the increasing evidence of different 
treatment responses of these phenotypes (Green et al. 2002a). Using 
cluster analyses Haldar et al (Haldar et al. 2008) identified in study 
populations of primary and secondary care five different phenotypes: 
“early symptom predominant”, “obese female non-eosinophilic”, “early 
onset atopic asthma”, “benign asthma” and “inflammation predominant”. 
“Early symptom dominant” and “obese female non-eosinophilic” asthma 
had high symptom expression but little evidence of eosinophilic inflam-
mation; therefore consideration of down titration of ICS was suggested. 
In contrast “early onset atopic” and “benign asthma” phenotypes showed 
concordance between symptoms, inflammation and lung function and 
the authors suggested symptom based treatment titration to be probably 
suitable. Patients with “inflammation predominant” asthma tended to 
be males and had high prevalence of rhinosinusitis, nasal polyps, aspirin 
sensitivity and despite prominent eosinophilic inflammation relatively 
few symptoms. The targeting of corticosteroids by monitoring inflam-
mation was thought be useful. 
In severe disease with poor treatment response the distinction between 
asthma and COPD can be challenging because of shared causal factors. 
Therefore, the suggestion of moving the focus from diagnostic labelling 
to the analysis of main mechanism and individual phenotype in order 
to find most effective phenotype-specific treatment exists (Pavord 2012).
severity
The definition of asthma severity has evolved during recent years (Taylor 
et al. 2008a). In the severity evaluation it is important to include both 
the severity of underlying disease and its response to treatment. Asthma 
severity is not a static phenomenon, but can change over months and 
years. Asthma severity may be influenced by the underlying disease 
activity and by the asthma phenotype.
In the 1995 GINA guidelines, overall asthma severity was assessed 
on the basis of the patient’s clinical characteristics prior to commenc-
ing therapy (GINA 1995). The 2002 version of the GINA guidelines 
classified asthma relying on three dimensions: 1) perceived symptoms, 
2) lung function and 3) type of asthma treatment (Global Intiative for 
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Asthma (GINA) 2002). In this classification the clinical severity is clas-
sified in 1 of 4 steps according to the frequency of nocturnal and diurnal 
symptoms and FEV1% predicted. Treatment is classified in 1 of 4 steps 
according to the reported daily medication use. Final asthma severity is 
a composition of these two independent classifications. The following 
categories were used: intermittent, mild persistent, moderate persistent 
and severe persistent. 
According to the current GINA guidelines asthma severity is clas-
sified on the basis of intensity of treatment required to achieve good 
asthma control (GINA 2012). Mild asthma is asthma that can be well 
controlled with low-dose inhaled corticosteroids or leucotriene modi-
fiers or chromones. Severe asthma is asthma that requires high inten-
sity treatment to maintain good control or where good control is not 
achieved despite of high intensity treatment. This classification suits 
poorly to population based studies, where a portion of the asthmatics 
are untreated, undertreated or overtreated. Additionally asthma severity 
is highly dependent on the steroid response, which is usually poor in 
neutrophilic asthma (Green et al. 2002a). It has been postulated, that 
when phenotype-specific treatment becomes available some asthmatics 
currently classified as having severe disease might be changed to the mild 
asthma category (GINA 2012). 
In a Swedish study multi-symptom asthma was defined as having 
reported physician-diagnosed asthma, use of asthma medication, recur-
rent wheeze, attacks of shortness of breath and at least one additional 
respiratory symptom (Ekerljung et al. 2011). As multi-symptom asthma 
was related to signs of more severe disease – lower FEV1% predicted 
higher FENO and more pronounced hyperresponsiveness – it was sug-
gested as a useful epidemiological marker of asthma severity. Eisner et al 
validated another score called the severity of asthma score, which is based 
on a validated disease-specific questionnaire that addresses frequency of 
asthma symptoms, use of systemic corticosteroids, use of other asthma 
medications, and history of hospitalisation/intubation for asthma (Eis-
ner et al. 2012). The severity score of asthma demonstrated an ability to 
predict asthma exacerbations better than the asthma control test (ACT) 
and FEV1 in moderate to severe asthma for example.
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Control
The 1995 GINA guidelines already introduced the concept of the 
medication required to maintain control (GINA 1995). This was further 
developed by Cockcroft and Swystun, who established asthma severity by 
the minimum treatment required to maintain asthma control (Cockcroft 
et al. 1996). The aim of asthma medication is to achieve and maintain 
control for prolonged periods. Assessment of asthma control should 
incorporate both current clinical control (e.g. symptoms, reliever use 
and lung function) and future risk (e.g. exacerbations, lung function 
decline and side-effects of medication) (Taylor et al. 2008a; Reddel et 
al. 2009; GINA 2012). 
However there is no golden standard in the measurement of asthma 
control (Reddel et al. 2009). According to current GINA classification, 
subjects having daytime symptoms less than three times a week and/
or need of rescue medication, no nocturnal symptoms or limitation of 
activities and PEF/FEV1 ≥ 80% or personal best are considered to have 
currently clinically controlled asthma (GINA 2012). Asthma is consid-
ered to be partly controlled if 1 or 2 of the above features are absent and 
uncontrolled if more than 2 features are absent. Assessment of current 
asthma control should preferably be conducted over a four week period. 
Several validated self-administered questionnaires are available to 
measure current asthma control. ACT is a widely used questionnaire, 
which assesses key components of asthma control over the previous 4 
weeks with five items: shortness of breath, interference of activity, use of 
rescue medications, night time awakenings and patient rating of asthma 
control (Nathan et al. 2004). The ACT scale ranges from 5 to 25, with 
higher scores indicating better asthma control and subjects scoring less 
than 20 are considered to have poorly controlled asthma. The ACT has 
been validated against specialist rating of asthma control and spirometry 
(Nathan et al. 2004; Schatz et al. 2006). The ACT result cannot, however, 
been changed directly to GINA guidelines based asthma control classifica-
tion. The Asthma Therapy Assessment Questionnaire is a four-item ques-
tionnaire about asthma symptoms during the previous 4 weeks (Vollmer 
et al. 1999). In the Asthma Control Questionnaire, FEV1% predicted 
is included in a six-item questionnaire about asthma symptoms during 
the previous week (Juniper et al. 1999). The Asthma Control Scoring 
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System includes FEV1 values and induced sputum eosinophilic count 
in addition to asthma symptoms, use of rescue medication and effects 
on activities in the evaluation of asthma control (Boulet et al. 2002).
2.1.5  Asthma medication
Based on the current international (GINA 2012) and Finnish guidelines 
(Asthma: Current Care guideline, 2012) the goal of asthma treatment 
is to achieve and maintain clinical control. Based on GINA 2012 the 
treatment is increased or decreased in steps and can be divided into 
controllers (ICS, oral corticosteroids, leukotriene modifiers, long-acting 
β2–agonists, theophylline, cromones and anti-IgE) and relievers (short 
acting β2–agonists and inhaled anticholinergics). Finnish guidelines 
include long-acting anticholinergics to the controllers in adults, while 
cromones are not included. ICS are the most effective controller therapy 
and they are recommended to be used on daily bases in persistent asthma, 
although some subjects with mild disease might achieve good control 
with leukotriene modifiers. ICS has shown to be effective in reducing 
asthma symptoms, decreasing airway hyperresponsiveness, controlling 
airway inflammation and reducing exacerbations (Juniper et al. 1990). 
Improved deposition of ICS to peripheral airways is achieved with new 
small particle size inhalers, which are theoretically benefitting patients 
with evidence of small airway disease (Barnes 2012). 
Based on GINA 2012 if asthma is poorly controlled with a low dose 
of ICS another controller medication, usually leukotriene modifier or 
long-acting β2–agonists, is added or the dose of ICS is increased to a 
moderate level. In the next step a third controller therapy is added or the 
dose of ICS is increased to a high level. A low dose of oral corticosteroids 
is recommended regularly, if asthma is severely uncontrolled with high 
dose ICS in combination with several other control therapies. Anti-IgE is 
a novel therapy for severe allergic asthma patients with high-level serum 
total IgE and uncontrolled disease on ICS.
Recently the role of this “one-size-fits-all” type therapy has been de-
bated (Pavord 2012). Pavord (2012) suggested that phenotype specific 
treatment, requiring evaluation of mechanisms of mortality, would be 
beneficial for patients with more complex disease. In neutrophilic asthma 
treatment approaches has not been investigated extensively, but aggressive 
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therapy with ICS is unlikely to be helpful (Green et al. 2002a). Simpson 
reported reduced neutrophilic inflammation and better quality of life in 
response to long-term macrolide antibiotics, although no effect on symp-
toms or lung function was detected (Simpson et al. 2008). Macrolides 
have an anti-inflammatory effect and several non-antibiotic macrolides 
are now in development (Barnes 2012). In addition several new mediator 
specific blockers, including IL-5, IL-13, IL-9, and prostaglandin D2 are 
in clinical trials and might be beneficial to asthma patients.
2.2  epidemiology in working age
2.2.1  Prevalence
Asthma is the most common chronic respiratory disease in the world and 
approximately 300 million people in the world currently have asthma 
(Bahadori et al. 2009). Lack of a golden standard for defining asthma in 
epidemiological studies makes the evaluation of asthma prevalence and 
incidence a challenge. As Anderson stated “The reliable assessment of 
the trend in asthma prevalence requires repeated cross-sectional studies 
on different occasions on the same population using the same methods 
to define asthma. Unfortunately only very few studies with these char-
acteristics are available” (Anderson 2005).
In questionnaire studies, both questions about asthma symptoms and 
physician diagnosed asthma have been used, however the prevalence rates 
based on these data are highly dependent on the awareness of asthma in 
the population studied (Eder et al. 2006). In 1992, Toelle et al showed 
that a combination of bronchial hyperresponsiveness and recent wheez-
ing (in the 12 months prior to study) identified subjects having more 
severe asthma and concluded this definition to be useful in measuring 
the prevalence of clinically important asthma in populations (Toelle et 
al. 1992). The question about physician-diagnosed asthma has yielded 
high specificity, but rather low sensitivity (mean 68%), when validated 
with clinically verified asthma (Toren et al. 1993). Airway hyperrespon-
siveness also has high specificity (about 80%), but low sensitivity (below 
50%) (Peat et al. 2001). Questions on asthma related symptoms have 
been shown to attain a better combination of sensitivity and specificity 
(Pekkanen et al. 1999). 
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The prevalence of asthma increased worldwide in the second half of 
the last century until the 1990s, but since then there has been no clear 
temporal pattern (Eder et al. 2006). Some studies suggest a stabilising 
or even decreasing prevalence of asthma (Chinn et al. 2004; Lotvall et 
al. 2009), while others suggest that it is still increasing (Anandan et al. 
2010; Gershon et al. 2010). The recent systematic review of epidemio-
logical studies found no overall signs of reduction of asthma prevalence; 
on the contrary an increasing prevalence in many parts of the world was 
suggested (Anandan et al. 2010). However the utilisation of emergency 
healthcare is reported to be reduced in some economically developed 
countries, most probably due to an improvement in the quality of care. 
De Marco et al reported an increase in median prevalence of current 
asthma from 4.1% to 6.6% in Italian young adults in 1991–2010 (de 
Marco et al. 2012). The prevalence of asthma was stable during the nine-
ties and increased from 1998–2000 to 2007–2010 mainly in subjects 
who did not report allergic rhinitis.
Asthma prevalence has increased in Finland during recent decades. 
In 1980, the prevalence of asthma was 4.1% in the urban population 
and 2.7% in the rural population (Heinonen et al. 1987). In 1996, a 
postal questionnaire survey performed in southern Finland showed a 
non-response adjusted asthma prevalence of 4.4% among adults aged 
18–65 years (Hedman et al. 1999). The FinEsS study from northern 
Finland reported asthma prevalence of 6.0% in adults aged 20–69 years 
based on the question regarding physician-diagnosed asthma (Kotaniemi 
et al. 2002). In the same study, asthma prevalence was 6.8% in 1996 
and 9.4% in 2007 in the Helsinki area (Pallasaho et al. 1999; Pallasaho 
et al. 2011). 
Asthma prevalence among young Finnish men recruited to military 
service remained steady between 0.02% and 0.08% from 1926 to 1961, 
while from 1961 to 1989 20-fold increase was shown (Haahtela et al. 
1990). Latvala et al showed a further increase with no signs levelling off 
and a prevalence of 3.45% was reached in 2003 (Latvala et al. 2005). By 
contrast, the trends of disabelling asthma turned downwards. 
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2.2.2  Incidence
The different definitions of asthma and different methods used make the 
comparison of incidence rates in different studies difficult. In the 16–50 
years old Swedish general population the incidence rate was 1.1/1000/
year (Toren et al. 1999a), while in the Danish twin study of young 
adults it was 5.5./1000/year (Thomsen et al. 2005). In the European 
Community Respiratory Health survey (ECRHS) 4588 young adults 
(20–44 years old) who were free from asthma at baseline in 1990–1995 
were followed for 9 years (Anto et al. 2010). The incidence rate of new-
onset asthma was 4.5 per 1000 person-years
Karjalainen et al reported incidence rates of 1.65/1000/year for men 
and 2.47/1000/year for women in Finland in a large follow-up cohort of 
nearly 50 000 incident cases of asthma in 1986–1998, which were iden-
tified from national registers for reimbursement of asthma medication 
and occupational diseases (Karjalainen et al. 2001). This compensation is 
given only to persons fulfilling strict diagnostic criteria, which probably 
has led to underestimation of real asthma incidence. In the FinEsS study 
inhabitants of Helsinki aged between 20 and 69 years were followed for 
11 years with the questionnaire and the reported incidence rate ranged 
from 2.5 to 3.7/1000/year depending on how the population at risk was 
defined (Pallasaho et al. 2011). 
2.2.3  etiology
Asthma in working-age population may have persisted from childhood, 
may have occurred as a relapse of earlier childhood asthma or may be 
true adult-onset of asthma without symptoms in earlier life. Therefore 
etiological factors of both childhood-onset and adult-onset asthma need 
to be taken into account. Both host related factors (eg. genes, gender 
and obesity) and environmental factors influence the development of 
asthma in a complex and interactive way.
Host related factors
Family and twin studies have indicated that genetics plays an important 
role in the development of asthma and allergy, likely through several 
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genes of moderate effect (Willemsen et al. 2008). Although a positive 
family history predicts an increased risk of asthma, it has been shown 
only to identify a minority of children at risk (Burke et al. 2003). In the 
ECRHS, young adults reporting maternal asthma had 1.91-fold risk of 
new-onset asthma. (Anto et al. 2010). 
Gender affects the development of asthma in time-dependent manner 
(Almqvist et al. 2008). Asthma is far more common in boys than girls 
during early childhood. The prevalence equalises between the genders 
during adolescence and then switches to a female predominance in 
adulthood. In a recent report by the ECRHS, the follow-up of young 
adults without asthma at baseline showed a higher incidence of asthma 
in women than in men (Odds ratio, OR 1.97, 95% Confidence inter-
val, 95%CI 1.38–2.81) (Anto et al. 2010). Atopy is strongly associated 
with asthma, especially with asthma starting at a young age (Sears et 
al. 1991; Thomsen et al. 2006). The role of atopy seems more unclear 
in new-onset asthma in adults and the possible overestimation of its 
meaning has been argued (Pearce et al. 1999). In the ECRHS, only one 
in five cases of new-onset asthma was estimated to be attributable of 
atopy (Anto et al. 2010). Allergic rhinitis has shown to increase asthma 
risk in adults (Anto et al. 2010; Pallasaho et al. 2011), as well as aspirin 
intolerance and nasal polyposis (Hedman et al. 1999). In a recent study 
chronic rhinosinusitis without nasal allergies was associated with late-onset 
asthma (Jarvis et al. 2011). Bronchial hyperresponsiveness and FEV1 < 
100% predicted increased significantly the risk of new-onset asthma in 
the ECRHS (Anto et al. 2010). 
There is increasing evidence relating to subjects that are overweight 
and obese and the prevalence and incidence of asthma in both adults (Sin 
et al. 2008) and children (Chu et al. 2009), although most consistently 
in adolescent girls (Ho et al. 2011). It is considered to be unlikely that 
the association is attributable to a reverse causation – that is, asthma 
causes reduced physical exercise and weight gain (Schaub et al. 2005).
environmental factors
Environmental factors play also important role in the development of 
asthma. According to a meta-analysis parental smoking is concluded 
to be very likely causally related to childhood asthma (Strachan et al. 
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1998). In another meta-analysis it was concluded that exposure to passive 
smoking increases the incidence of wheeze and asthma in children and 
young people by at least 20% and that particularly prenatal and post-
natal maternal smoking is associated with increased asthma risk (Burke 
et al. 2012). A number of studies have also shown that active smoking is 
associated with the onset of asthma in adolescents and adults (Strachan 
et al. 1996; Withers et al. 1998; Piipari et al. 2004). 
The exposure to evident indoor moulds or dampness in children and 
adults is associated with asthma onset and asthma exacerbations. The 
evidence of causal relationship is however lacking except for asthma ex-
acerbations in children (Mendell et al. 2011). The relationship between 
exposure to indoor and outdoor allergens as well as air pollution and the 
asthma onset is unclear (Anto 2012). The role of occupational exposures 
is described in chapter 2.3 
The role of respiratory tract infections in the development of asthma 
is still poorly understood (Rosenthal et al. 2010), although physicians 
have long recognised an association between common respiratory tract 
illnesses and the onset and worsening of wheeze and asthma. 
The role of diet and particularly that of breast feeding in the onset of 
asthma has been widely studied. As the effect of breast feeding is mostly 
limited to early childhood wheezing disease, it is not referred to here. 
The evidence of a causal relationship between asthma and other dietary 
intake is still poor (McKeever et al. 2004; Eder et al. 2006). There is ac-
cumulating evidence that vitamin D deficiency is related to an increased 
risk of asthma, but on-going clinical trials need to show the protective 
effect of vitamin D supplementation on asthma prevalence (Paul et al. 
2012). Interestingly, vitamin D sufficiency has also been associated with 
improved lung function in ICS treated children with asthma (Wu et al. 
2012). A recent study demonstrated the association between prevalence of 
asthma, rhinoconjuctivitis and eczema symptoms and the consumption 
of fast food in children and adolescents (Ellwood et al. 2013). 
2.2.4 Prognosis of asthma
The natural history of asthma is still poorly known and measuring asthma 
prognosis in a population-based framework is challenging and not well 
established. The methods used are the evaluation of asthma remission, 
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severity and control as well as occurrence of severe asthma and lung 
function measurements. The use of asthma medication, mortality, hos-
pitalisation rate, emergency visits, doctor visits and work disability due 
to asthma have been used as markers of asthma prognosis for example 
in community-based educational programmes (Haahtela et al. 2006). 
The age at which patients with asthma die does not differ from the 
population as whole and death is usually caused by the same diseases as 
the general population (Silverstein et al. 1994). However older adults 
with asthma die of respiratory diseases more often than individuals in 
the general population.
Remission
There is no universally accepted definition for asthma remission. Most 
studies include the absence of respiratory symptoms and asthma medi-
cation use (De Marco et al. 2002), whereas others also include normal 
lung function and/or absence of airway hyperresponsiveness (Vonk et al. 
2004; Spahn et al. 2008). The time period without asthma symptoms 
and asthma medication required for asthma remission has varied from 
one to three years in different studies (Ronmark et al. 1999; van den 
Toorn et al. 2001; Vonk et al. 2004; Spahn et al. 2008). Several different 
definitions of asthma remission used and different populations studied 
(children/young adults/older adults) may partly explain the varying 
results between studies on asthma remission. One can also argue that 
the basis of asthma diagnosis significantly affects the remission rates.
In unselected population-based or preselected cohorts the propor-
tion of subjects with childhood asthma being in remission varies from 
10–70% (Spahn et al. 2008). The longest longitudinal study of the 
natural history of asthma was completed in Australia using a 1957 birth 
cohort of 30 000 children. Only 30% of the children with an asthma 
diagnosis at the age of 7 years were free of wheezing at the age of 42 years 
(Phelan et al. 2002). Vonk et al followed a cohort of 119 children with 
asthma over a period of 30 years and found that 22% of the cohort was 
in complete remission and 30% in clinical remission (Vonk et al. 2004). 
The latter was defined as having no wheeze or asthma exacerbations or 
use of ICS during last three years. Normal lung function and absence 
of airways hyperresponsiveness were additional criteria for complete 
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remission. In another follow-up cohort of 613 children with wheezing 
at baseline, 25% were shown to be in remission at 26 years of age (Sears 
et al. 2003).
In a cross-sectional study of young Italian adults, remission was 
defined as no asthma attacks during the previous 2 years and no use of 
asthma drugs during the previous 12 months (De Marco et al. 2002). 
Overall 45.8% of the subjects were in remission (41.6% of women and 
49.5% of men). In the RHINE study, the young adult population of 
Northern Europe was studied and a remission rate of 20.2 per 1000 
person years was found, i.e. about 20% of the subjects recovered from 
their asthma during a 10-year period (Holm et al. 2007). In the Swed-
ish population based study of middle-aged and older subjects, asthma 
remission during the 10 year period under study was only 6% (Ronmark 
et al. 1999).
Quitting smoking (Ronmark et al. 1999; Holm et al. 2007), having 
mild disease (Panhuysen et al. 1997; Ronmark et al. 1999; de Marco 
et al. 2006; Holm et al. 2007), shorter duration of disease (De Marco 
et al. 2002), and in children male sex (Sears et al. 2003) and normal 
lung function (Sears et al. 2003; Vonk et al. 2004) have been shown to 
predict asthma remission. In the studies of young adults, the earlier age 
of asthma onset has been associated with asthma remission (Panhuysen 
et al. 1997; De Marco et al. 2002) and a reverse association with change 
in body mass index, BMI has also been found (de Marco et al. 2006).
Asthma severity
As described earlier in chapter 2.1.4 the evaluation of asthma severity in 
population-based studies has been mainly based on different versions of 
GINA guidelines or self-made scores of specific researches. 
In the first survey of ECRHS I asthma was classified as mild, mod-
erate or severe based on score derived from Ronchetti (Ronchetti et al. 
1997) and FEV1 of predicted values (Zureik et al. 2002). Of the 1132 
subjects 50% had mild asthma, 29% had moderate asthma and 21% 
had severe asthma. In the cross-sectional part of second survey about 
30% of subjects suffered from moderate-to-severe asthma (Cazzoletti 
et al. 2010). In the prospective part of second survey (ECRHS II) 856 
young adults having asthma were followed for 9 years and then asthma 
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severity was evaluated based on the 2002 GINA classification (GINA 
2002). At the end of the follow-up 11.9% of the subjects were in remis-
sion (no symptoms, no exacerbations, no asthma medications in the last 
year), and 45.3% had intermittent, 8.1% had mild persistent, 16.7% 
moderate persistent and 18.0% severe persistent asthma (de Marco et al. 
2006). The similar distribution of asthma severity has also been reported 
by other authors (Porpodis et al. 2009).
In the cross-sectional ECRHS I and II studies sensitisation to moulds 
(Alternaria alternata or Cladosporium herbarum) associated with severe 
asthma (Zureik et al. 2002; Cazzoletti et al. 2010). Associations between 
persistent asthma and sensitization to house dust mite, nonseasonal 
asthma, an older age at asthma onset, and chronic cough and phlegm were 
also reported, while sensitisation to cat was related to severe asthma only 
(Cazzoletti et al. 2010). In the prospective part of ECRHS II participants 
with moderate or severe persistent asthma at follow-up were compared 
with those having intermittent asthma. Poorer FEV1% predicted, a poorer 
symptom control, higher IgE levels and a higher prevalence of chronic 
cough/mucus hypersecretion at baseline predicted moderate or severe 
persistent asthma (de Marco et al. 2006). No gender difference in asthma 
severity has been found in ECRHs studies (Raherison et al. 2009).
In birth cohort studies smoking, airway hyperresponsiveness, female 
sex, atopy and a decreased FEV1/FVC ratio in young adults predict 
persistence of asthma in older age (Sears et al. 2003; Taylor et al. 2005). 
In a Swedish study the prevalence of multi-symptom asthma was 2.0% 
and it was more common among females and in the obese (Ekerljung 
et al. 2011). 
Asthma control
Asthma control reflects to the extent to which the various asthma 
manifestations can be reduced by treatment. The definition of asthma 
control is described in details 2.1.4. Although poor asthma control may 
be due to underlying severe disease or resistance to therapy, it is far more 
frequently due to poor compliance, poor inhaler technique, smoking or 
allergen exposure (Taylor et al. 2008a).
Only 10% of asthmatics were found to have asthma under control 
in the study of young adult population of Italy carried out between 
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1998 and 2000 (de Marco et al. 2003). At the beginning of 2000s in a 
worldwide survey including countries in North America, Europe and 
Asia current asthma control was also evaluated to be poor and the use 
of preventive medication to be low (Rabe et al. 2004). In another web-
based survey 1812 patients were assessed, of whom 45% had controlled 
asthma and 55% uncontrolled asthma based on the score of the ACT 
(Peters et al. 2007). In this study all subjects had physician-diagnosed 
asthma for at least 1 year and were receiving multiple controller medi-
cations. In ECRHS II the distribution of asthma control was evaluated 
in a population-based setting with 1042 adult asthmatics. Overall 32% 
of asthmatics had completely controlled asthma, 36% partly controlled 
and 32% uncontrolled (Cazzoletti et al. 2007). This probably reflects the 
severity of the underlying disease which was more often uncontrolled 
among the subjects using ICS during last year: only 15% of them had 
controlled asthma, 49% had uncontrolled asthma and 36% partly con-
trolled asthma. Uncontrolled asthma was also more common among 
ICS users in a French case-control and family study of asthma (Siroux et 
al. 2009). A total of 27.6% of ICS users had controlled, 35.0% partly-
controlled and 37.4% uncontrolled asthma compared with non-ICS 
users having proportions of 60.0%, 23.9% and 16.1%, respectively.
Being a smoker, female and having a BMI greater than 30 kg/m2 
seem to be independent determinants of poor asthma control (Laforest 
et al. 2006) as well as long-term exposure to air pollution (Jacquemin 
et al. 2011). Additionally, a chronic cough and phlegm (Cazzoletti et al. 
2007; Siroux et al. 2009), being female (Siroux et al. 2009), overweight 
(Cazzoletti et al. 2007) and having sensitisation to Cladosporium (Caz-
zoletti et al. 2007) have associated with poor asthma control in subjects 
using ICS. The reported risk factors of non-ICS users for poor asthma 
control have been partly different including high total IgE (Cazzoletti 
et al. 2007; Siroux et al. 2009), non-seasonal asthma (Cazzoletti et al. 
2007), sensitisation to moulds (Siroux et al. 2009) and chronic cough 
and phlegm (Cazzoletti et al. 2007).
occurrence of severe refractory asthma 
Based on the WHO consultation severe asthma, includes three groups: 
(1) untreated severe asthma, (2) difficult-to-treat severe asthma, and (3) 
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treatment-resistant severe asthma (Bousquet et al. 2010). The last group 
includes asthma for which control is not achieved despite the highest 
level of recommended treatment and asthma for which control can be 
maintained only with the highest level of recommended treatment. 
This type of asthma is also called severe refractory asthma (Chanez et 
al. 2007). Bell et al suggested the step approach in which a person with 
uncontrolled asthma and/or at least two exacerbations during the past 
12 months is firstly identified (Bel et al. 2011). Then it is confirmed 
that each of the following aspect is fulfilled: prescription of high dose 
ICS, confirmed asthma diagnosis, correct use of inhalers and asthma 
education received, good compliance with asthma treatment, excluding/
controlling exposure to sensitising and non-sensitising substances at work 
and at home, discontinuing drugs that may cause bronchoconstriction, 
optimal treatment of co-morbidities, and reassessing the patient after 
at least 6 months follow-up. After these steps the diagnosis of severe 
refractory asthma can be established. 
The prevalence of severe asthma is poorly known partly due to the 
variation in definitions. However, it is estimated that 5% to 10% of 
the population with asthma has symptomatic disease despite maximum 
recommended treatment with combinations of anti-inflammatory and 
bronchodilator drugs (Holgate et al. 2006). Typical characteristics of 
these subjects are the occurrence of frequent exacerbations, low baseline 
lung function, reliance on high dose corticosteroids and near daily symp-
toms. Subjects having severe refractory asthma represent a heterogeneous 
group of asthmatics, some of whom have a more severe form of allergic 
asthma, whereas many others do not. The risk factors identified for 
severe asthma are female gender, neutrophilic inflammation and being 
less atopic (ENFUMOSA 2003) as well as reporting less family history 
of allergy (Gaga et al. 2005). 
Loss of lung function
Airway remodelling caused by chronic inflammation may lead to ir-
reversible loss of lung function in asthma. This can be measured with 
spirometry by detecting persistent airflow limitation, usually defined by 
a low FEV1, FEV1/vital capacity or FEV1/FVC of predicted after bron-
chodilatator administration, or increased loss of FEV1. Persistent airflow 
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limitation is a sign of more severe disease and a predictor of mortality in 
the asthmatic population (Panizza et al. 2006). 
Several investigations found that asthma is associated with increased 
decline in lung function (Peat et al. 1987; Ulrik et al. 1994; Phelan et 
al. 2002; Rasmussen et al. 2002; Sears et al. 2003). For example; Peat 
et al found that the average rate of decline in FEV1 was 50ml/year in 
non-smoking asthmatics compared with 35ml/year in non-smoking 
non-asthmatic men (Peat et al. 1987). Data of the Childhood Asthma 
Management Programme suggested that about 25% of asthmatic chil-
dren had a persistent decline in lung function that was not impacted by 
corticosteroid therapy (Covar et al. 2004). The irreversible loss of lung 
function seems to start already in childhood (Rasmussen et al. 2002). 
Risk factors for progressive loss of lung function in patients with 
asthma include smoking (Ulrik 1999), adult onset (Ulrik 1999; ten 
Brinke et al. 2001), asthma severity (ten Brinke et al. 2001), BMI gain 
(Marcon et al. 2009), occurrence of severe asthma exacerbations (O’Byrne 
et al. 2009a) increased reversibility of obstruction (Ulrik 1999), increased 
numbers of airway eosinophils (Ulrik 1999; ten Brinke et al. 2001) and 
airway hyperresponsiveness (Ulrik 1999; ten Brinke et al. 2001). 
As ICS are the first line therapy for persistent asthma, their effect on 
loss of lung function has been widely studied (Dijkstra et al. 2006; Lange 
et al. 2006; de Marco et al. 2007; O’Byrne et al. 2009b). The conclu-
sions of these studies are that treatment with ICS may possibly decrease 
the rate of FEV1 decline in asthma although there are no randomised 
double blinded studies that really prove such an effect.
2.3  Impact of work on asthma
2.3.1  Risk of asthma due to occupational factors
evaluation of occupational risk of asthma
The literature in this field has methodological variability in several aspects. 
Firstly, the definition of asthma differs widely and can be based on report-
ing asthma symptoms or doctor diagnosed asthma in a questionnaire or 
on a clinically verified disease. 
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Secondly, the evaluation of occupational exposure varies. Large popu-
lation samples are achieved with register studies, but the data on occupa-
tions is restricted to job titles and work tasks and exposures cannot be 
evaluated in detail (Karjalainen et al. 2001). Additionally, smoking data 
is often lacking and control of this important confounder is not satisfac-
tory. In more specific (case-control or cohort) studies the work tasks and 
occupational exposure as well as smoking habits can be evaluated in detail, 
but participation rate varies and lack of power is a common problem 
due to a small number of subjects having worked in a certain occupation 
or having been exposed to a specific agent. Job Exposure Matrix (JEM) 
allows for the generation of more detailed exposure information from 
job title related information in large population based studies. During 
the last decade the use of JEM has gained increased support due to its 
relatively unbiased way to assess occupational exposure (Kennedy et al. 
2000). The principals of JEM are described in a later section (2.5.2); 
briefly, JEM estimates the probable exposure to asthma inducing agents 
based on job titles and more detailed information on work tasks. 
Thirdly, the type of population studied has effect on the associations 
between work and asthma. To illustrate some of the above methodologi-
cal variability one can observe the asthma risk in painting or lacquering 
in different studies. In a large Finnish register based study, painting or 
lacquering work was associated with an approximate 2-fold risk with 
narrow confidence intervals (OR 1.92, 95%CI 1.70–2.17), but due to 
the job title based approach the authors could not evaluate the specific 
risk in spray painting (Karjalainen et al. 2001). The cross-sectional part of 
the ECRHS also showed an approximate 2-fold risk of clinically verified 
asthma among other painters (OR 2.34, 95%CI 1.04–5.28) and spray 
painters (OR 1.96, 95%CI 0.72–5.34), but both risk estimates had rather 
wide confidence intervals (Kogevinas et al. 1999). In the Spanish part of 
the ERCHS spray painters had an 8-fold risk of asthma, however without 
statistical significance (OR 8.01, 95%CI 0.65–99.02) (Kogevinas et al. 
1996). A recent Swedish study showed a significantly increased asthma 
risk among male spray painters (OR 7.5, 95%CI 2.4–24.1) (Lillienberg 
et al. 2012). A higher risk among spray painters than other painters looks 
plausible when taking into account that spray painters are exposed to 
high levels of a respiratory sensitising chemical group, di-isocyanates, 
which are known to increase asthma risk (Lillienberg et al. 2012).
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Calculating population attributable factor 
The population attributable fraction (PAF) measures the fraction of 
disease cases that are attributable to exposure in a population and that 
would not have been observed if the exposure had been non-existent. 
The PAF quantifies the proportion of disease that can be attributed to a 
certain risk factor and is a critical measure of the adverse public health 
impact of that risk factor (Levin 1953; Northridge 1995; Nurminen et 
al. 2001; Steenland et al. 2006). The PAF can be calculated as follows:
PAF% = Prevalence exp(RR–1)/[1+ Prevalence exp (RR–1)]. 
RR is the risk ratio or rate ratio (whichever measure was estimated) for 
the exposed Prevalence exp is the proportion of exposed in the popula-
tion. As far as occupational factors are concerned, the fractions refer to 
the working aged population only, i.e. adult onset asthma.
Other terms like attributable risk/fraction or population attributable 
risk are sometimes also used, but in the chapters below PAF is used.
PAf due to workplace environment
In a review about 43 published citations from 1966 to 1999, the median 
value for the PAF of occupational exposure in asthma was 9% overall 
and 15% based on the 12 highest scored studies (Blanc et al. 1999b). 
A few years after this the American Society Statement carried out the 
critical synthesis of population-based literature on this field (Balmes et 
al. 2003). All published articles before January 2000 that include PAF 
calculations or presented data from which PAF could be calculated were 
analysed. The reported or calculated PAF range from 4% to 58% and 
had the median value of 15%. Accordingly to a recent systematic analy-
sis including both earlier studies and articles from 1999 to December 
2007 about 18% of adult-onset asthma is estimated to be caused by the 
workplace environment (Toren et al. 2009a).
In the prospective part of the ECRHS 6837 subjects without asthma 
were followed up for approximately 9 years. Asthma was assessed by 
methacholine challenge test and by questionnaire data on asthma 
symptoms or medication. The PAF for occupational exposures ranged 
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from 10–25% in cases of new-onset of asthma. The PAF was highest in 
southern Europe (23%) and lower in central (12%) and northern parts 
of Europe (6%) (Kogevinas et al. 2007). In the large Canadian general 
population study the PAF for adult-onset of asthma in high risk jobs 
and exposure was 18.2% (Johnson et al. 2000).
PAf in nordic studies
In the RHINE study over 13 000 people from seven different areas 
in Denmark, Iceland, Norway, Estonia and Sweden were followed up 
from 1989–1992 to 1999–2001 (Lillienberg et al. 2012). Based on 
the questionnaire data, 429 new-onset cases of asthma occurred and 
asthma incidence was 1.3 cases per 1000 person-years for men and 
2.4 for women. PAF for the proportion of new-onset of asthma due to 
exposure to agents at the workplace causing asthma was 14% for men 
and 7% for women.
The study basis of the Karjalainen et al study covered the entire 
population aged 25–59 year in Finland between 1986 and 1998. Their 
occupations were classified and the onset of asthma was followed-up. 
Altogether 49 575 incident cases of asthma were recognised from the 
Medication Reimbursement Register of National Health Insurance 
and Finnish Register of Occupational Disease (FROD). To obtain the 
reimbursement rights objective data on reversible bronchial obstruction 
and the typical symptoms of persistent asthma need to be demonstrated. 
The detailed criteria of these rights have varied during past decades, in 
2001 at least one of the following physiological criteria were applied: 1) 
a diurnal variation of ≥ 20% in PEF, 2) an increase of ≥ 15% in PEF or 
FEV1 with β2-agonist, 3) a decrease of ≥ 15% in PEF or FEV1 in exercise 
test. Additionally regular use of asthma medication had to last at least 
6 months. The FROD is explained in detail in chapter 2.3.3). The PAF 
of occupation was as high as 29% for men and 17% for women (Kar-
jalainen et al. 2001). However in this study the authors were not able to 
make adjustments with smoking status at an individual level, although 
occupation-specific aggregate data on smoking were used to estimate 
confounding by smoking.
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occupations with increased asthma risk
In the Spanish part of the ERCHS a study, population selected randomly 
from five different areas was evaluated firstly with questionnaire and 
later with clinical tests (Kogevinas et al. 1996). The participation rate 
in clinical tests was only 41% from the selected population. Cleaners 
(OR 2.53, 95%CI 1.03–6.20) and laboratory technicians (OR 9.29, 
95%CI 3.28–26.2) had a significantly increased risk for clinically verified 
asthma. Welders, painters excluding spray painters, construction workers 
or miners and housewives showed a significantly increased asthma risk 
for asthma symptoms or use of asthma medication. 
In the first part of the ECRHS the data of 15 637 people aged 
20–44, randomly selected from the general population of 26 areas in 12 
industrial countries was assessed in 1989–1992. Asthma was diagnosed 
by the metacholine challenge test and by questionnaire data on respira-
tory symptoms and use of asthma medication. Significantly increased 
asthma risk was shown in farmers (OR 2.62, 95%CI 1.29–5.35), painters 
(OR 2.34, 95%CI 1.04–5.28), cleaners (OR 1.97, 95%CI 1.33–2.92) 
and agricultural workers (OR 1.79, 95%CI 1.02–3.16). In the second 
part of the ECRHS, the highest occupational risks included nursing, 
cleaning, spray painting, baking and agriculture as well as exposure to 
high-molecular-weight agents, low-molecular-weight agents and irritants 
increased the asthma risk (Kogevinas et al. 2007). 
A French study including over 14 000 adults found associations be-
tween asthma and specific jobs, such as personal care workers, waiters, 
and stock clerks were observed, with age-, sex-, and smoking-adjusted 
ORs between 1.5 and 1.7 (Le Moual et al. 2004). In a Canadian study 
nursing, clerical and food preparation associated most commonly with 
work-related asthma (Johnson et al. 2000). In the National Health Inter-
view Survey 2001 over 20 000 currently employed adults in the popula-
tion of the United States of America reported an association between 
working in printing/publishing industries and health care and asthma 
were found in whites. In blacks, significant associations were related to 
furniture/lumber/wood and entertainment/recreation industries (Bang 
et al. 2005). 
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occupations with increased asthma risk in nordic studies
In a Swedish nested case-referent study the asthma diagnosis based on 
reporting physician diagnosed asthma or asthma symptoms in a ques-
tionnaire (Toren et al. 1999b). The highest OR for physician diagnosed 
asthma was associated with exposure to flour dust (OR 2.8, 95%CI 
1.5–5.2) and occupational handling of paints containing isocyanates 
(OR 3.0, 95%CI 1.6–5.9). Exposure to welding fumes, textile dust, and 
work with glues containing acrylates was also associated with an increased 
OR for “physician-diagnosed” asthma. In another case-control, study 
increased risks of asthma associated with exposure to welding fumes (OR 
2.0, 95%CI 15–3.4), man-made mineral fibres (OR 2.6, 95%CI 1.4–7.3) 
and solvents (OR 2.2, 95%CI 1.2–3.2). In a large questionnaire study 
of a randomly selected population, over 18 000 subjects in west Sweden, 
occupational exposure to dust or fumes associated with new-onset of 
asthma (Hazard ratio, HR 1.8, 95%CI 1.4–2.3) (Toren et al. 2011). 
In the Rhine Study occupations with highest risk of asthma among 
men were spray-painters (OR 7.5, 95%CI 2.4–24.1), plumbers/pipe 
fitters (OR 4.0, 95%CI 1.6–10.0), food and tobacco processing work-
ers (OR 2.7, 95%CI 0.97–7.3), cleaners/building caretakers (OR 2.6, 
95%CI 1.1–5.9) and child and other personal care work (OR 2.5, 95%CI 
1.0–6.3) (Lillienberg et al. 2012). Among women cleaner/building care-
takers (OR 1.9, 95%CI 1.2–3.0) and drivers (OR 3.7, 95%CI 1.2–11.6) 
had significantly increased asthma risk. Based on JEM, men exposed to 
plant-associated antigens, epoxy chemicals, di-isocyantes, cleaning agents 
and accidental peaks to irritants had significantly increased asthma risk. 
Additionally non-atopic men exposed to acrylates and women exposed 
to cleaning agents showed increased asthma risk.
In a large Finnish Register based study, Karjalainen et al reported 
increased asthma risks especially in occupations related to agriculture (RR 
2.1, 95%CI 2.0–2.3 in men and RR 1.8, 95%CI 1.8–1.9 in women), 
mining (RR 2.0, 95%CI 1.6–2.4 in men, RR 1.0, 95%CI 0.3–4.0 in 
women), manufacturing (RR 1.6, 95%CI 1.5–1.7 in men and RR 1.3, 
95%CI 1.3–1.4 in women), and service work (RR 1.5, 95%CI 1.4–1.7 
in men and RR 1.4, 95%CI 1.4–1.5 in women) (Karjalainen et al. 2001). 
In the extended analyses of this same material Karjalainen et al used a 
more detailed level of occupational classification (three digit) (Karjalainen 
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et al. 2002). A significantly increased risk was found for either men or 
women in 125 occupations. For the men, the risk was highest among 
bakers, laundry workers, shoemakers and repairers, tanners, fellmon-
gers and pelt dressers, and metal plating and coating workers. For the 
women, the risk was highest among shoemakers and repairers, railway 
and station personnel, jewellery engravers, engine room crew, moulders, 
round-timber workers and bakers. In a case-control study of 521 cases 
of new-onset of asthma from Tampere region, significantly increased 
asthma risk was reported among men in metal work (OR 4.52, 95%CI 
2.35–8.70) and among female waitresses (OR 3.03, 95%CI 1.10–8.31) 
(Jaakkola et al. 2003).
Table 1 lists occupations that have frequently been associated with 
an increased asthma risk.
Table 1. Some occupations with increased risk of asthma
Occupation References
Baking or other food 
processing or beverage 
work
(Kogevinas et al. 1996; Kogevinas et al. 1999; 
Johnson et al. 2000; Karjalainen et al. 2001; 
Jaakkola et al. 2003; Kogevinas et al. 2007; 
Lillienberg et al. 2012)
Agriculture, farming or 
forestry work
(Kogevinas et al. 1996; Kogevinas et al. 1999; 
Karjalainen et al. 2001; Kogevinas et al. 2007)
Cleaning/building 
caretaking
(Kogevinas et al. 1999; Karjalainen et al. 2001; 
Kogevinas et al. 2007; Lillienberg et al. 2012)
Spray painting or painting (Kogevinas et al. 1996; Kogevinas et al. 1999; 
Karjalainen et al. 2001; Kogevinas et al. 2007; 
Lillienberg et al. 2012)
Nursing or other health care (Johnson et al. 2000; Bang et al. 2005; Kogevinas 
et al. 2007)
Chemical processing (Johnson et al. 2000; Karjalainen et al. 2001; 
Jaakkola et al. 2003)
Plastic working (Kogevinas et al. 1999; Jaakkola et al. 2003)
Metal working (Karjalainen et al. 2001; Jaakkola et al. 2003)
Woodwork (Karjalainen et al. 2001; Bang et al. 2005)
Child and other personal 
care
(Le Moual et al. 2004; Lillienberg et al. 2012)
Waitressing (Jaakkola et al. 2003; Le Moual et al. 2004)
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the role of high-level exposure of irritants in the onset  
of asthma
Several epidemiological studies provide evidence on the impact of single 
or multiple high-level exposures to irritants in the initiation of asthma. 
In the Swedish study of sulphite workers asthma incidence was nearly 
6-fold among males reporting sulphur dioxide gas exposure compared 
to unexposed males (Andersson et al. 2006). In another study bleacher 
workers exposed to ozone had an increased risk of physician diagnosed 
asthma and wheezing attacks (Henneberger et al. 2005). In the ECRHS 
II inhalation accidents, such as fire, mixing cleaning products, or chemical 
spills were associated with a 3.3-fold increased risk of new-onset asthma 
(Kogevinas et al. 2007). 
2.3.2		Definitions	of	work	related	asthma,	
occupational asthma and work-aggravated 
asthma
In the previous chapter the work-related risk of asthma was assessed at 
population level. When looking at the same relation at individual level, 
important conceptual definitions need to be made. The evidence-based 
guidelines give the following definitions: “Asthma is work-related when 
there is an association between symptoms and work” (Nicholson et 
al. 2010). The different types of work-related asthma should be dis-
tinguished since the implications for the worker and the occupational 
health management of the disease differ. Work-related asthma includes 
two distinct categories:
1. “occupational asthma (OA), i.e. asthma induced by exposure in the 
work environment to airborne dust, vapours or fumes, in workers 
with or without pre-existing asthma”
2. “work-exacerbated asthma (WEA), i.e. pre-existing or coincidental 
new-onset adult asthma which is made worse by non-specific factors 
in the workplace e.g. cold, dry air, dust and fumes”
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2.3.3 occupational asthma
Occupational asthma can be subdivided into sensitiser-induced and 
irritant-induced OA. A latency period between first exposure to a res-
piratory sensitizer at work and the development of allergy symptoms 
is characteristic to sensitiser-induced OA. Irritant-induced OA occurs 
typically within few hours of a high concentration exposure to an irritant 
gas, fume or vapour at work (Tarlo et al. 2008; Nicholson et al. 2010). 
There is increasing epidemiological evidence for the relationship between 
multiple exposures to irritants and the onset of asthma and it has been 
postulated, that this type of asthma could be an occupational disease. 
However the diagnostic criteria on individual level are not established 
(Tarlo et al. 2008; Dykewicz 2009).
Over 400 agents have been identified to cause OA (www.asthme.csst.
qc.ca) and many new agents are reported each year. Agents that cause 
allergic OA can be divided in two groups according to their molecu-
lar weight: high molecular (HMW) and low molecular weight agents 
(LMW) (Malo et al. 2009). The most typical HMW agents causing OA 
are cereals and flours, animal epithelium, latex and enzymes. Virtually 
all proteins of animal or plant origins are capable to cause IgE-mediated 
sensitisation, rhinoconjuctivitis and asthma. LMW agents causing OA 
include, e.g. anhydrides, di-isocyantes, metals, disinfecting agents, co-
lophony used as a flux in electronic industry. The commonest agents 
causing irritant induced OA are chlorine and ammonium, but many 
other agents have also been implicated (Tarlo et al. 2008).
Based on the recent evidence-based report atopy is considered to in-
crease risk of developing OA caused by exposure to many HMW-agents 
(Nicholson et al. 2010). Cigarette smoking can increase the risk of OA 
with some sensitising agents, while occupational rhinitis is considered 
to be a co-morbidity factor with OA. In a study of Karjalainen occu-
pational rhinitis increased the risk of asthma nearly 5-fold (Karjalainen 
et al. 2003).
Clinical, functional and pathophysiological alterations are consid-
ered to be similar in OA and non-OA (Bernstein et al. 2006). HMW 
and some LMW agents typically induce Th2 cytokine/ IgE mediated 
inflammation, while some other chemicals (isocyanates, methacrylates) 
are considered to induce asthma through immunological mechanisms 
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that may be independent of classical IgE-mediated pathway. In a study 
of Anees et al of 38 workers with OA caused by LMW agents only 37% 
had sputum eosinophilia (Anees et al. 2002). The mechanisms of irritant 
induced asthma are poorly understood. It has been speculated that the 
inhalation of high-level irritant may cause bronchial epitehelium dam-
age which could induce the loss of its protective function (Lemiere et 
al. 1997).
diagnosis and management
Partly due to different legislation for compensation of occupational dis-
eases, the diagnostic practices vary worldwide. In sensitiser induced OA 
commonly used diagnostic tests include proving sensitisation, peak flow 
recording at work and at home, changes in hyperreactivity and specific 
inhalation challenge test (SIC) (Tarlo et al. 2008; Nicholson et al. 2010; 
Lindstrom et al. 2011; Suojalehto et al. 2011). The last mentioned test 
is considered to be a golden standard for diagnosing OA to a specific 
sensitiser. SIC is an expensive and time consuming test and false nega-
tives as well as severe asthmatics or anaphylactic reactions are possible 
(Vandenplas et al. 2012). Therefore, the use of SIC is restricted to a few 
centres (approximately 30 centres in Europe, personal information by 
Hille Suojalehto) and in many countries the diagnosis of OA is based 
on the other diagnostic tests mentioned above and/or typical pattern 
of disease. 
In Finland OA entitles workers to a relatively generous compensation 
including the re-training costs, when it is required. Therefore a reliable 
diagnosis OA is needed and SIC is commonly used. However, in the 
recent recommendation of the Finnish Expert Group on Occupational 
Lung Diseases it was concluded that OA can be diagnosed without SIC, 
when there is a typical pattern of disease, asthma has been proven, clear 
sensitisation to a relevant occupational agent is shown and PEF recording 
at work and at home is typical for OA (Suojalehto et al. 2011).
Based on the recent European Respiratory Society Task Force Report 
the best treatment option for OA is ceasing exposure to the causative 
agent (Baur et al. 2012). If it is not possible, reduction of exposure is the 
second best option, whereas respirators are of limited value. 
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Incidence and causes
There are differences between the reporting schemes for occupational dis-
eases and National Registers are lacking in many countries (Bakerly et al. 
2008). Additionally heterogeneity in definition, diagnostic approaches, 
legislation, and compensation of OA exists. Therefore the comparison 
of incidence of OA in different countries is a challenge. There are only 
few studies showing the incidence rates at population level. 
In Catalonia, both compulsory and voluntary reporting systems have 
been used and the latter proved to be more efficient (Orriols et al. 2006). 
Based on the voluntary reporting scheme the annual rate of OA was 
77.2 cases/million persons in 2002 and the most frequent causes were 
isocyanates, persulphates and cleaning products. In the West Midlands, 
UK, a voluntary reporting scheme by physicians has been used and 
the annual incidence of OA was 42 per million working population in 
1991–2005 (Bakerly et al. 2008). Welders and occupations related to 
health care were the two most frequently reported occupations with OA, 
while isocyanates were the most common causative agents.
In Sweden registration has been based on employees’ own reports and 
the overall annual rate of OA was 91/million for men and 70/million for 
women in 1990–1992 (Toren 1996). The highest rates among men were 
working as bakers, furnace men and welders and among female chemi-
cal and plastic production workers and poultry and dairy farm workers.
finnish Register of occupational disease
Reporting all known or suspected cases of occupational diseases to labour 
protective authorities is compulsory for Finnish physicians. These reports 
and complementary data from insurance companies are collected in the 
FROD. Due to changes in communication arrangements and principles 
regarding compensation, the data for 2005 onward is comparable, but it 
should not compared directly with earlier FROD data. Since 2005 the 
numbers of suspected cases and those verified by an insurance company 
have been presented separately. 
Using the FROD data, Karjalainen et al reported 2602 incident 
cases of OA between 1989 and 1995 and an annual incidence rate of 
174/million employed workers (Karjalainen et al. 2000). The incidence 
46
2 Literature review 
rate was the highest in bakers, other painters and lacquerers, veterinary 
surgeons, chemical workers, farmers, animal husbandry workers, other 
food manufacturing workers, welders, plastic product workers, butchers 
and sausage makers, and floor layers. Cases caused by animal epithelia, 
hairs and secretions or flours, grains, and fodders accounted for 60% of 
the total. Piipari et al reported the decreased trend of OA cases starting 
between 1995–1998 and indoor molds becoming the most common 
causative agent in 2002 (Piipari et al. 2005). 
The numbers suspected and verified OA cases and their propor-
tions of estimated new asthma cases of the total working population in 
2005–2010 are presented in table 2. The estimation of incident asthma 
cases is based on the annual incidence rate of the general population 
study of Helsinki area, (Pallasaho et al. 2011), while the total workforce 
is nationwide and non-employed individuals are not included. Therefore 
the data should be interpreted with caution. Nevertheless, 5–8% of the 
new asthma cases of the working population seem to have suspicion of 
OA and only 1–2% of the cases are verified to OA by worker’s compensa-
tion scheme. As approximately 18% of adult-onset asthma is estimated 
to be caused by occupational exposures (Toren et al. 2009a), one might 
conclude that only about one in ten of those cases is getting individual 
level confirmation and compensation for occupational disease based on 
the Finnish practices. In the recent reports of the FROD the highest OA 
figures were notified in the food industry and agricultural occupations 
(Oksa et al. 2009; Oksa et al. 2010). The most common causes of OA 
were indoor moulds, flour, grain and animal feed as well as animal epi-
thelia, hair and extracts. The most common chemicals causing asthma 
were cosmetics substances, resins, plastics and di-isocyanates.
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Table 2. Number of suspected and verified occupational asthma 
cases in 2005–2010 and their proportions of estimated new asthma 
cases of the total working population based on the data of Finnish 
Register of Occupational Disease 
 
Year Total 
working 
population
(n)
Estimated 
incident 
asthma 
cases
(n)*
Suspected
OA cases
(n)
Suspected
OA cases
%**
Verified
OA cases
(n)
Verified
OA cases
%**
2005 2400811 8883 499 5.6 143 1.6
2006 2443477 9041 523 5.8 145 1.6
2007 2491638 9219 551 6.0 116 1.3
2008 2530898 9364 612 6.5 120 1.3
2009 2457265 9092 679 7.5 152 1.7
2010 2447482 9056 708 7.8 102 1.1
* = The estimation is based on the annual incidence rate of 3.7/1000 persons 
(Pallasaho et al. 2011) and the number of total working population
** = of the number of estimated incident asthma cases in total working population
2.3.4 Work-exacerbated asthma
WEA is defined as “pre-existing or concurrent asthma that is worsened 
by workplace conditions” (Henneberger et al. 2011). Based on the recent 
ATS Statement, the following four criteria can be used in both clinical 
and research settings to identify the subjects with WEA:
1. Presence of pre-existing or concurrent asthma
2. Temporal relationship between exacerbation of asthma and work
3. Conditions exists at work that can exacerbate asthma
4. OA is unlikely
Prevalence 
In most population-based studies of WEA both asthma diagnosis and 
the presence of WEA are based on self-reports. Some of the studies 
report a prevalence of WEA as a percentage of working adults with 
asthma (Mancuso et al. 2003; Saarinen et al. 2003; Bolen et al. 2007) 
and some as a percentage of all adults with asthma (Blanc et al. 1999a; 
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Henneberger et al. 2002). In some of the studies both of these parameters 
were presented (Henneberger et al. 2003; Henneberger et al. 2006). In 
the twelve general population-based studies referred in the ATS state-
ment the prevalence of WEA ranged from 13% to 58% with a median 
21.5% (Henneberger et al. 2011). 
In the study of over 1400 asthma cases enrolled in Health Maintenance 
Organization of United States, 25% of the responders reported their 
current work environment as having a worsening effect on their asthma 
(Henneberger et al. 2002). In a population-based questionnaire study by 
the State of Maine only 64 asthma cases were identified and 25% of these 
subjects reported worsening of asthma symptoms at work (Henneberger 
et al. 2003). In a third study by Henneberger et al 557 working partici-
pants with asthma based on the medical record data were identified from 
a register held by the Health Maintenance Organization (Henneberger 
et al. 2006). The occurrence of WEA was based on self-reports of work 
aggravated symptoms and expert judgment that a participant was likely 
exposed to asthmogenic agents at work. A total of 23% of all asthmatics 
and 24% of working asthmatics fulfilled the criteria of WEA.
In a Brazilian birth cohort study of young adults, the ECRHS ques-
tionnaire was used and 227 cases of clinically verified asthma were iden-
tified (Caldeira et al. 2006). Based on the personal interview 81(32%) 
cases of work-related asthma were found. Johnson et al. reported an 
18% prevalence of WEA in currently employed adult asthmatics in the 
Australian general population (Johnson et al. 2006).
nordic studies
Blanc reported in the Swedish part of the ECRHS that 61 (38%) sub-
jects from 160 participants with clinically verified asthma reported chest 
tightness at work (Blanc et al. 1999a). 
In the Finnish population-based survey the asthma cases were identi-
fied from the Medication Reimbursement Register of National Health 
Insurance and work related asthma symptoms were evaluated with the 
questionnaire (Saarinen et al. 2003). A total of 21% of the currently 
employed 969 respondents reported work-aggravated asthma symptoms 
at least weekly during the past month. 
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Causes
Those with WEA have been reported to be less educated (Henneberger 
et al. 2002; Caldeira et al. 2006). One study reported an increased risk 
in current or ex-smokers and males (Henneberger et al. 2002), while 
these associations were not present in the large Finnish study (Saarinen 
et al. 2003), in which the prevalence of those with WEA increased by 
age. WEA has also been associated with self-reported more severe asthma 
(Henneberger et al. 2002) and recent asthma symptoms (Henneberger 
et al. 2006). 
The proportion of WEA of all asthma cases has been reported to 
be highest in service work (Goe et al. 2004), mining and construction 
(Henneberger et al. 2002), sales work (Henneberger et al. 2002; Goe et 
al. 2004), and administration (Henneberger et al. 2002; Goe et al. 2004).
WEA is often associated with irritant exposures (Tarlo et al. 1995; 
Saarinen et al. 2003; Goe et al. 2004) and second-hand tobacco smoke 
(Tarlo et al. 1995; Berger et al. 2006). In the Saarinen study, the preva-
lence of those with work-aggravated symptoms increased by self-reported 
occupational exposure to dust, abnormal temperatures or poor indoor 
air quality, physically strenuous work and expert-evaluated probability 
of daily occupational exposure to airborne dust, gases or fumes (Saarinen 
et al. 2003). Lemiere et al compared occupational exposure in OA and 
WEA in the patients of tertiary care clinic and demonstrated that those 
53 patients with WEA were exposed to ammonia, engine exhaust fumes, 
silica, mineral fibres, aerosol propellants and solvents significantly more 
often than the 68 OA cases (Lemiere et al. 2012).
Clinical characteristics
There are only a few studies available. PEF recording at work and at home 
showed a typical pattern in only about half of the WEA cases (Chiry et al. 
2007). The risk of asthma exacerbations was increased when compared to 
subjects with non-work related asthma both in WEA and in OA (Lemiere 
et al. 2007). Vandeplas et al reported that 61% of 105 WEA patients from 
a tertiary care hospital had nasal symptoms (Vandenplas et al. 2010). 
In a prospective observational survey with a 2-year follow-up 53 WEA, 
68 OA and 33 subjects with non-work related asthma were evaluated 
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(Lemiere et al. 2013). The authors collected baseline data on the visit 
to the tertiary medical clinic and follow-up data based on the provin-
cial administrative databases. WEA was associated with more frequent 
prescriptions of inhaled corticosteroids, a noneosinophilic phenotype, 
a trend toward a lower FEV1 and a higher proportion of smokers than 
the diagnosis of OA. Both OA and WEA were associated with greater 
health care use and 10-fold higher costs related to outpatient clinical 
visits, emergency department visits and hospitalisations than non-work 
related asthma.
2.3.5  severity and occurrence of exacerbations
There is conflicting data on the influence of occupational exposure on 
asthma severity. Gaga et al. found that a larger proportion of severe 
asthma patients reported symptoms at work or changes of jobs, while 
exposure at work to gas, dust or fumes did not differ compared with 
the group of subjects with mild asthma (Gaga et al. 2005). LeMoual et 
al studied 228 controls without asthma and 148 asthmatics including 
78 severe and 70 mild asthma cases (Le Moual et al. 2005). JEM based 
exposure to HMW-agents (OR 3.7, 95%CI 1.3–11.1), LMW-agents 
(OR 4.4, 95%CI 1.9–10.1), including industrial cleaning agents (OR 
7.2, 95%CI 1.3–39.9) and mixed environmental agents (OR 7.5, 95%CI 
2.4–23.5) was significantly associated with more severe adult-onset 
asthma, although confidence intervals were broad due to a small number 
of asthmatics. In childhood-onset asthma, exposure to asthmogens was 
not associated with asthma severity.
In the prospective part of the ECRHS with 966 working adults with 
asthma, Hennenberger et al defined asthma exacerbation as unplanned 
care for asthma in the past 12 months (Henneberger et al. 2010). High 
dust, gas and fumes exposure was associated of a 3-fold risk of exacer-
bations (RR 3.1, 95%CI 1.9–5.1). Based on this RR, the population 
attributable risk was 14.7% among workers with current asthma and 
a total of one in seven asthma exacerbations was estimated to be of oc-
cupational origin. 
In a Swedish general population based study of approximately 1700 
participants with asthma, 24% of the asthmatics had multi-symptom 
asthma (Ekerljung et al. 2011). Work-related exposure to gas, dust and 
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fumes was linked to multi-symptom asthma, which was considered to 
be a sign of more severe asthma.
2.3.6  Healthy worker effect
“The healthy worker effect (HWE) is the potential bias caused by the 
phenomenon that sicker individuals may choose work environments in 
which exposures are low; they may be excluded from recruitment, or once 
hired; they may seek transfer to less exposed jobs or leave work” (Li et al. 
1999). This bias has been well described in occupational mortality studies
The HWE leads to the less healthy worker leaving work during follow-
up. HWE has proved to be a more important bias for diseases appearing 
at young age, presenting early symptoms and having a short period of 
latency between exposure and symptoms (Chen et al. 1996). Therefore 
asthma is potentially a disease, in which HWE plays an important role. 
Le Moual stated that “Controlling of this bias needs prospective studies 
including dynamic cohorts, which can enter the study population, when 
they are hired and are followed even after they leave employment” (Le 
Moual et al. 2008). The time-varying exposure and its relation to asthma 
related factors need to be well documented.
In a follow-up study of Israeli military conscripts, job changes were 
seen among the asthmatics more frequently than among the controls, 
especially among those with a more severe form of the disease (Kivity et 
al. 1995). In the ECRHS study, the respondents with asthma manifest-
ing before completion of full-time education were at a decreased risk of 
having jobs with high risk of asthma or exposure to dust, gases or fumes 
(Olivieri et al. 2010). It was concluded that having asthma prior to enter-
ing the workforce may affect a person’s career path. Whether this choice 
was done prior or after full-time education could not be determined. In 
contrast, a French follow-up study of asthma cohort suggested a healthy 
worker hire effect in subjects with more severe or symptomatic asthma 
in childhood, because these subjects were less likely to be exposed to the 
asthmogens in their first job (Dumas et al. 2011).
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2.4  Work ability
2.4.1		Conceptual	framework	and	definition
The diversity of work ability makes its evaluation and definition a chal-
lenge (Gould et al. 2008). One basic question in evaluating work ability 
is the perspective from which it is evaluated. The evaluation of work 
ability can be thus based on the person’s own view or it can be made by 
health care or social insurance professionals. Determining work ability 
solely according to objective criteria or expert evaluation is problematic, 
due to the complex nature of the concept. In fact, subjective estimations 
have proved to be a good predictor of future work ability or disability 
(Ilmarinen et al. 1997). Cessation of employment and disability pension 
are the most severe consequences of reduced work ability. Temporary sick 
leave, change of employer, job or work tasks and reduced self-assessed 
work ability are more common and have an impact on work productiv-
ity. Furthermore a high rate of sickness absenteeism has been shown to 
increase the risk of job termination and unemployment among women 
in temporary public sector jobs (Virtanen et al. 2006). 
Health and work are the main determinants of work ability. Work 
related factors, such as work tasks, work conditions, occupational roles 
and an organisation’s values can influence a person’s work ability. Worker’s 
physical and mental capacity, occupational skills and general skills are 
also important factors. The variation of work ability by age is wide and 
younger people perceive their work ability to be much better than older 
people, while men and women have no significant differences in their 
self-estimated work ability (Gould et al 2008). In the Finnish Health 
2000 survey clear difference in perceived work ability were found between 
five different educational groups (higher academic, higher vocational, 
secondary, upper basic and basic education) and the level of work ability 
increased as the level of education increased.
2.4.2 Asthma and work ability
Based on the current knowledge asthma is associated with decreased work 
ability, although the outcomes as well as populations studied are highly 
variable. Only few longitudinal studies on the effect of asthma on work 
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ability exist (Blanc et al. 1993; Thaon et al. 2008; Kauppi et al. 2010; 
Hakola et al. 2011), especially those based on the general population 
(Toren et al. 2009b). Table 3 summarises some studies about asthma 
and work ability.
Labour	force	participation,	disability	pension
In a population survey of adults in Northern California aged 18–50 year 
those with asthma were more likely to have no labour force participa-
tion after diagnosis (OR 3.0, 95%CI 1.1–7.7) and less likely to report 
decreased job effectiveness among those remaining employed (OR 0.4, 
95%CI 0.2–0.9) compared with the rhinitis group (Blanc et al. 2001). 
Yelin et al reported in another U.S. population based study an elevated 
risk of leaving work prior to age 65 among persons with COPD, asthma 
or rhinitis (Yelin et al. 2006). Thanon et al. followed-up from 1990 to 
1995 over 10 000 of working aged participants including 398 subjects 
with asthma (Thaon et al. 2008). In 1995, current adult-onset asthmat-
ics had stopped working due to disability more frequently than never-
asthmatics. In a study of 465 subjects with severe asthma 14% reported 
having left the workforce due to asthma and among those being currently 
employed 38% reported partial asthma-related work disability (Eisner 
et al. 2006). 
Based on the study of the Finnish National Asthma Programme in 
1993, 7212 patients of working age (9% of 80 133 asthmatics) received 
a disability pension from the Social Insurance Institution compared with 
1741 in 2003 (1.5% of 116 067 asthmatics) (Haahtela et al. 2006). 
In a study of 2332 asthmatic and 66 354 non-asthmatic public sector 
employees in Finland asthma increased the risk of all long-term work 
disability causes with HR 1.8 (95%CI 1.62–2.09) compared to controls 
without asthma (Hakola et al. 2011). Asthma accompanied with another 
chronic disease increased the risk 2.2-fold (95%CI 1.8–2.8) and with 
two or more other chronic conditions 4.5-fold (95%CI 3.0–6.8). Asthma 
and depression increased the risk with HR 3.6 (95%CI 2.6–5.0), and 
the risk was especially high for permanent work disability (HR 6.8, 
95%CI 4.6–10.2).
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Change of job due to respiratory symptoms
Change of job due to work-related respiratory symptoms was reported 
to be common among persons with asthma in two asthma outpatient 
clinic studies (Blanc et al. 1993; Blanc et al. 1996), in two cross-sectional 
general-population studies (Blanc et al. 1999a; Blanc et al. 2003) and in 
a prospective study (Toren et al. 2009b).
In the Swedish part of the ECRHS, 4% of the total study population 
and 13% of those 350 participants with asthma reported a job change or 
work loss due to breathing affected by a job (Blanc et al. 1999a). In the 
cross-sectional part of ERCHS, 4% of the total population and 11% of 
the participants with asthma or chronic bronchitis reported a job change 
due to breathing difficulties at work (Blanc et al. 2003). Occupations 
with a high risk of asthma and self-reported job exposure to vapours, 
gases, dust, or fumes (VGDF) were associated with reduced work abil-
ity in both these studies, while self-reported exposure to environmental 
tobacco smoke at work showed an association only in the Swedish part 
of the ECRHS study.
In the prospective part of the ECRHS, data from 11 European 
countries and 1 centre in the U.S was evaluated (Toren et al. 2009b). 
There were 6659 randomly sampled controls and 779 subjects reporting 
physician-diagnosed asthma at baseline and the mean follow-up time 
was 9 years. The incidence rate of job change due to breathing problems 
was 1.2/1000 person-years of observation in the random sample (95%CI 
1.0–1.5) and 5.7/1000 person-years in the asthma cohort (95%CI 
4.1–7.8). In the asthma cohort, female sex (HR 2.8, 95%CI 1.3–5.9) 
and high occupational exposure to biological dust, mineral dust or gases 
or fumes predicted increased risk of job changes.
Murgia et al. demonstrated that a change of job or work task due to 
respiratory problems was common among pulp mill workers (Murgia 
et al. 2011). Asthma increased the risk of respiratory work disability 
6.7-fold (95%CI 4.1–11.0). Interestingly a clear association between 
irritant peak exposures and work disability was found both in workers 
with asthma and workers without any chronic respiratory disease.
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Work absenteeism
Nathel et al used both register and questionnaire based information on 
reasons for sick-leave and demonstrated that asthma is an underdiag-
nosed disorder in sick leave registers (Nathel et al. 2000). In another 
study obesity was found to be more frequent among asthmatics on sick 
leave, when compared with the non-specific pain patients on sick leave 
and the controls (Nathell et al. 2002). 
In a Danish study, the register data for receiving unemployment, 
welfare, sick-leave and disability benefits over a 5-year period was com-
bined with the ECRHS II screening questionnaire data in 7241 persons 
(Hansen et al. 2012). Adult-onset asthma was significantly associated 
with receiving disability (Prevalence rate ratio, PRR 2.4, 95%CI 1.7–
3.4), sick leave (PRR 1.3, 95%CI 1.1–1.6) and welfare benefits (PRR 
2.0 95%CI 1.6–2.0), while childhood-onset disease only had marginal 
correlations. Blue collar work significantly increased the probability of 
all public transfer incomes. 
Kauppi et al. reported in a prospective cohort study of 48 296 Finnish 
public sector employees, that mean sick leave days per year for respond-
ents were 17.6 days for rhinitis alone, 23.8 days for asthma alone and 24.2 
days for both conditions combined (Kauppi et al. 2010). Respondents 
with neither condition were absent for a mean of 14.5 days annually. 
Rhinitis, asthma and both these conditions combined increased the risk 
of days off work, but the impact of asthma and rhinitis combined on 
the risk of sick leave days was marginal compared to asthma alone (RR 
1.1, 95%CI 1.0–1.3).
self-estimated work ability
In a Swedish study of 332 subjects with recent-onset asthma, 56% esti-
mated having full (100%) work ability (Balder et al. 1998). Significant 
predictors for decreased work ability (< 100%) were asthma severity, 
workplace-associated respiratory symptoms and bronchial hyperrespon-
siveness. However there were no controls in this study.
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2.5  Assessment of occupational exposure   
 in epidemiological studies
2.5.1		Self-reported,	job	title,	expert	judgement
In earlier large population-based studies occupational exposure es-
timation was based on self-reports or job titles. However both these 
approaches have limitations. The potential limitation of self-reports is 
that asthmatic workers may be more likely to report certain exposures, 
especially if this exposure aggravates asthma symptoms (de Vocht et al. 
2005). This phenomenon is called reporting bias.
The job or industry titles are less likely to be affected by reporting 
bias, but they are relatively poor surrogates for exposure to specific oc-
cupational agent. Professional judgement of occupational hygiene experts 
based on job titles and tasks has proved to be a good method of assessing 
occupational exposure. However, it is time-consuming and expensive 
and also dependent on the skills of the expert.
2.5.2  Job exposure matrix
Due to the limitation of the methods mentioned above a new approach, 
in which the job titles are merged with an external JEM was developed 
in the 1980s. The first JEM were generated and used for population-
based cancer studies (Pannett et al. 1985). In the first part of the ECRHS 
a matrix that classified respiratory exposure into three broad general 
categories, mineral dust, biological dust and gases or fumes was used 
(Kogevinas et al. 1999). Each occupation type was classified as non-
exposed, exposed to low levels and exposed to high levels of each of the 
three groups of pollutants. 
Kennedy et al developed the asthma specific JEM in 2000 in order to 
assess exposures relevant to OA (Kennedy et al. 2000). The matrix is two 
dimensional with job codes on one axis and exposure categories on the 
other. The job codes are from the international classification of occupa-
tions (ISCO). The exposure axis contains 22 exposure groups including 
18 high risk groups based on known risk factors for OA, divided into high 
molecular weight agents, low molecular weight agents, and mixed envi-
ronments. In practice an experienced coder needs to revise codes before 
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applying the JEM. The matrix also flags “needs individual re-evaluation”, 
when the exposure estimation is not reliable without description of work 
tasks. Table 4 demonstrates the use of asthma specific JEM. The asthma 
specific JEM by Kennedy has been used in several studies (Saarinen 
et al. 2003; Le Moual et al. 2004; Le Moual et al. 2005; Dumas et al. 
2011), although JEM based exposure assessment has been argued to be 
a potential cause of misclassification (Lillienberg et al. 2012).
Table 4. An example of the use of asthma specific job exposure 
matrix by Kennedy
Job title ISCO-
88 code
Matrix exposure 
group
Possible change required
Baker 7412 HMW, flour No
Life science 
technicians
3211 HMW, derived from 
animals
Class as exposed if job title 
or description of work tasks 
suggests laboratory animal 
exposure
ISCO = International classification of occupations
HMW = high molecular weight agent
Recently a Swedish group has developed a new asthma-JEM for the 
countries in northern Europe named N-JEM (Lillienberg et al. 2012). 
The same principles as in earlier respiratory specific JEMs (Kogevinas 
et al. 1999; Kennedy et al. 2000) is used in this new N-JEM, but the 
working conditions in northern Europe are taken into account. N-JEM 
includes six main groups: HMW agents, LLMW agents, irritating agents, 
‘accidental peak exposure to irritants’, ‘uncertain or low exposed group’ 
and an unexposed reference group. 
2.5.3  some comparisons between the methods used
In the ECRHS I, the specificity of self-reported occupational exposure 
to VGDF was relatively high among asthmatics, approximately 0.83, but 
the sensitivity was relatively low (0.48), when compared with the JEM 
evaluation (de Vocht et al. 2005). In non-asthmatics the corresponding 
specificity and sensitivity were 0.87 and 0.42. Self-reported exposure, 
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but not JEM based exposure was more prevalent in the areas where 
asthma was more common. It was concluded that reporting occupational 
exposure seems to be dependent on asthmatic health status both at indi-
vidual and at community level. Therefore self-reported exposure might 
be biased and should be used only in combination with more objective 
data on occupational exposure.
Quinlan et al. reported the sensitivity and specificity of VGDF against 
JEM to be 71% and 66%, respectively (Quinlan et al. 2009). Interest-
ingly, 32% of those 199 subjects with the same job in two distinct in-
terviews had discordance in self-reported exposure to VGDF. In a study 
of 176 hospital workers, Donnay et al. found large underestimation of 
self-reported exposure regarding to cleaning and disinfecting agents and 
a lack of knowledge of product components (Donnay et al. 2011). 
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The aim was to study the short-term and long-term asthma prognosis 
and the effect of asthma on work ability in men with asthma since youth. 
The more specific objectives were: 
1. To evaluate the determinants of asthma severity among young male 
asthmatics (a) over a period of 6 to 12 months of military service 
during which they were exposed to many predisposing factors for 
asthma and (b) conduct a further evaluation of these effects at a 
follow-up two years later. (Study I)
2. The impact of individual characteristics and lung function tests at 
the age of around 20 as a risk factor for persistent asthma at the 
age around 40 (Study II)
3. The work ability at around 40 years of age and risk factors for 
decreased work ability in men with asthma since youth (Study III)
4. The effect of current work and workplace exposures on current 
asthma severity, asthma control and occurrence of exacerbations at 
around 40 years of age in men with asthma since youth (Study IV)
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4.1  subjects and design
We used Finnish Defence Force registers to select the study population. 
In Finland it is obligatory for all young men of sufficiently good health 
to participate in either military or civil service. Up to 98% of all men 
underwent a medical examination at the age of 18–19. Subjects having 
mild asthma with normal lung function were evaluated as fit for most 
service duties. Those having stable moderate asthma and good lung func-
tion were evaluated as fit for restricted duties. Subjects with unstable or 
deteriorating asthma, or clearly decreased lung function, were exempted 
from military service. In the 1980s, about 90% of young men carried 
out 8–11 months military service and in the 2000s about 81% of young 
men participated in 6–12 months service.
According to Finnish Defence Forces’ statistics, asthma is a common 
diagnosis among young men in military service and the major somatic 
reason for discharge from service. Many factors can aggravate asthma 
symptoms during military service, such as recurrent respiratory infec-
tions, physical exercise, and exposure to cold air, allergens or other dusts. 
Conscripts from all parts other than the northernmost regions of Finland 
with suspected or aggravated asthma are examined in the Central Mili-
tary Hospital. Two types of asthmatics are identified from the register of 
the Central Military Hospital. Men with earlier diagnosed asthma were 
admitted to hospital due to unstable or aggravated asthma and were 
mainly admitted for the purpose of restarting or adding medication or 
for evaluation of service ability. The other group had a new-onset asthma 
and came for confirmation of the diagnosis.
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4.1.1  study I
All 216 men with verified asthma in 2004–2005 from the register of 
the Central Military Hospital were included in the study base. These 
subjects represented an unselected population of men with mild or 
moderate asthma aged 18–27, from southern and central parts of Fin-
land. A follow-up questionnaire was sent approximately two years later 
in autumn 2007. The mean follow-up time (time between completing 
military service and completing the questionnaire) was 29 months. Of 
the 216 men, 69 did not respond to the questionnaire after two remind-
ers and one did not give his consent for the study and were therefore 
excluded. The response rate of the questionnaire was 68% and the final 
study population comprised 146 subjects. The diagnosis of asthma was 
based on medical records.
In this study we evaluated asthma severity during military service 
according to medical records and two years after service according to the 
questionnaire and studied the value of lung function tests and allergy tests 
during military service as prognostic factors for current asthma severity.
4.1.2 studies III and Iv
Asthma Group 1 (n = 505) consisted of all subjects who were referred to 
the Central Military Hospital between 1987–1990 due to a diagnosis 
of asthma (including both men in military service with asthma already 
diagnosed before the service, and men with a new-onset asthma during 
service). This group represented an unselected population of men, who 
had mild or moderate asthma and were living in southern and central 
parts of Finland at the age of 18–27.
Asthma Group 2 (n = 393) included men who were exempted from 
military service in 1986–89 due to asthma and were alive in January 
2009, representing an unselected population of Finnish men with rela-
tively severe asthma at the age of 18.
The controls (n = 1500) were randomly selected from the 7,433 young 
men who entered military service in five large military units in Southern 
Finland between 1986 and 1990, who had no asthma diagnosis during 
military service according to the Defence Force register and were alive 
in January 2009. The 28 subjects reporting in the study questionnaire 
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as having asthma during their military service were excluded. The con-
trols represented an unselected population of men, without asthma or 
any other disabling illness in their youth and who lived in southern or 
central parts of Finland. The description of the study is presented in 
more detail in figure 1.
A postal questionnaire was sent out in the spring of 2009, that is 
approximately twenty years (18–23 years) after military service or ex-
emption at call-up. After two reminders, 232 men (54%) from Asthma 
Group 1, 161 men (44%) from Asthma Group 2, and 608 (44%) of 
the controls answered and thus comprised the final study population 
for the studies III and IV.
In study III, work ability was an outcome variable and among others 
current asthma severity and work exposure were explanatory variables. 
In study IV, current asthma severity, control and occurrence of exacerba-
tions were end points, which were explained by current work exposure, 
professional status and release of asthma symptoms on days off.
4.1.3  study II
All 232 respondents of the follow-up questionnaire from Asthma Group 
1 were invited to clinical tests at the Finnish Institute of Occupational 
Health (FIOH). A total of 119 (51.3%) respondents accepted and at-
tended the tests between August 2009 and April 2010, i.e. approximately 
twenty years (18–23 years, mean 21.1 years) after their military service 
and these respondents comprised the final study population for study 
II (figure 1).
The baseline data from Central Military Hospital medical records of 
all 232 respondents to the follow-up questionnaire from Asthma Group 
1 were collected. The clinical findings of the participants in the follow-
up visit were compared with the non-participants. The results of lung 
function and allergy tests during military service were used as explanatory 
variables to current asthma severity, which two different chest physicians 
evaluated based on the follow-up visit. 
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4.2  Register data used to compare    
 respondents and non-respondents
We used the nationwide registers of the Finnish Social Insurance Insti-
tution to obtain information on the non-respondents to the follow-up 
questionnaire in studies II–IV. We obtained data at group level from 
respondents and non-respondents of Asthma Group 1 and from Asthma 
Group 2 without individual level information. We collected the following 
data: 1) special medication reimbursement rights for asthma medication 
in 1992 and 2009 (objective data on reversible bronchial obstruction 
and the typical symptoms of persistent asthma must be demonstrated 
in order to obtain the reimbursement rights, see Saarinen et al. 2003 
for details of the definition and criteria of these rights), 2) asthma 
medication purchases in 2008, 3) the number of sick leave periods due 
to respiratory illness lasting over nine days of 2009. The Finnish Social 
Insurance Institution provides compensation for an employer when sick 
leave lasts over nine days, therefore those with a shorter period are not 
found in the register.
4.3  Clinical methods
In study I, clinical investigations were carried out at the Central Mili-
tary Hospital in 2004–05. In study II, the subjects were examined at 
baseline (1987–1990) at the Central Military Hospital and at follow up 
(2009–2010) at the Finnish Institute of Occupational Health.
4.3.1  Lung function tests
spirometry
Ventilatory function was measured by a flow-volume spirometer (study 
I: Jaeger Masterlab spirometer, study II: on baseline Pneumoscreen, Eric 
Jaeger, Germany and at follow-up Medikro) according to the guidelines 
valid at the time of the studies (study I: ATS 1995, study II at baseline: 
ATS 1987 and study II at follow-up: Miller et al. 2005). We used the 
predicted values for the Finnish population (Viljanen 1982). The cut-
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Figure 1. Description of the study populations in studies II–IV
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off values for decreased spirometric parameters were based on the lower 
limits of normal, and were for FEV1% below 81% of predicted, FEV1/
FVC% below 88% of predicted, and FEF50%below 62% of predicted . A 
significant reversibility of airway obstruction was defined as an increase 
of at least 12% and 200ml in FEV1 after bronchodilator administration.
exercise test
A standardised field exercise test was performed using an eight minute 
free-running test outdoors on a 150 metre circular track between 9 and 
11 a.m. (Karjalainen 1991). The running speed was adjusted by moni-
toring the subject’s heart rate with a Sport Tester TM PE 3000 heart rate 
meter (Polar Electro Ky, Kempele, Finland). Subjects raised their heart 
rate to 85% of the predicted maximal rate during a two minute warm 
up and maintained that level for the remaining six minutes of the test. 
The PEF values were measured just before the exercise and immediately, 
5, 10, 20 and 30 minutes after the exercise. Of the three successive PEF 
measurements obtained on each occasion, the highest value was recorded 
for analysis. A positive exercise reaction was defined by at least 15% PEF 
fall in the 30-minute follow-up after exercise. The response to exercise 
challenge was the maximum percentage fall in PEF (ΔPEF%) after exer-
cise: % fall in PEF = [PEF(baseline) –PEF(after)]/ PEF(baseline) x100]. 
Air temperature ranged from –19°C to + 24°C, mean 5.4°C. Therefore, 
for all exercise challenges, ΔPEF% was adjusted to temperature of 5.4°C 
by using regression coefficient (–0.327) between air temperature (°C) 
and ΔPEF% as has been done in a previous study (Rouhos et al. 2005). 
The regression coefficient was obtained by a linear regression from simi-
lar outdoor exercise tests in 1809 conscripts with asthma (Latvala et al. 
2000). Those exercise tests were performed during years 1985–1998 in 
temperatures ranging from –25°C to +26°C.
Histamine challenge
In study I the airway hyperresponsiveness to histamine was assessed us-
ing Sovijarvi’s method (Sovijarvi et al. 1993) and in study II according 
to Laitinen’s method (Laitinen 1975). It was classified as severe if the 
concentration of histamine causing a 15% decrease in the FEV1 values 
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(PD15) was ≤ 0.10 mg, moderate for PD15 values of 0.11 to 0.39 mg, and 
mild for PD15 values of 0.40 to 1.60 mg. In some subjects the reaction 
was followed up with use of manual PEF meter and then the PEF values 
were used instead of FEV1 values.
serial Pef recording
Serial PEF recordings showing either a diurnal variation of ≥ 20% or a 
bronchodilatation effect of ≥ 15% at least three times during two weeks 
period were considered diagnostic for asthma.
4.3.2  skin prick tests
At baseline skin prick tests (SPT) were performed using both a negative 
and positive control and a panel of 10 common perennial and seasonal 
allergens with standardised allergen extracts (ALK). During the follow-
up, tests were done with corresponding allergen extracts (ALK-Abello) 
and positive and negative controls. In case of dermographismus (the 
negative control ≥ 2mm) the subject’s skin prick tests were not accepted 
for the evaluation. A wheal diameter of at least 3 mm and at least 50% 
histamine control in SPT was considered positive.
4.3.3		Definition	of	atopy
In study 1 definition of atopy was based on skin-prick testing in 110 
subjects. A subject was considered atopic when at least one positive skin 
test to common allergens was present. Subjects who reacted to at least 
four allergens were classified as having multiple sensitisations. If prick 
tests were missing or showed a dermografismus reaction, then subjects 
diagnosed with an allergic rhinitis or conjunctivitis by a doctor (n = 18), 
or a reliable anamnesis of positive skin prick tests (n = 12) were consid-
ered to be atopic. In six subjects the atopy status remained undefined.
4.3.4  other measurements
Blood eosinophils were counted in a B rker counting chamber. Total 
serum IgE was measured by solid phase immunoassay, and a concentra-
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tion of ≤ 110ku/l was considered normal. BMI was calculated as weight 
in kilograms divided by the square of height in metres, from measured 
height and weight during military service (studies I and III) and from 
self-reported measures at follow-up. Overweight was defined as a BMI 
≥ 25 kg/m2 and being obese as a BMI ≥ 30 kg/m2.
4.4  Questionnaire
In studies I, III and IV we used the previously validated Finnish questions 
of the Tuohilampi questionnaire to evaluate current asthma symptoms 
and their frequency, the presence of other atopic disorders, the current 
use of asthma medication and the age of asthma onset (Kilpelainen et 
al. 2001). Data was collected on personal characteristics, asthma his-
tory and family history, asthma symptoms and their frequency, use of 
asthma medication, lifestyle, weight, height, occupational and domestic 
exposures and social situation.
In studies III and IV, questions on, education, lifetime work history, 
current exposure at work, aggravation of asthma symptoms at work and 
work ability were included. Classification of asthma was based partly on 
the questionnaire data, while assessment of work ability and occupational 
exposure was based solely on the questionnaire. The details of the clas-
sifications for these variables are presented in the following chapters. 
4.4.1  basic characteristics
Education: Subjects having completed only comprehensive school, high 
school or vocational school were classified as having basic education. 
Those with college or other upper secondary education were classified 
as having mid-level education. Subjects with a university degree were 
classified accordingly (http://www.stat.fi/meta/kas/koulutusaste.html.).
Professional status was categorised as self-employed or farmer, up-
per level non-manual worker, lower level non-manual worker, manual 
worker, and other or unknown (http://www.stat.fi/meta/luokitukset/
sosioekon_asema/001-1989/index.html).
Smoking. According to the questionnaire data, the respondents were 
classified as current smokers, ex-smokers or non-smokers.
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Alcohol consumption. Subjects who reported drinking six or more 
standard units of alcohol (Brick 2006) at a time once a week or more 
often were categorized as frequently consuming multiple alcohol units.
Physical activity. Those who reported taking part in exercise that 
results in at least mild breathlessness and sweating for at least half an 
hour at a time, only once a week or less in their free time, were classified 
as physically inactive. 
4.4.2  Release of asthma symptoms on days off
The question: “Are your asthma symptoms releasing on days off?” was 
used. The answers yes, frequently or yes, sometimes were defined to have 
indicate a release of asthma symptoms on days off. In the risk factor analyses 
these subjects were compared with those choosing the answer alternative 
“no”. The subjects reporting that they did not have asthma symptoms at 
all during current job were excluded from the risk factor analyses. 
4.5		 Classification	of	asthma
4.5.1  Asthma severity
study II 
In study II, we used the GINA 2002 guidelines (GINA 2002) to evaluate 
current asthma severity at the follow-up visit. Two independent GINA 
classifications were combined, the first based on symptoms and FEV1 
and the second on current medication, in order to construct a final 
“symptom-FEV1-medication” classification as described earlier (Liard 
et al. 2000) and in table 5. Clinical severity was classified as one of four 
grades according to the frequency of diurnal and nocturnal symptoms 
in the last 12 months and the prebronchodilator FEV1 of predicted val-
ues. Treatment was also classifiedinto one of four grades, according to 
reported daily medication use. Finally, asthma severity was based on the 
independent classifications of clinical severity and medication, according 
to GINA. The following categories were used: remission, intermittent, 
mild persistent, moderate persistent and severe persistent. Remission was 
defined as having no asthma symptoms and using no asthma medication 
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for the last three years. Classification was carried out by two physicians (I. 
Lindström and H. Suojalehto) separately, and the results proved congru-
ent with each other. The kappa coefficient between the two observations 
was 0.90. If these two classifications differed from each other, then the 
asthma severity evaluation of I. Lindström was used.
In study II, baseline asthma severity was evaluated according to modi-
fied GINA guidelines and classified as intermittent, mild persistent or 
moderate/severe persistent. Treatment step classes were not used, because 
most subjects had no treatment, and the medication used differed from 
the current treatment guidelines.
studies I,	III	and	IV
In studies I, III and IV, we evaluated asthma severity based on the ques-
tionnaire data and used validated questions concerning frequency of 
various asthma symptoms and the use of medication during last 12–36 
months. We used the GINA 2002 classification as in study II, but we 
carried out the asthma severity evaluation without FEV1 values. Such a 
GINA classification without spirometry data has been used in previous 
studies (Taylor et al. 2008b). A chest physician (I. Lindström) made the 
classifications. Remission of asthma was defined as no attacks of short-
ness of breath with wheezing, no cough with wheezing, and no use of 
asthma medication during the last 12 months in study I and during the 
last 3 years in studies III and IV.
4.5.2  Asthma control
We used ACT (Finnish version of the Asthma Control Test™. The 
Asthma Control Test™ is a trademark of Quality Metric Incorporated © 
2002 GlaxoSmithKline) to evaluate current asthma control (Nathan et 
al. 2004) in study IV. This self-administered questionnaire assesses key 
components of asthma control over the prior 4 weeks, including asthma 
symptoms, everyday functioning, use of rescue medications, and night 
time awakenings. The ACT scale ranges from 5 to 25, with higher scores 
indicating better asthma control and subjects having a score less than 
20 are identified to have poorly controlled asthma. The subjects having 
a score of ≥ 20 are thought to have well-controlled asthma.
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Table 5. Asthma severity evaluation based on GINA 2002. The severity was 
evaluated by combining the current severity of the asthma treatment (horizontal 
axis) and the current severity of asthma based on symptoms and lung function 
(vertical axis). 
Current treatment step
Intermittent
Only when 
needed
Mild Persistent
ICS
≤ 800µg/day** 
or leucotriene 
modifier 
Moderate 
persistent
ICS > 800µg/
day**
or inhaled 
corticosteroid 
100–800µg/day 
plus long-acting 
inhaled β2agonist 
or inhaled 
corticosteroid 
100–800µg/day 
plus leucotriene 
modifier/
theophylline
Severe persistent
ICS ≥ 1000µg/
day ** with or 
without long-
acting inhaled 
β2agonist plus 
one or more of 
the following if 
needed:
– theophylline
– leukotriene 
modifier
– oral 
corticosteroid
Symptoms and 
lung function* 
Definitive severity
Intermittent
– Symptoms  
< once a week
– Nocturnal 
symptoms  
≤ twice a month
– FEV1≥80%
– PEF variability 
< 20%
Intermittent Mild Persistent Moderate 
Persistent
Severe persistent
Mild persistent
– Symptoms  
≥ once a week 
but
< once a day
– nocturnal 
symptoms  
> twice a month 
but ≤ once  a 
week
– FEV1≥80% 
– PEF variability 
20–30%
Mild Persistent Moderate 
Persistent
Severe Persistent Severe Persistent
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Current treatment step
Intermittent Mild Persistent Moderate 
persistent
Severe persistent
Moderate 
persistent
– daily
– nocturnal 
symptoms  
> once a week
– 60% < FEV1  
< 80%
– PEF variability 
> 30%
Moderate 
Persistent
Severe 
Persistent
Severe Persistent Severe Persistent
Severe persistent
– frequent 
exacerbations 
– frequent 
nocturnal 
asthma 
symptoms
– limitation of 
physical activities
– FEV1 ≤ 60%
– PEF variability 
> 30%
Severe Persistent Severe 
Persistent
Severe persistent Severe Persistent
*  = worst feature determines severity classification
**  = doses of inhaled corticosteroids are equivalent to Beclomethasone dipropionate
ICS  = inhaled corticosteroid
FEV1 = forced expiratory volume in one second
PEF  = peak expiratory flow
4.5.3  occurrence of exacerbations
The subjects were classified as having an asthma exacerbation, if they 
reported at least one of the following during the last 12 months: 1) an 
unscheduled office visit or an emergency department visit for asthma, 2) 
a hospitalisation for asthma or 3) an oral corticosteroid burst for asthma.
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4.6  Assessment of work ability
4.6.1  self-assessed work ability
We used the Work Ability Index (WAI) in assessing current work ability 
(Tuomi et al. 2006). The WAI is based on series of questions that take 
into consideration the physical and mental demands of work and the 
health resources of the worker. Due to the relatively young age of the 
population studied we used only five first questions of the WAI and left 
out several questions about chronic diseases. The participants were asked 
to compare their current work ability with their best lifetime work ability 
so that 0 represented full work disability and 10 indicated work ability at 
its best. This validated question was the main indicator for self-assessed 
work ability, and belonged to the Work Ability Index (WAI) question-
naire as did all other questions about self-assessed work ability (Tuomi 
et al. 2006). The subjects with current work ability ≤ 7 compared with 
lifetime best were classified as having decreased work ability, and those 
with values of 8–10 as having normal work ability. Based on Finnish 
Health 2000 Survey, 88% of men in the entire Finnish population aged 
30–44 had a work ability of 8–10 compared with lifetime best (Gould 
et al. 2008). 
4.6.2  Participation in work life
The subjects were asked if they were currently full-time employed, part-
time employed, unemployed, temporarily dismissed, studying, on sick 
leave, on disability pension, on another pension, or if they took care of 
households or children. As it was possible to choose many alternatives, 
the answers were classified by selecting the following groups in the fol-
lowing order: 1. The men who answered that they were either full-time 
or part-time employed were by default classified as employed, 2. The men 
who answered that they were unemployed or on temporary dismissal 
were classified as unemployed, 3. Those who answered that they received 
disability pension were classified as on disability pension, and 4. All the 
rest were classified as being temporarily out of work for other reasons. The 
subjects classified as unemployed, on disability pension or temporarily 
out of work for other reasons were defined as not employed. Informa-
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tion on ever having been unemployed or having changed occupation 
after military service and the number of such periods was also elicited. 
4.7  Workplace exposure
4.7.1  self-reported
The respondents were asked about exposure to each of the following 
factors in their current job using previously established questions: dusts, 
chemical agents or factors, abnormal temperatures (cold and heat), poor 
indoor air quality, mental stress, and physically strenuous work (Saarinen 
et al. 2003).
4.7.2  Job exposure matrix
The current or last occupation of the respondents was first coded ac-
cording to the 1997 Classification of Occupations of Statistics Finland 
(Käsikirjoja 14 (Handbook 14). Helsinki 1997), which is based on the 
European Community revision of the International Standard Classifica-
tion of Occupations (ISCO-88 (COM)). The coded occupational history 
was matched with the asthma specific JEM developed by Kennedy et al 
(Kennedy et al. 2000) in order to assign the study subjects to exposure 
risk groups based on ever having had a job that places them at high risk 
of developing OA or having been exposed to some other non-specific 
respiratory irritants. The asthmogens were classified into three groups as 
follows: high-molecular-weight agents (HMW), low-molecular-weight 
agents (LMW) or mixed environment; and the non-asthmogenic irritants 
were grouped into one separate group, as in the previous study (Le Moual 
et al 2005). Latex exposure was ignored in our study, as non-powdered 
low-latex gloves have been used in Finland for many years.
4.8  statistical methods
Our data set consisted of both continuous and categorical variables. 
When exploring relationships between variables we applied Chi-squared 
tests for categorical variables. In the same way, one-way ANOVA was 
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used for continuous normally distributed variables and Kruskal-Wallis for 
continuous non-normally distributed variables. A p-value of < 0.05 was 
considered statistically significant. We used logistic regression analyses 
for examining the associations between explanatory determinants and 
current persistent asthma in study II, decreased work ability at follow-up 
in study III and poorly controlled asthma/asthma exacerbations/current 
asthma severity in study IV. The ORs with 95%CI are presented.
All analyses were carried out using the Statistical Analysis System 9.1 
programme (SAS Institute Cary, USA).
4.9  ethics
The study was approved by the Ethical Committee of the Department 
of Medicine of Helsinki University Central Hospital. Written informed 
consent was obtained from the study subjects in studies I–IV.
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5.1  Asthma prognosis of young male    
 conscripts
5.1.1  short-term prognosis (study I)
The mean age of the subjects was 19.7 years at baseline and 22.4 years 
at follow-up and approximately 75% of the patients were atopic. Two 
groups of asthmatics were identified: those who already had asthma 
when entering the military service (n = 71, 48.6%) and those, who had 
a new-onset asthma during service (n = 75, 51.4%). The subjects who 
had asthma before military service were more frequently sensitised in 
skin prick tests (p = 0.017) and reported higher prevalence physician-
diagnosed allergic conjunctivitis (p = 0.020), allergic rhinitis (p = 0.008) 
and atopic eczema (0.145) than those suffering from new-onset asthma.
At baseline, asthma was intermittent in 4% of men, mild persistent 
in 26% of men, moderate persistent in 69% and severe persistent in 
0.7% of men. The age of onset tended to predict asthma severity dur-
ing military service. Asthma was moderate persistent in 88.9% of the 
27 patients whose asthma had been confirmed under seven years of age, 
compared with 72.5% and 62.3% of study members who had been 
diagnosed at the age of 7–18 and over 18 years respectively (p = 0.108). 
At follow-up, asthma was in remission in 19.7%, mild intermittent in 
41.8%, mild persistent in 22.6%, and moderate persistent in 15.6%. 
Overall asthma was less severe at two year follow-up than during military 
service (p = 0.036). Both during military service and at two-year follow-
up, asthma was milder among the men, who had a new-onset asthma 
during military service.
78
5 results
Atopy (p = 0.002), number of positive skin prick tests (p = 0.005) and 
higher total serum IgE (p = 0.001) at baseline were significant predictors 
for more severe asthma at follow-up.
5.1.2  Long-term prognosis (study II)
We found no statistically significant differences in baseline characteristics 
of study participants and those 109 subjects, who answered the ques-
tionnaire without participating in the clinical visit. The characteristics 
of study participants at baseline and 20-year follow-up are presented in 
table 6. Asthma was less severe at follow-up than at baseline. At follow-up, 
11.8% of the men were in remission, 42.0% had intermittent asthma, 
10.9% had mild persistent asthma, and 35.3% had moderate/severe 
persistent asthma. A total of 56.3% (67) of the subjects had positive 
exercise test at baseline.
Smoking habits and the results of lung function and allergy tests 
during military service were used as explanatory variables for current 
asthma severity. Smoking (p = 0.050), decreased FEV1% predicted 
(p=0.001), decreased FEV1/FVC% predicted (p < 0.0001), decreased 
FEF50%% predicted (p = 0.001), PEF decrease of ≥ 10% in exercise tests 
(p = 0.011), and more severe asthma (p = 0.028) at baseline showed a 
statistically significant association with persistent asthma at follow-up. No 
significant associations were found between asthma severity at follow-up 
and the age of asthma onset, positive skin prick tests, or airway hyper-
responsiveness to histamine at baseline.
We assessed the predictive value of spirometry and exercise test find-
ings at baseline for persistent asthma at follow-up by using univariate 
and multivariate models. Decreased FEV1 % predicted, decreased FEV1/
FVC % predicted, decreased FEF50% % predicted and a positive exercise 
test (PEF decrease ≥ 15%) at baseline associated with persistent asthma 
at follow-up (table 7). The risk remained after adjustment for smoking 
and asthma severity at baseline. In our final multivariate model exercise 
test results and FEV1/FVC% predicted results at baseline were adjusted 
for each other as well as for smoking and asthma severity at baseline (data 
not shown). In this model the OR for current persistent asthma was 3.2 
(95%CI 1.0–9.8) in subjects with a positive exercise test and 4.0 (95%CI 
1.7–9.3) in subjects with a decreased FEV1/FVC ratio.
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Table 6. Characteristics of participants at baseline and follow-up in 
study II. Data provided as % (n) unless otherwise stated.
Baseline
1987–90
Follow-up
2009–10
p-value
n = 119 n = 119
Age, mean, years, (SD) 20.1 (1.4) 41.2 (1.9)
Smoking* 0.002
   Non-smoker 52.9% (63) 65.5% (78)
   Ex-smoker 10.9 % (13) 14.3 % (17)
   Smoker 36.1 % (43) 20.2 % (24)
BMI, mean, kg/m², (SD) 22.9 (3.0) 27.7 (5.1) < 0.001
Skin prick tests* 0.026
   0 positive 13.8% (15) 13.6% (16)
   1–3 positive 25.7% (28) 14.4% (17)
   ≥ 4 positive 60.5% (66) 72.0% (85)
Prebronchodilator spirometry*
   FVC % predicted, mean (SD) 98.2 (11.6) 93.7 (11.4) < 0.001
   FEV1 % predicted, mean (SD) 88.3 (12.0) 88.5 (13.3) 0.827
   FEV1/FVC % predicted, mean (SD) 89.7 (9.6) 94.3 (9.1) < 0.001
   FEF50% % predicted, mean (SD) 62.7 (16.6) 74.4 (23.9) < 0.001
Asthma severity < 0.001
   Remission 0% (0) 11.8% (14)
   Intermittent 33.6% (40) 42.0% (50)
   Mild persistent 19.3% (23) 10.9% (13)
   Moderate/severe persistent 47.0% (56) 35.3% (42)
Using inhaled corticosteroid 0 22.7% (27)
* = due to some missing data the number of subjects varies from 119.
BMI = body mass index, FVC = forced vital capacity, FEV1 = forced expiratory 
volume in 1 second, FEF50% = forced expiratory flow rate at 50% of vital capacity, 
PD = provocative dose, PEF = peak expiratory flow, ND = not done, SD = standard 
deviation
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5.2  Characteristics of the study population  
 in studies III–Iv
5.2.1  Characteristics of the study participants
The characteristics of the study groups are presented in table 8. The so-
cioeconomic status of Asthma Group 2 differed from the other groups: 
these men had a lower educational level and more often worked as manual 
workers. JEM based exposure to LMW asthmogens in the most recent 
occupation was more common among the controls, but other differences 
in occupational exposure could not be found. Asthma was currently more 
severe in Asthma Group 2. The asthmatics smoked currently slightly 
more often than the controls. The use of asthma medication based on 
the questionnaire data is presented in table 9. 
Table 8. Characteristics of study population in studies III–IV
Asthma Group 1
n = 232
Asthma Group 2
n = 161
Controls
n = 608
p-value
Mean age, years 
(SD)
40.9 (1.7) 40.6 (1.9) 41.0 (1.9) 0.048
Smoking 0.252
   Non-smoker 41.6 (96) 45.0 (72) 42.8 (259)
   Ex-smoker 22.9 (53) 25.0 (40) 28.8 (174)
   Smoker 35.5 (82) 30.0 (48) 28.4 (172)
BMI kg/m² 0.153
   < 25 29.4 (68) 39.8 (64) 37.3 (223)
   25.0–29.9 47.6 (110) 40.4 (65) 44.5 (266)
   ≥ 30.0 22.9 (53) 19.9 (32) 18.2 (109)
Doctor diagnosed 
allergic rhinitis
77.6 (177) 82.3 (130) 30.1 (182) < 0.001
Education 0.032
   Basic 57.0 (126) 63.3 (95) 56.2 (320)
   Mid-level 29.9 (66) 24.0 (36) 23.6 (134)
   University 13.1 (29) 12.7 (19) 20.2 (115)
Continues on next page 
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Asthma Group 1
n = 232
Asthma Group 2
n = 161
Controls
n = 608
p-value
Occupation 0.063
   Upper-level non-    
   manual worker
25.0 (58) 15.5 (25) 27.9 (169)
   Lower-level non-   
   manual worker
14.2 (33) 14.3 (23) 11.7 (71)
   Manual worker 32.8 (76) 41.0 (66) 35.5 (215)
   Self-employed 18.5 (43) 14.9 (24) 16.7 (101)
   Not currently    
   employed
5.6 (13) 9.9 (16) 5.6 (34)
   Other or unknown 3.9 (9) 4.4 (7) 2.5 (15)
JEM based 
occupational 
exposure*
   HMW asthmogens 3.3 (7) 4.4 (6) 2.6 (14) 0.517
   LMW asthmogens 3.8 (8) 5.1 (7) 10.2 (56) 0.006
   Mixed environment 
   asthmogens
5.7 (12) 4.4 (6) 8.4 (46) 0.170
   Any asthmogen 9.1 (19) 12.3 (17) 15.9 (87) 0.045
   Non-asthmogenic    
   irritants
35.7 (75) 31.9 (44) 37.3 (205) 0.486
Self-reported 
occupational 
exposure*
   Dust/chemical  
   agents/gases/ 
   fumes
66.7 (140) 74.6 (103) 66.9 (367) 0.192
   Abnormal  
   temperatures
42.9 (90) 44.2 (61) 42.3 (232) 0.917
   Bad indoor quality 24.3 (51) 23.9 (33) 21.9 (120) 0.727
   Physically  
   strenuous work
49.1 (103) 46.4 (64) 49.5 (272) 0.801
Change of 
occupation ever
67.0 (150) 55.7 (78) 57.1 (338) 0.025
Change of 
occupation due to 
asthma
0.430
   No 86.2 (188) 83.2 (124)
   Yes, partly 11.5 (25) 12.1 (18)
   Yes, mainly 2.3 (5) 4.7 (7)
Data is presented as % (n) unless otherwise stated. P-values for χ2-test for 
categorical variables and one-way ANOVA for continuous variables
* = The subjects who were not currently employed were excluded (After the 
exclusions, n = 210 in Asthma Group 1, n = 138 in Asthma Group 2 and n = 549 in 
Controls)
BMI = body mass index, JEM = asthma specific job exposure matrix, HMW = high 
molecular weight, LMW = low molecular weight.
83
5 results
Table 9. Use of asthma medication during past 12 months based on 
the questionnaire data (studies III–IV)
Medication Asthma Groups 1+2
n = 393*
None 24.4 (96)
Only when needed 34.4 (135)
Only bronchodilator regularly** 2.0 (8)
ICS regularly 18.3 (72)
ICS+LABA regularly 18.3 (72)
Other combination regularly 1.05 (6)
Data is presented as % (n)
* = missing data in 4 subjects
** = regularly means daily or almost daily
ICS = inhaled corticosteroid LABA = long acting bronchodilator
5.2.2 Comparison between respondents and  
non-respondents
Based on the nationwide registers of the Finnish Social Insurance In-
stitution there were no significant differences between respondents and 
non-respondents in Asthma Group 1. The respondents of Asthma Group 
2 had special medication reimbursement rights for asthma medication 
statistically significantly more often in 1992 (p = 0.022) and in 2009 
(p = 0.007) than non-respondents. We found no significant differences 
in asthma medication purchased in 2008 or the number of periods of 
sick leave due to respiratory illness between the respondents and non-
respondents of Asthma Group 2.
5.3  the work ability (study III)
5.3.1  Participation in work life and the current self-
assessed work ability
A total of 9.2% of the subjects in Asthma Group 1, 14.3% of the subjects 
in Asthma Group 2, and 9.4% of the controls were not currently em-
ployed (p = 0.165) (table 8). Being ever unemployed was most common 
84
5 results
among men in Asthma Group 2, while having ever changed occupation 
was most common in Asthma Group 1.
The asthmatics had reduced self-assessed work ability: current work 
ability compared with lifetime best was ≤ 7 in 28.9% of Asthma Group 1, 
in 31.1% of Asthma Group 2, and in 19.7% of the controls (p = 0.0007). 
Work ability as regards physical job demands was moderate or bad in 
the groups, at 32.0%, 34.2% and 23.4%, respectively (p = 0.004), and 
17.3%, 24.0% and 15.4% (p = 0.037) as regards mental job demands. 
No significant difference in the mean number of sick leave days during 
the last 12 months and the self-assessed estimate of work ability two 
years from baseline were found between the groups. 
Table 10. Risk of decreased self-assessed work ability in the 
univariate and multivariate models (study III)
Unadjusted Adjusted with 
education, 
professional status 
and life style factors
OR 95%CI OR 95%CI
Current work ability compared with 
life time best ( ≤ 7 vs. 8–10)
   Controls 1 reference 1 reference
   Asthma Group 1 1.7 1.2–2.3 1.5 1.0–2.2
   Asthma Group 2 1.8 1.2–2.7 1.6 1.0–2.5
Work ability in the relation 
to physical demands of work 
(moderate or bad vs. very good or 
quite good)
   Controls 1 reference 1 reference
   Asthma Group 1 1.5 1.1–2.2 1.4 1.0–2.1
   Asthma Group 2 1.7 1.2–2.5 1.5 1.0–2.3
Work ability in the relation to 
mental demands of work (moderate 
or bad vs. very good or quite good)
   Controls 1 reference 1 reference
   Asthma Group 1 1.1 0.8–1.7 1.1 0.7–1.6
   Asthma Group 2 1.7 1.1–2.7 1.6 1.1–2.5
* = life style factors consisted of BMI classes, current smoking, frequent use of 
multiple alcohol doses and physical inactivity
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The increased risk of decreased self-assessed work ability remained 
when adjusted with education, professional status and lifestyle factors in 
the multivariate models (table 10). Work ability in relation to the mental 
demands of the work was reduced only in Asthma Group 2.
5.3.2  Risk factors for decreased work ability among 
asthmatics
In the logistic regression analysis current smoking, only basic education, 
being a manual worker or being self-employed, and suffering from current 
severe asthma were most strongly associated with decreased work ability 
among the asthmatics (table 11). Occupational exposure to nonasthmo-
genic irritants according to JEM and self-reported occupational exposure 
to abnormal temperatures were also related to the same outcome. The 
association with smoking strengthened in the logistic model including all 
listed variables, while others weakened, becoming no longer significant 
(data not shown). The term risk factor is used, although the determinants 
of decreased work ability are measured at the time of follow-up.
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Table 11. The odds ratios (ORs) for decreased self-assessed current 
work ability compared with lifetime best (≤ 7 vs. 8–10) among 
asthmatics and controls (study III)
Risk factor Asthma Groups  
1 and 2
Controls
OR 95%CI OR 95%CI
Long lasting rhinitis 1.8 1.0–3.1 1.6 1.1–2.4
Current smoking 2.5 1.6–3.9 1.5 1.0–2.4
BMI over 30 1.7 0.9–3.0 2.8 1.6–4.9
Education
   University 1 reference 1 reference
   Mid-level 1.8 0.7–4.3 2.1 1.0–4.4
   Basic 2.6 1.1–5.8 3.2 1.6–6.2
Professional status
   Upper level non-manual worker 1 reference 1 reference
   Lower level non-manual worker 1.6 0.7–3.9 1.6 0.7–3.5
   Manual worker 2.7 1.4–5.6 2.0 1.1–3.5
   Self-employed 2.5 1.1–5.6 1.5 0.7–3.0
   Other or unknown 9.7 4.1–23.0 11.4 5.4–24.1
JEM based occupational exposure 
   HMW asthmogens 1.6 0.6–4.6 0.5 0.1–2.4
   LMW asthmogens 0.6 0.2–1.9 0.9 0.4–1.7
   Mixed environments asthmogens 0.9 0.4–2.5 1.0 0.5–2.0
   Any asthmogen 1.1 0.5–2.1 0.8 0.4–1.4
   Nonasthmogenetic irritants 1.7 1.1–2.7 1.3 0.9–2.0
Self -reported occupational 
exposure
   Dusts, chemic agents, gases or fumes 1.3 0.8–2.1 1.3 0.8–1.9
   Abnormal temperatures 1.7 1.1–2.7 1.2 0.8–1.8
   Bad indoor air quality 1.6 0.9–2.5 1.7 1.1–2.7
   Mental stress 1.2 0.8–1.9 1.3 0.8–1.9
   Physically strenuous work 0.6 0.4–1.0 0.9 0.6–1.3
Current asthma severity
   Remission (1) 1 reference
   Intermittent (2) 2.1 0.7–6.5
   Mild persistent (3) 1.8 0.5–5.9
   Moderate (4) 2.1 0.6–7.0
   Severe (5) 3.8 1.1–13.5
Statistically significant results are shown in bold. JEM = asthma specific job exposure 
matrix, HMW = high-molecular-weight agents, LMW = low-molecular-weight agents.
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5.4  Work and workplace exposure  
 associations with current asthma    
 status (study Iv)
5.4.1		Current	asthma	control,	occurrence	of	
exacerbations and asthma severity
A total of 40.5% of the subjects in the Asthma Group 2 had currently 
moderate or severe persistent asthma, while only 17.7% of the men in 
Asthma Group 1 had these severity forms of asthma (table 12). Asthma 
was also more often uncontrolled in Asthma Group 2 and exacerbations 
during last 12 months were more frequent.
Table 12. Current asthma status (study IV)
Asthma Group 1
n = 232
Asthma Group 2  
n = 161
p-value
Asthma control 0.002
   Well controlled (≥ 20) 85.2 (172) 72.0 (113)
   Poorly controlled (< 20*) 15.1 (30) 28.0 (44)
Asthma exacerbation 
during last 12 months
0.036
   No 88.4 (205) 80.8 (130)
   Yes 11.6 (27) 19.3 (31)
Asthma severity** < 0.001
   Remission 8.3 (17) 3.8 (6) 0.0793
   Intermittent 58.3 (119) 29.7 (47)
   Mild persistent 15.7 (32) 26.0 (41)
   Moderate persistent 11.8 (24) 24.0 (38)
   Severe persistent 5.9 (12) 16.5 (26)
Data are presented as % (n) unless otherwise stated. P-values for χ2 test
* = Asthma Control Test value
** = Based on the modified 2002 GINA-guidelines
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5.4.2  determinants of current poor asthma outcome
In the univariate model (data not shown) current smoking was associated 
with poorly controlled asthma in Asthma Group 1 (OR 3.6, 95%CI 
1.4–9.3) and in Asthma Group 2 (OR 2.5, 95%CI 1.1–5.5), whereas 
asthma exacerbations did not significantly correlate with smoking. In the 
smoking adjusted model (current smoker vs. ex-/non-smoker) Asthma 
Group 1 (men with mild/moderate asthma in youth) and Asthma Group 
2 (men with relatively severe asthma in youth) are analysed separately 
using logistic regression. 
Poorly controlled asthma
Being obese (OR 4.2, 95%CI 1.2–14.9) was significantly associated 
with poorly controlled asthma in Asthma Group 1. Not being currently 
employed yielded an OR of 3.5 (95%CI 1.1–11.0) and relief of asthma 
symptoms on days off an OR of 2.4 (95%CI 1.0–5.7) for currently 
poorly controlled asthma in Asthma Group 2.
occurrence of asthma exacerbations
Obesity and educational level showed no statistically significant associa-
tions with asthma exacerbations in past 12 months. In Asthma Group 
2, being a manual worker/self-employed (OR 4.5, 95%CI 1.2–16.3) 
and not being currently employed (OR 4.9, 95%CI 1.1–22.3) was sig-
nificantly associated with asthma exacerbations (table 13). Self-reported 
occupational exposure to asthma aggravating factors showed a clear 
tendency to associate with exacerbations in Asthma Group 2, with ORs 
between 2.0 and 3.5. However they had no statistical significance. We 
also detected some tendency of association between JEM-based exposure 
to non-asthmogenic irritants and asthma exacerbations. 
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Table 13. Determinants of occurrence of exacerbations studied with 
smoking adjusted model (study IV) 
Determinants at follow-up Asthma exacerbations
Asthma Group 1
n = 27
Asthma Group 2
n = 31
OR 95%CI OR 95%CI
Occupation 
   Non-manual worker 1 reference 1 reference
   Manual worker/self-employed 0.7 0.3–1.7 4.5 1.2–16.3
   Not employed/other/unknown 1.1 0.3–4.2 4.9 1.1–22.3
JEM-based occupational 
exposure in current job*
   Any asthmogen -no 1 reference 1 reference
   Any asthmogen -yes 0.4 0.1–3.5 0.6 0.1–2.7
   Non-asthmogenic irritants -no 1 reference 1 reference
   Non-asthmogenic irritants -yes 0.6 0.2–1.8 1.6 0.6–3.9
Self-reported occupational 
exposure in current job*
   Dust/chemical agents/gases/ 
   fumes -no
1 reference 1 reference
   Dust/chemical agents/gases/ 
   fumes -yes
0.7 0.3–1.9 3.5 0.8–16.6
   Abnormal temperatures -no 1 reference 1 reference
   Abnormal temperatures -yes 0.7 0.3–1.8 2.0 0.8–5.0
   Poor indoor quality -no 1 reference 1 reference
   Poor indoor quality -yes 1.3 0.5–3.7 2.2 0.8–5.7
   Physically strenuous work -no 1 reference 1 reference
   Physically strenuous work -yes 0.9 0.4–2.2 2.2 0.8–5.8
Significant OR values are shown in bold. This model is smoking adjusted (current 
smoker vs. ex-smoker or non-smoker). Other adjustments were not made, because 
all study participants were male and of the same age, and occupational exposure-
related variables correlated closely with each other and with the educational level.
* = Participants who were not currently employed or had changed jobs in 2008 
or 2009 were excluded from the analysis (44 participants in Asthma Group 1 and 
37 participants in Asthma Group 2). After the exclusion, 20 participants in Asthma 
Group 1 and 24 in Asthma Group 2 had asthma exacerbations. 
JEM = asthma specific job exposure matrix, CI = confidence interval
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Moderate or severe persistent asthma
We also analysed associations between current moderate or severe per-
sistent asthma and all the listed variables in table 13, educational level 
and obesity (data not shown). We found no significant associations.
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6.1  study population and methods
6.1.1 study population
We used the Finnish Defence Forces registers to select the study popula-
tions. In studies I and II, we selected the populations from the Register 
of Central Military Hospital, while in studies III–IV we also included 
data from a nationwide register, which has been used in earlier studies 
(Haahtela et al. 1990; Latvala et al. 2005). Our study subjects represented 
mainly men with the early onset atopic asthma -phenotype (Pavord 2012) 
and therefore our results are restricted to this asthma type.
study I
In study I, all 216 men with verified asthma in 2004–2005 from the 
register of the Central Military Hospital were included in the study base. 
These subjects represented a population of men with mild or moderate 
asthma aged 18–27, from southern and central parts of Finland. This 
population was homogenous as regards age and sex. The response rate 
was fairly high (68%). We limited our study to those men whose asthma 
was aggravated to such an extent that they were referred for a clinical 
evaluation in a pulmonary medicine unit. In 2004 and 2005 altogether 
about 55 000 young men aged around 20 started their military service 
in Finland. The prevalence of ever having had asthma before that age can 
be estimated to be about 6% in those men. Thus one can conclude that 
the majority of young men with an asthma history could complete their 
service without being referred for a clinical evaluation. No conclusions 
can be drawn on the prognosis of such cases of asthma.
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studies II–Iv
In the studies II–IV, the study population was homogenous as regards 
age and sex and represented unselected men from Southern and Cen-
tral parts of Finland. The asthma groups had a clinically verified disease 
at the age of 19–21 and represented various severity forms of asthma, 
while the control group had no asthma in youth. The asthma sever-
ity in youth of all asthmatics could be roughly evaluated based on the 
Defence Forces exemption criteria from military service. We identified 
two groups of asthmatics: recruits with asthma (Asthma Group 1) and 
asthmatics exempted from service (Asthma Group 2). This longitudinal 
setting allowed us to study associations between asthma lasting at least 
20 years and work ability as well as current asthma status. Although our 
results cannot be generalised to females or asthma starting later, the work 
ability of this subgroup of asthmatics as well as associations between 
workplace exposure and asthma are essential. These asthmatics have 
suffered from asthma for their entire or almost entire career and being 
male they are more likely to work in dusty workplaces. Furthermore 
most of the men we studied have had asthma since the age, when career 
choices are usually made.
The limitation of this study was the low response rate and the further 
non-participation of many subjects in the clinical follow-up visit. Based 
on the nationwide registers of the Finnish Social Insurance Institution on 
asthma medication and sick leave: 1) no significant differences between 
respondents and non-respondents in recruits with asthma were found and 
2) no significant differences between respondents and non-respondents 
in asthmatics exempted from service in asthma medication purchased in 
2008 or the number of periods of sick leave due to respiratory illness 
were found. We proved neither a statistically significant difference in 
baseline characteristics of men participating clinical follow-up visit and 
men, who answered the questionnaire without participating the clinical 
visit. However the possibility of selection bias cannot be ruled out. In 
questionnaire studies it is common for men in younger age-groups not 
to respond. A recent Swedish study with a male response rate of 56% 
showed no difference in respiratory symptoms between responders and 
non-responders (Ronmark et al. 2009). 
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HWE (Le Moual et al. 2008) is possible in this type of setting and 
may have led to an underestimation of associations between occupational 
exposures and asthma as well as work ability. As a large proportion of 
men in our study suffered from asthma already when career choices were 
made, one could expect that asthma could lead the asthmatics to choose 
less exposed jobs. However, in our study, current occupational exposure 
to asthma aggravating factors based on asthma-JEM and self-reports 
differed only slightly between the asthmatics and the control group. 
A change in occupation was most common in recruits with asthma ie. 
those with a later onset of the disease. Due to the 20 year follow-up we 
evaluated only occupations at the age of around 40 years, while Dumas 
et al studied first occupational choices and reported that the subjects 
having more severe asthma in childhood tended to choose less exposed 
jobs (Dumas et al. 2011).
One interesting finding was the lower socioeconomic status of 
asthmatics exempted from service i.e. those with more severe asthma in 
youth, when compared with recruits with asthma and controls. These 
men also currently had more severe asthma. The link between more 
severe asthma and low socioeconomic status has previously been shown 
among children (Almqvist et al. 2005) and adults (Bacon et al. 2009). 
The lower socioeconomic status of asthmatics exempted from service may 
have affected their work ability and the exposure to asthma aggravating 
factors in their current job.
Smoking was as common among the asthmatics as among the controls 
and associated with decreased work ability and poorer asthma outcome, 
which is in line with earlier reports (Ulrik 1999; Eisner et al. 2006; La-
forest et al. 2006; McLeish et al. 2010). Based on the Finnish guidelines 
“all health care workers should register smoking among patients, urge 
them to quit and offer help in cessation” (Tobacco dependence and 
cessation: Current Care guideline, 2012) and asthmatics in particular 
should be encouraged to stop (Asthma: Current Care guideline, 2012). 
Therefore, the high number of smoking asthmatics in our study is of con-
cern and disappointing as regards many health educational programmes.
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6.1.2  Methods
Lung function tests
In studies I and II we used the results of lung function tests and allergy 
tests as predictors for current asthma status. All lung function tests at 
baseline were performed by qualified technicians with uniform and 
validated methods in the clinical physiology laboratory of the Central 
Military Hospital, which had strict quality control procedures. The 
repeatability of measurements was always controlled according to the 
guidelines (ATS 1987; ATS 1995; Miller et al. 2005) and measurements 
with too large a variability were not accepted. 
In studies I and II, we used at baseline both a histamine challenge 
and exercise test in measuring airway hyperresponsiveness. Exercise tests 
have shown to have higher specificity, but lower sensitivity in diagnosing 
asthma in comparative studies of these tests (Cockcroft 2010). In another 
study, adding the inhalation of cold air increased the sensitivity of the 
exercise test, while still maintaining specificity (Carlsen et al. 1998). The 
severity of exercise-induced bronchocontriction depends on the level of 
ventilation and on the temperature of the inspired air. Thus, the exercise 
tests in this study were heart-rate conducted and temperature adjust-
ments for PEF calculations were included, as Rouhos et al. described in 
an earlier study (Rouhos et al. 2005). Despite temperature adjustments, 
the complex effect of the season on the exercise test results cannot be 
ruled out, because exercise tests were performed outdoors in all seasons. 
Karjalainen et al demonstrated aggravated exercise-induced asthma 
response in asthmatics with pollen allergy, when the outdoor exercise 
test was performed during the pollen season rather than in wintertime 
(Karjalainen et al. 1989). However, subjects with non-allergic asthma 
had diminished exercise-induced bronchoconstriction in spring time 
probably due to more humid, warmer weather. Goldberg et al. reported 
a lower proportion of positive exercise test results during the summer 
than in other seasons, and suggested that this was related to the lower 
activity of asthma during the summer (Goldberg et al. 2005). However 
this study is from Israel, where, contrary to Finland, summer is not a 
pollen season. The other limitation in our study was the use of manual 
PEF-meter and PEF values instead of spirometric FEV1 in the evaluation 
of exercise reaction.
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Assessment of asthma severity
Assessment of asthma severity is complex and lacks a golden standard 
suitable for epidemiological studies. In our studies we used the 2002 
GINA severity classification, which combines parameters of asthma treat-
ment, lung function and frequency of asthma symptoms (GINA 2002). 
The 2002 GINA severity classification has been used in epidemiological 
studies and it has been held as a good determinant of asthma morbidity 
(Liard et al. 2000; Limb et al. 2005; de Marco et al. 2006; Cazzoletti et 
al. 2010). Due to the complexity of this classification it is poorly suited 
to clinical practice and may be also difficult in epidemiological studies 
(Taylor et al. 2008a). In our study II, two chest physicians classified 
the asthma severity separately using GINA 2002 classification. These 
classifications proved congruent with each other having the kappa coef-
ficient between the two observations 0.90. In studies I, III and IV, we 
carried out current severity assessment without FEV1, as has been done 
previously (Taylor et al. 2008b). This might have led to underestima-
tion of asthma severity rather than overestimation. Previously bronchial 
hyperresponsiviness and airway inflammation were observed despite a 
clinically apparent remission of asthma (van Den Toorn et al. 2000).
Based on recent recommendations, asthma severity should be classi-
fied on the basis of the intensity of treatment required to achieve good 
asthma control (GINA 2012). “This concept is appropriate for patients 
who have access to optimal drug treatments and to evaluate the response 
of patients to these interventions”, as WHO Consultation –document 
summarises (Bousquet et al 2010). In epidemiological population stud-
ies, as in our study, this type of severity classifications is difficult because 
many patients are undertreated based on treatment guidelines. It is 
also noteworthy that control usually refers to events occurring recently, 
whereas severity refers to those occurring over a longer period (6–12 
months) (Bousquet et al 2010). In our study the severity classification 
was based on the asthma morbidity during the previous 12 months and 
took account both the severity of disease and its response to the treatment, 
although it differed from the current recommendation (GINA 2012). 
The majority of asthmatics in our study had the atopic phenotype which 
typically has concordance between symptoms, inflammation and lung 
function as well as a good response to ICS, Therefore the GINA 2002 
severity classification may have been particularly suitable for our study. 
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Assessment of work ability
The diverse nature of work ability makes its definition and measurement 
a challenge. As the age of the population studied has a remarkable effect 
on the work ability (Gould et al 2008), the indicators of severe forms of 
work disability, like disability pension or long-term sick leave were not 
appropriate in our study with relatively young participants.
We used the Work Ability Index (WAI) in assessment of current work 
ability. WAI has been developed in a follow-up study that involved age-
ing municipal workers in different types of occupations (Ilmarinen et 
al. 1997; Tuomi et al. 2006). The WAI is based on a series of questions 
that take into consideration the physical and mental demands of work 
and the health resources of the worker. The internal validity of WAI 
has shown a satisfactory relationship between the subjects’ WAI results 
and more objective measurements (Eskelinen et al. 1991; Nygard et al. 
1991) and the test-retest reliability has proved to be good (de Zwart et 
al. 2002). Our main indicator of work ability was the single question 
of current work ability compared with lifetime best on a scale of 0–10. 
This question has appeared to have a strong association with the whole 
WAI and predict the future degree of sick leave (Ahlstrom et al. 2010). 
Assessment of occupational exposure
In our study the occupational exposure evaluation was based on self-
reports and the asthma specific JEM developed by Kennedy et al (Ken-
nedy et al. 2000). The former is subject to reporting bias (de Vocht et al. 
2005), while the latter is subject to classification bias. One limitation in 
our study was that we were not able to evaluate the occupational exposure 
during the whole career. The whole working history was included in the 
questionnaire, but due to a significant amount of missing and conflicting 
data we were not able to obtain reliable information. 
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6.2  Main results
6.2.1  Majority of asthmatics have mild disease
In study I, we found that asthma was significantly less severe two years 
after military service than during it and over 60% of the participants had 
remitted or intermittent asthma based on the questionnaire. Subjects with 
new-onset asthma during military service had less atopic characteristics 
and also milder asthma at the two-year follow-up. Earlier studies have 
demonstrated an increased frequency of asthma exacerbation among re-
cruits who already have the disease, and new-onset asthma was associated 
with military service in combat units (Katz et al. 1999). However, only 
limited knowledge about asthma prognosis after military service exists.
In study II, based on the clinical data of 119 men with asthma since 
youth, 11.8% of the men were in remission, 42.0% had intermittent 
asthma, 10.9% had mild persistent asthma, and 35.3% had moderate/
severe persistent asthma at around 40 years of age. This distribution of 
asthma severity is in line with that of the ECRHS II, where in the follow-
up cohort 11.9% were in remission, 45.3% had intermittent asthma, 
8.1% mild persistent asthma and 34.7% moderate/severe persistent 
asthma (de Marco et al. 2006). Both in the ECRHS II and in our study, 
asthma severity classification was based on GINA 2002 and the mean age 
of study population was around 40 years. Our study population consisted 
of men only, but Raherison et al reported no gender difference in asthma 
severity in the ECRHS II (Raherison et al. 2009). In the follow-up part 
of OLIN study a higher proportion of participants had more severe 
forms of asthma. However in that study only subjects who developed 
asthma after the age of 20 years were included (Ronmark et al. 2007). 
In study IV, based on the questionnaire data of 393 asthmatics, 15% 
of men in recruits with asthma and 28% of the men in asthmatics exempted 
from service had poorly controlled asthma based on the ACT scores. 
Earlier population-based studies have reported a higher proportion of 
asthmatics having uncontrolled disease (de Marco et al. 2003; Rabe et 
al. 2004; Peters et al. 2007). For example, in ERCHS II some 66% of 
participants had poorly controlled asthma (Cazzoletti et al. 2007). These 
differences between our results and other studies can be explained by 
the fact that significant proportion of the asthmatics in our study had 
remitted or intermittent disease.
98
6 discussion
6.2.2 Predictors of persistent asthma 
More severe asthma at baseline was a clear predictor of persistent asthma 
short-term (study I) and long-term (study II). Furthermore based on 
our questionnaire data those (studies III–IV) men who were exempted 
from military service, i.e. had roughly evaluated more severe disease in 
youth, currently also had a more severe form of the disease compared to 
subjects belonging to recruits with asthma -group at baseline. The severity 
of childhood asthma has also been shown to predict asthma severity in 
adulthood in an earlier study (Limb et al. 2005). 
Atopy, number of positive skin prick tests, and total serum IgE was 
significantly associated with persistent asthma in 2-year follow-up. Sev-
eral earlier studies have linked presence of allergic sensitisation to the 
persistence of asthma from childhood to adulthood (Sears et al. 2003; 
Guerra et al. 2004; Limb et al. 2005; Taylor et al. 2005). In the ECRHS 
studies sensitisation to outdoor moulds, atopy and higher IgE levels have 
been associated with more severe forms of asthma (Zureik et al. 2002; 
de Marco et al. 2006; Cazzoletti et al. 2010).
A decreased FEV1 and a decreased FEV1/FVC ratio in prebronchodilator 
spirometry was significantly associated with current persistent asthma 20-
year later. Many earlier studies have associated obstructive spirometry, for 
example, a decreased FEV1/FVC ratio in asthmatic children, with poorer 
asthma prognosis (Rasmussen et al. 2002; Sears et al. 2003; Toelle et al. 
2004; Vonk et al. 2004). In adult studies, a decreased FEV1 has predicted 
more severe asthma later (Panhuysen et al. 1997; de Marco et al. 2006). 
In addition to other spirometry parameters, a decreased FEF50% at 
baseline was associated with persistent asthma at follow-up. FEF25–75% and 
FEF50% are the spirometric variables most commonly cited as indicators 
of small airway obstruction. Although small airways have been linked 
to recurrent exacerbations of asthma (in ‘t Veen et al. 2000), nocturnal 
asthma (Lehtimaki et al. 2002) and also milder asthma (Beigelman-Aubry 
et al. 2002), there are only a few longitudinal studies related to small 
airways (van Veen et al. 2008).
A positive exercise test was associated with asthma persistence 20 years 
later in our study, but airway hyperresponsiveness to a histamine chal-
lenge had no effect on asthma prognosis. About three quarters of study 
subjects underwent a histamine challenge, while all of them underwent 
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the exercise test. The histamine challenge was not performed on some 
subjects due to obstructive spirometry and thismay affect its predic-
tive value. Airway hyperresponsiveness to metacholine or histamine in 
childhood has previously been connected to the persistence of asthma 
symptoms or their onset in adult life (Sears et al. 2003; Toelle et al. 2004). 
Moreover, less severe airway hyperresponsiveness has been associated with 
the development of irreversible airflow limitation (Vonk et al. 2003). 
Little is known about the effect of positive exercise tests on the long-term 
prognosis of asthma, although exercise-related respiratory symptoms have 
predicted persistence of asthma in children (Frank et al. 2007).
6.2.3 Reduced work ability in men with asthma 
since youth
We found that asthma which begins in childhood or early adulthood is 
associated with a reduction of self-assessed work ability in men around the 
age of 40. Our first asthma group had mild to moderate asthma, and the 
second relatively severe asthma in their youth. We compared the work abil-
ity of these groups with that of the controls without asthma in youth. The 
self-assessed work ability compared with lifetime best and work ability as 
regards physical job demands were reduced in both recruits with asthma 
and asthmatics exempted from service even when taking into account the 
confounders. Work ability in relation to the mental demands of the work 
was reduced only in asthmatics exempted from service. These results seem 
to make sense, because physical exertion may increase asthma symptoms 
and thus may have an effect on work ability as regards of physical job 
demands even in subjects with mild asthma.
Several aspects support considering that the observed reduction of 
work ability of the asthmatics is important from socioeconomic per-
spective. Firstly, asthma is a common disease with increasing incidence 
in younger age groups (Lai et al. 2009) and in the future the number of 
workers with early-onset asthma will probably be higher than currently. 
Secondly, 40-year- old men are an essential part of workforce and they 
should generally have good work ability and be without any disabling 
diseases (Gould et al 2008). Thirdly, as reduced self-assessed work abil-
ity is predictive of future sick leave and disability (Ahlstrom et al. 2010, 
Ilmarinen et al 1997), it can be suggested that ageing of our study subjects 
may lead to increased absence from work and possibly shorter career.
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Reduced self-estimated work ability has been connected to asthma 
also in earlier studies. Balder et al reported that 44% of 332 subjects with 
recent-onset asthma had decreased self-estimated work ability (Balder 
et al. 1998). In the Finnish Health 2000 Survey the mean work ability 
compared with lifetime best in on a scale of 0–10 was 7.1 in men with 
asthma and 8.0 in men without asthma (p < 0.001) (Gould et al 2008).
A French cohort study with a five-year follow-up showed no dif-
ference in the employment situation of working-age male asthmatics 
with childhood-onset asthma compared with non-asthmatics. These 
asthmatics worked in blue-collar jobs less often (Thaon et al. 2008). 
The somewhat different results in our study may indicate that choices 
concerning career and other selection mechanisms play different roles 
among French asthmatics than among the Finnish survey participants. 
It is noteworthy that nearly all subjects in our study currently have ac-
tive asthma, while in the French study over 70% of the subjects with 
childhood-onset asthma were classified as having asthma only in the past. 
Whether these differences are due to selection processes or a different 
overall severity or phenotype of asthma at baseline level is difficult to 
judge. Other population-based studies have shown that asthma is asso-
ciated with reduced employment (Blanc et al. 2001; Yelin et al. 2006).
6.2.4  the risk factors of decreased work ability
Among the asthmatics, current severe asthma, currently smoking, lower 
educational level and a blue collar occupation had the strongest associa-
tions with decreased work ability. Exposure to irritants, based on JEM, 
and self-reported occupational exposure to abnormal temperatures, was 
also associated with reduced work ability.
Most of the risk factors for decreased work ability that we found have 
also been reported previously, such as the severity of the disease (Blanc 
et al. 1993; Blanc et al. 1996; Balder et al. 1998; Eisner et al. 2006), 
smoking (Blanc et al. 2003; Eisner et al. 2006), workplace exposures to 
irritants (Blanc et al. 1999a; Blanc et al. 2003; Toren et al. 2009b), a 
blue-collar occupation (Hansen et al. 2012) and a lower educational level 
(Mancuso et al. 2003; Eisner et al. 2006). The lack of information on 
co-morbidities was a disadvantage in our study, as co-morbidities have 
been associated with decreased work ability among asthmatics (Hakola 
et al. 2011).
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6.2.5  the associations between current 
occupational exposure and current asthma 
status
In asthmatics exempted from service, working as a manual worker/self-
employed was significantly associated with asthma exacerbations and 
self-reported occupational exposure to asthma-aggravating factors showed 
a clear tendency to be associated with asthma exacerbations. In recruits 
with asthma, their current professional status and exposure had less ef-
fect on current asthma status. The ECRHS demonstrated a stronger 
association between occupational exposure and asthma exacerbations. 
The relative risk of a severe asthma exacerbation during the last year was 
3.1 in participants with JEM-based occupational exposure to dust/gas/
fumes (Henneberger et al. 2010). This association, which was stronger 
than that of our results, can be explained by the fact that the ECRHS 
included females and participants with adult-onset asthma, and also by 
the use of a different JEM.
In our study, current occupational exposure did not correlate with 
asthma severity. Gaga et al. reported neither associations between oc-
cupational exposure and severe asthma (Gaga et al. 2005). In another 
study a positive association between severe asthma and the exposure to 
occupational asthmogens or irritants was found among participants with 
adult-onset, while the authors did not detect this association among 
participants with childhood-onset asthma (Le Moual et al. 2005). In a 
Swedish study, occupational exposure to gas dust or fumes yielded an 
OR of 2.0 for multi-symptom asthma, which could be used as a marker 
of more severe asthma (Ekerljung et al. 2011). 
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As our study populations consisted mainly of men with early-onset 
atopic asthma, the conclusions cannot be generalised to other types of 
populations or asthma phenotypes. 
Asthma is significantly milder two years after military service than 
during service. The short-term asthma prognosis is particularly good in 
subjects who suffered new-onset asthma during service. We found an 
association between allergic sensitisation and more severe asthma during 
service and after it. Asthma onset during early childhood tended to be 
associated with more severe asthma, but below statistical significance in 
this relatively small population. These prognostic factors can be useful 
when planning the criteria for exemption at call-up.
About half of the male conscripts suffering from different severity 
forms of asthma at the age of around 20 had persistent asthma approxi-
mately 20 years later. A decreased FEV1/FVC, a decreased FEF50% and 
a positive exercise test were associated with persistence of asthma. Over 
half of the subjects had a decreased FEF50% as well as a positive exercise 
test at baseline and these parameters may be clinically meaningful prog-
nostic measurements in males with asthma that began at a young age. 
The exercise test was superior to the histamine challenge in predicting 
the persistence of asthma, and it could be useful in evaluating long-term 
asthma prognosis, although further studies are needed to confirm this. 
Clinicians should not ignore the decreased forced expiratory flow rate at 
50% of vital capacity in spirometry and a positive exercise test. 
Both mild and more severe asthma at the age of around 20 seems to 
be associated with reduced work ability in 40-year-old males. The high-
est risk for decreased work ability is in asthmatics having a severe form 
of the disease, smoking or working in blue-collar jobs with exposure to 
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irritants. Therefore occupational health care professionals should pay 
attention to the work ability of men with asthma from youth, especially 
those with currently severe symptoms of the disease and support their 
work ability accordingly.
In middle-aged men who had relatively severe asthma at the age of 
around 20 current work and occupational exposure may be associated 
with the occurrence of asthma exacerbations. However, in men with 
milder asthma the role of current workplace exposure on asthma seems 
to be less significant. Therefore, it is advisable to take asthma severity into 
account in the vocational guidance of young male asthmatics. Based on 
our results the career restrictions seem to be unjustified for young men 
with relatively mild asthma. However, paying attention to the choice 
of future work environment and avoidance of exposure to respiratory 
irritants may be relevant for young men with a more severe form of 
asthma. These conclusions are in line with the current recommendation 
of the Finnish Allergy Programme. 
104
ACknoWLedgeMents
The studies in this thesis were carried out in the Finnish Institute of Oc-
cupational Health, in the Finnish Defence Forces and in the Division 
of Respiratory Diseases, Department of Medicine, Faculty of Medicine, 
University of Helsinki.
I owe my warmest thanks to my supervisor Professor Antti Lauerma, 
who played an invaluable role in the starting and in the financing of 
this project. I appreciate his expertise in mechanisms of allergy and im-
munology as well as his skill in leading research projects. I admire my 
other supervisor Docent Antti Karjalainen for his excellence in the field 
of respiratory epidemiology. I am deeply grateful for his constant wise 
advising, accurate editing of the manuscripts, and teaching of epide-
miological methods.
I express my gratitude to Professor Paula Maasilta for her support and 
to my former and current superiors, namely, Professor Helena Taskinen, 
Professor Kaj Husman, Docent Kristina Aalto-Korte and Jorma Mäki-
talo, PhD for their interest in my research and for providing me with 
opportunities to conduct the studies. I also acknowledge the Finnish 
Defence Forces for co-operation in particular Harri Pihlajamäki, Kari 
Kelho, Olli Ohrankämmen, Miika Rouvinen, and Ritva Saari-Uusitalo.
I thank the official reviewers of this dissertation, Professor Hannu 
Kankaanranta and Docent Jussi Karjalainen for their elegant way of 
performing the review process. I appreciate their constructive comments 
which made me learn more about the current concepts of asthma inflam-
mation and greatly improved this thesis.
My warmest appreciation goes to all my co-authors, to Ritva Luuk-
konen for her aid with statistics and methods, to Jouko Karjalainen for 
his always relevant comments and support, to Harri Lindholm for his 
105
ACKNOWLEDGEMENTS
expertise in clinical physiology, to Paula Kauppi for her support, and to 
Pekka Koponen and Jari Latvala for being active in starting this study. 
I thank my dear colleague, Paula Pallasaho for her firm support, her 
insightful comments, and, in particular, her making the last push to 
get me to finalize this work. I am most grateful to Hille Suojalehto for 
her valuable advice, for sharing bad and good moments in the field of 
science as well as in personal life, and for her friendship.
I warmly thank Outi Fischer, Tuula Suomela, Seija Karas, Sari Fisher, 
Tuula Riihimäki, Suvi-Päivikki Salo, and the other nurses for profes-
sionally conducting this study always with a positive attitude as well as 
my colleagues in the policlinic of Occupational Medicine and my co-
workers in the unit of System Toxicology for their co-operation as nice 
workmates. In particular, Kirsi Karvala, Heikki Frilander, Aki Vuokko, 
and Eva Helaskoski receive my gratitude for their peer support. I owe 
my warmest thanks to Virve Mertanen-Halinen and Mari Pakarinen 
for professional editing of this thesis. My warmest appreciation goes to 
the colleagues with whom I shared the years of specialization for all the 
joy we have had. 
I thank all of the 1147 men who voluntarily took part in the studies 
and thus made them possible.
I sincerely acknowledge the Finnish Work Environment Fund, the 
Finnish Defence Forces, Hengityselinliitto, the Ida Montin Foundation, 
the Väinö ja Laina Kivi Foundation, and the Yrjö Jansson Foundation 
for funding the study. 
Dear Laura L., Laura R., Satu, Susanna, Sanna, Sini, Heli, Mari, Tiina, 
and Tuija I am highly privileged to have such great women as you as 
my close friends. My lovely parents-in-law Hans and Pirkko Lindström 
as well as my dear aunt Anita Koivu, I am so happy that we belong to 
the same family. I am grateful to my dear brother Ilkka, his wife Tarja 
and their sons Teemu, Antti and Lauri as well as my other dear brother 
Tapio with his partner Helena for the support of all of them, and for all 
the happy moments we have shared throughout the years.
I thank my parents Arna and Paavo Kalo for providing me with firm 
grounding for life and for encouragement and love through my life. I 
am so grateful to my parents, my parents-in-law and our dear Eva-Stina 
Berglund for all your practical help during these past busy years; your 
presence in our daily life has certainly given stronger wings to our dear 
106
ACKNOWLEDGEMENTS
daughters. My wise Sonja, my sweetheart Ellen and my brave Hanna, I 
love you so much and hope that all your dreams will come true. At last, 
my beloved Petu, the brightest light of my life, thanks for being you and 
standing by me throughout this work. I am sorry about my absences 
during the past months, but be aware I will be back soon!
Helsinki, June 2013
Irmeli Lindström
107
RefeRenCes
Ahlstrom L, Grimby-Ekman A, Hagberg M and Dellve L. The work ability index and single-
item question: associations with sick leave, symptoms, and health – a prospective study 
of women on long-term sick leave. Scand J Work Environ Health 2010; 36(5):404–412.
Almqvist C, Pershagen G and Wickman M. Low socioeconomic status as a risk factor for asthma, 
rhinitis and sensitization at 4 years in a birth cohort. Clin Exp Allergy 2005; 35(5):612–618.
Almqvist C, Worm M and Leynaert B. Impact of gender on asthma in childhood and adolescence: 
a GA2LEN review. Allergy 2008; 63(1):47–57.
Anandan C, Nurmatov U, van Schayck OC and Sheikh A. Is the prevalence of asthma declining? 
Systematic review of epidemiological studies. Allergy 2010; 65(2):152–167.
Anderson HR. Prevalence of asthma. Bmj 2005; 330(7499):1037–1038.
Andersson E, Knutsson A, Hagberg S, Nilsson T, Karlsson B, Alfredsson L and Toren K. Inci-
dence of asthma among workers exposed to sulphur dioxide and other irritant gases. Eur 
Respir J 2006; 27(4):720–725.
Anees W, Huggins V, Pavord ID, Robertson AS and Burge PS. Occupational asthma due to 
low molecular weight agents: eosinophilic and non-eosinophilic variants. Thorax 2002; 
57(3):231–236.
Anto JM. Recent Advances in the Epidemiologic Investigation of Risk Factors for Asthma: A 
Review of the 2011 Literature. Curr Allergy Asthma Rep 2012.
Anto JM, Sunyer J, Basagana X, Garcia-Esteban R, Cerveri I, de Marco R, Heinrich J, Janson C, 
Jarvis D, Kogevinas M, Kuenzli N, Leynaert B, Svanes C, Wjst M, Gislason T and Burney 
P. Risk factors of new-onset asthma in adults: a population-based international cohort study. 
Allergy 2010; 65(8):1021–1030.
Asthma (online). Current Care guideline. Working group set up by the Finnish Medical Society 
Duodecim, the Finnish Respiratory Society, the Finnish Pediatric Society and the Finnish 
Society of Clinical Physiology. Helsinki: Finnish Medical Society Duodecim, 2012 (referred 
24 September, 2012). Available online at: www.kaypahoito.fi
ATS. Standardization of spirometry – 1987 update. Statement of the American Thoracic Society. 
Am Rev Respir Dis 1987; 136(5):1285–1298.
ATS. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit 
Care Med 1995; 152(3):1107–1136.
108
references
Bacon SL, Bouchard A, Loucks EB and Lavoie KL. Individual-level socioeconomic status is 
associated with worse asthma morbidity in patients with asthma. Respir Res 2009; 10:125.
Bahadori K, Doyle-Waters MM, Marra C, Lynd L, Alasaly K, Swiston J and FitzGerald JM. 
Economic burden of asthma: a systematic review. BMC Pulm Med 2009; 9:24.
Bakerly ND, Moore VC, Vellore AD, Jaakkola MS, Robertson AS and Burge PS. Fifteen-year 
trends in occupational asthma: data from the Shield surveillance scheme. Occup Med 
(Lond) 2008; 58(3):169–174.
Balder B, Lindholm NB, Lowhagen O, Palmqvist M, Plaschke P, Tunsater A and Toren K. 
Predictors of self-assessed work ability among subjects with recent-onset asthma. Respir 
Med 1998; 92(5):729–734.
Balmes J, Becklake M, Blanc P, Henneberger P, Kreiss K, Mapp C, Milton D, Schwartz D, Toren 
K and Viegi G. American Thoracic Society Statement: Occupational contribution to the 
burden of airway disease. Am J Respir Crit Care Med 2003; 167(5):787–797.
Bang KM, Hnizdo E and Doney B. Prevalence of asthma by industry in the US population: a 
study of 2001 NHIS data. Am J Ind Med 2005; 47(6):500–508.
Barnes PJ. New drugs for asthma. Semin Respir Crit Care Med 2012; 33(6):685–694.
Baur X, Sigsgaard T, Aasen TB, Burge PS, Heederik D, Henneberger P, Maestrelli P, Rooyackers 
J, Schlunssen V, Vandenplas O and Wilken D. Guidelines for the management of work-
related asthma. Eur Respir J 2012; 39(3):529–545.
Beigelman-Aubry C, Capderou A, Grenier PA, Straus C, Becquemin MH, Similowski T and 
Zelter M. Mild intermittent asthma: CT assessment of bronchial cross-sectional area and 
lung attenuation at controlled lung volume. Radiology 2002; 223(1):181–187.
Bel EH, Sousa A, Fleming L, Bush A, Chung KF, Versnel J, Wagener AH, Wagers SS, Sterk 
PJ and Compton CH. Diagnosis and definition of severe refractory asthma: an interna-
tional consensus statement from the Innovative Medicine Initiative (IMI). Thorax 2011; 
66(10):910–917.
Berger Z, Rom WN, Reibman J, Kim M, Zhang S, Luo L and Friedman-Jimenez G. Prevalence 
of workplace exacerbation of asthma symptoms in an urban working population of asth-
matics. J Occup Environ Med 2006; 48(8):833–839.
Bernstein IL, Chan-Yeung M, Malo JL and Bernstein D, Eds. (2006). Asthma in the Workplace. 
New York, Taylor&Francis.
Blanc PD, Burney P, Janson C and Toren K. The prevalence and predictors of respiratory-
related work limitation and occupational disability in an international study. Chest 2003; 
124(3):1153–1159.
Blanc PD, Cisternas M, Smith S and Yelin EH. Asthma, employment status, and disability 
among adults treated by pulmonary and allergy specialists. Chest 1996; 109(3):688–696.
Blanc PD, Ellbjar S, Janson C, Norback D, Norrman E, Plaschke P and Toren K. Asthma-related 
work disability in Sweden. The impact of workplace exposures. Am J Respir Crit Care Med 
1999a; 160(6):2028–2033.
109
references
Blanc PD, Jones M, Besson C, Katz P and Yelin E. Work disability among adults with asthma. 
Chest 1993; 104(5):1371–1377.
Blanc PD and Toren K. How much adult asthma can be attributed to occupational factors? Am 
J Med 1999b; 107(6):580–587.
Blanc PD, Trupin L, Eisner M, Earnest G, Katz PP, Israel L and Yelin EH. The work impact 
of asthma and rhinitis: findings from a population-based survey. J Clin Epidemiol 2001; 
54(6):610–618.
Bolen AR, Henneberger PK, Liang X, Sama SR, Preusse PA, Rosiello RA and Milton DK. The 
validation of work-related self-reported asthma exacerbation. Occup Environ Med 2007; 
64(5):343–348.
Boulet LP, Boulet V and Milot J. How should we quantify asthma control? A proposal. Chest 
2002; 122(6):2217–2223.
Bousquet J, Mantzouranis E, Cruz AA, Ait-Khaled N, Baena-Cagnani CE, Bleecker ER, Bright-
ling CE, Burney P, Bush A, Busse WW, Casale TB, Chan-Yeung M, Chen R, Chowdhury 
B, Chung KF, Dahl R, Drazen JM, Fabbri LM, Holgate ST, Kauffmann F, Haahtela T, 
Khaltaev N, Kiley JP, Masjedi MR, Mohammad Y, O’Byrne P, Partridge MR, Rabe KF, 
Togias A, van Weel C, Wenzel S, Zhong N and Zuberbier T. Uniform definition of asthma 
severity, control, and exacerbations: document presented for the World Health Organization 
Consultation on Severe Asthma. J Allergy Clin Immunol 2010; 126(5):926–938.
Brannan JD, Koskela H, Anderson SD and Chan HK. Budesonide reduces sensitivity and reac-
tivity to inhaled mannitol in asthmatic subjects. Respirology 2002; 7(1):37–44.
Brannan JD and Lougheed MD. Airway hyperresponsiveness in asthma: mechanisms, clinical 
significance, and treatment. Front Physiol 2012; 3:460.
Brick J. Standardization of alcohol calculations in research. Alcohol Clin Exp Res 2006; 
30(8):1276–1287.
Burke H, Leonardi-Bee J, Hashim A, Pine-Abata H, Chen Y, Cook DG, Britton JR and McKeever 
TM. Prenatal and Passive Smoke Exposure and Incidence of Asthma and Wheeze: Systematic 
Review and Meta-analysis. Pediatrics 2012.
Burke W, Fesinmeyer M, Reed K, Hampson L and Carlsten C. Family history as a predictor of 
asthma risk. Am J Prev Med 2003; 24(2):160–169.
Caldeira RD, Bettiol H, Barbieri MA, Terra-Filho J, Garcia CA and Vianna EO. Prevalence 
and risk factors for work related asthma in young adults. Occup Environ Med 2006; 
63(10):694–699.
Carlsen KH, Engh G, Mork M and Schroder E. Cold air inhalation and exercise-induced 
bronchoconstriction in relationship to metacholine bronchial responsiveness: different 
patterns in asthmatic children and children with other chronic lung diseases. Respir Med 
1998; 92(2):308–315.
Cazzoletti L, Marcon A, Corsico A, Janson C, Jarvis D, Pin I, Accordini S, Bugiani M, Cerveri 
I, Gislason D, Gulsvik A and de Marco R. Asthma Severity According to Global Initiative 
for Asthma and Its Determinants: An International Study. Int Arch Allergy Immunol 2010; 
151(1):70–79.
110
references
Cazzoletti L, Marcon A, Janson C, Corsico A, Jarvis D, Pin I, Accordini S, Almar E, Bugiani 
M, Carolei A, Cerveri I, Duran-Tauleria E, Gislason D, Gulsvik A, Jogi R, Marinoni A, 
Martinez-Moratalla J, Vermeire P and de Marco R. Asthma control in Europe: a real-world 
evaluation based on an international population-based study. J Allergy Clin Immunol 2007; 
120(6):1360–1367.
Chalmers GW, MacLeod KJ, Thomson L, Little SA, McSharry C and Thomson NC. Smoking 
and airway inflammation in patients with mild asthma. Chest 2001; 120(6):1917–1922.
Chanez P, Wenzel SE, Anderson GP, Anto JM, Bel EH, Boulet LP, Brightling CE, Busse WW, 
Castro M, Dahlen B, Dahlen SE, Fabbri LM, Holgate ST, Humbert M, Gaga M, Joos GF, 
Levy B, Rabe KF, Sterk PJ, Wilson SJ and Vachier I. Severe asthma in adults: what are the 
important questions? J Allergy Clin Immunol 2007; 119(6):1337–1348.
Chen R and Seaton A. The influence of study characteristics on the healthy worker effect: a 
multiple regression analysis. Occup Med (Lond) 1996; 46(5):345–350.
Chinn S, Jarvis D, Burney P, Luczynska C, Ackermann-Liebrich U, Anto JM, Cerveri I, De Marco 
R, Gislason T, Heinrich J, Janson C, Kunzli N, Leynaert B, Neukirch F, Schouten J, Sunyer 
J, Svanes C, Vermeire P and Wjst M. Increase in diagnosed asthma but not in symptoms 
in the European Community Respiratory Health Survey. Thorax 2004; 59(8):646–651.
Chiry S, Cartier A, Malo JL, Tarlo SM and Lemiere C. Comparison of peak expiratory flow 
variability between workers with work-exacerbated asthma and occupational asthma. Chest 
2007; 132(2):483–488.
Chu YT, Chen WY, Wang TN, Tseng HI, Wu JR and Ko YC. Extreme BMI predicts higher 
asthma prevalence and is associated with lung function impairment in school-aged children. 
Pediatr Pulmonol 2009; 44(5):472–479.
Cockcroft DW. Direct challenge tests: Airway hyperresponsiveness in asthma: its measurement 
and clinical significance. Chest 2010; 138(2 Suppl):18S–24S.
Cockcroft DW and Swystun VA. Asthma control versus asthma severity. J Allergy Clin Immunol 
1996; 98(6 Pt 1):1016–1018.
Covar RA, Spahn JD, Murphy JR and Szefler SJ. Progression of asthma measured by lung fun-
ction in the childhood asthma management program. Am J Respir Crit Care Med 2004; 
170(3):234–241.
The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic 
severe asthma. European Network for Understanding Mechanisms of Severe Asthma. Eur 
Respir J 2003; 22(3):470–477.
de Marco R, Bugiani M, Cazzoletti L, Carosso A, Accordini S, Buriani O, Carrozzi L, Dallari 
R, Giammanco G, Ginesu F, Marinoni A, Lo Cascio V, Poli A, Struzzo P and Janson C. 
The control of asthma in Italy. A multicentre descriptive study on young adults with doctor 
diagnosed current asthma. Allergy 2003; 58(3):221–228.
de Marco R, Cappa V, Accordini S, Rava M, Antonicelli L, Bortolami O, Braggion M, Bugiani 
M, Casali L, Cazzoletti L, Cerveri I, Fois AG, Girardi P, Locatelli F, Marcon A, Marinoni A, 
Panico MG, Pirina P, Villani S, Zanolin ME and Verlato G. Trends in the prevalence of asth-
ma and allergic rhinitis in Italy between 1991 and 2010. Eur Respir J 2012; 39(4):883–892.
111
references
de Marco R, Locatelli F, Cerveri I, Bugiani M, Marinoni A and Giammanco G. Incidence and 
remission of asthma: a retrospective study on the natural history of asthma in Italy. J Allergy 
Clin Immunol 2002; 110(2):228–235.
de Marco R, Marcon A, Jarvis D, Accordini S, Almar E, Bugiani M, Carolei A, Cazzoletti L, 
Corsico A, Gislason D, Gulsvik A, Jogi R, Marinoni A, Martinez-Moratalla J, Pin I and 
Janson C. Prognostic factors of asthma severity: a 9-year international prospective cohort 
study. J Allergy Clin Immunol 2006; 117(6):1249–1256.
de Marco R, Marcon A, Jarvis D, Accordini S, Bugiani M, Cazzoletti L, Cerveri I, Corsico A, 
Gislason D, Gulsvik A, Jogi R, Martinez-Moratalla J, Pin I and Janson C. Inhaled steroids 
are associated with reduced lung function decline in subjects with asthma with elevated 
total IgE. J Allergy Clin Immunol 2007; 119(3):611–617.
de Vocht F, Zock JP, Kromhout H, Sunyer J, Anto JM, Burney P and Kogevinas M. Compari-
son of self-reported occupational exposure with a job exposure matrix in an international 
community-based study on asthma. Am J Ind Med 2005; 47(5):434–442.
de Zwart BC, Frings-Dresen MH and van Duivenbooden JC. Test-retest reliability of the Work 
Ability Index questionnaire. Occup Med (Lond) 2002; 52(4):177–181.
Dijkstra A, Vonk JM, Jongepier H, Koppelman GH, Schouten JP, ten Hacken NH, Timens W 
and Postma DS. Lung function decline in asthma: association with inhaled corticosteroids, 
smoking and sex. Thorax 2006; 61(2):105–110.
Donnay C, Denis MA, Magis R, Fevotte J, Massin N, Dumas O, Pin I, Choudat D, Kauffmann 
F and Le Moual N. Under-estimation of self-reported occupational exposure by questionnaire 
in hospital workers. Occup Environ Med 2011; 68(8):611–617.
Dumas O, Smit LA, Pin I, Kromhout H, Siroux V, Nadif R, Vermeulen R, Heederik D, Hery 
M, Choudat D, Kauffmann F and Le Moual N. Do young adults with childhood asthma 
avoid occupational exposures at first hire? Eur Respir J 2011; 37(5):1043–1049.
Dykewicz MS. Occupational asthma: current concepts in pathogenesis, diagnosis, and mana-
gement. J Allergy Clin Immunol 2009; 123(3):519–528; quiz 529–530.
Eder W, Ege MJ and von Mutius E. The asthma epidemic. N Engl J Med 2006; 355(21):2226–
2235.
Eisner MD, Yegin A and Trzaskoma B. Severity of asthma score predicts clinical outcomes in 
patients with moderate to severe persistent asthma. Chest 2012; 141(1):58–65.
Eisner MD, Yelin EH, Katz PP, Lactao G, Iribarren C and Blanc PD. Risk factors for work 
disability in severe adult asthma. Am J Med 2006; 119(10):884–891.
Ekerljung L, Bossios A, Lotvall J, Olin AC, Ronmark E, Wennergren G, Toren K and Lundback 
B. Multi-symptom asthma as an indication of disease severity in epidemiology. Eur Respir 
J 2011; 38:825–836.
Ellwood P, Innes Asher M, Garcia-Marcos L, Williams H, Keil U, Robertson C and Nagel G. 
Do fast foods cause asthma, rhinoconjunctivitis and eczema? Global findings from the Inter-
national Study of Asthma and Allergies in Childhood (ISAAC) Phase Three. Thorax 2013.
112
references
Eskelinen L, Kohvakka A, Merisalo T, Hurri H and Wagar G. Relationship between the self-
assessment and clinical assessment of health status and work ability. Scand J Work Environ 
Health 1991; 17 Suppl 1:40–47.
Frank PI, Hazell ML, Morris JA, Linehan MF and Frank TL. A longitudinal study of changes in 
respiratory status in young adults, 1993–2001. Int J Tuberc Lung Dis 2007; 11(3):338–343.
Gaga M, Papageorgiou N, Yiourgioti G, Karydi P, Liapikou A, Bitsakou H, Zervas E, Koulouris 
NG and Holgate ST. Risk factors and characteristics associated with severe and difficult to 
treat asthma phenotype: an analysis of the ENFUMOSA group of patients based on the 
ECRHS questionnaire. Clin Exp Allergy 2005; 35(7):954–959.
Gershon AS, Guan J, Wang C and To T. Trends in asthma prevalence and incidence in Ontario, 
Canada, 1996–2005: a population study. Am J Epidemiol 2010; 172(6):728–736.
Gibson PG. Inflammatory phenotypes in adult asthma: clinical applications. Clin Respir J 
2009; 3(4):198–206.
Gibson PG, Simpson JL and Saltos N. Heterogeneity of airway inflammation in persistent 
asthma : evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 
2001; 119(5):1329–1336.
GINA 1995. Global Intiative for Asthma Management and Prevention. NIH publication number 
95-3659A. Bethesda, National Institutes of Health, 1995.
GINA 2002. Global Intiative for Asthma. Workshop report. Global strategy for asthma mana-
gement and prevention 2002. Available from http://www.ginasthma.com.
GINA 2012. From the Global Strategy for Asthma Management and Prevention, Global Initiative 
for Asthma (GINA) 2012. Available from:http://www.ginasthma.org/.
Goe SK, Henneberger PK, Reilly MJ, Rosenman KD, Schill DP, Valiante D, Flattery J, Harrison 
R, Reinisch F, Tumpowsky C and Filios MS. A descriptive study of work aggravated asthma. 
Occup Environ Med 2004; 61(6):512–517.
Gould R, Ilmarinen J, Järvisalo J and Koskinen S, Eds. (2008). Dimensions of Work Ability, 
Results of the Health 2000 Survey. Helsinki, Finnish Centre for Pensions (ETK), The Social 
Insurance Institution (Kela), National Public Health Institute (KTL), Finnish Institute of 
Occupational Health (FIOH).
Green RH, Brightling CE, Woltmann G, Parker D, Wardlaw AJ and Pavord ID. Analysis of 
induced sputum in adults with asthma: identification of subgroup with isolated sputum 
neutrophilia and poor response to inhaled corticosteroids. Thorax 2002a; 57(10):875–879.
Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, Wardlaw AJ and 
Pavord ID. Asthma exacerbations and sputum eosinophil counts: a randomised controlled 
trial. Lancet 2002b; 360(9347):1715–1721.
Guerra S, Wright AL, Morgan WJ, Sherrill DL, Holberg CJ and Martinez FD. Persistence of 
asthma symptoms during adolescence: role of obesity and age at the onset of puberty. Am 
J Respir Crit Care Med 2004; 170(1):78–85.
113
references
Haahtela T, Lindholm H, Bjorksten F, Koskenvuo K and Laitinen LA. Prevalence of asthma in 
Finnish young men. Bmj 1990; 301(6746):266–268.
Haahtela T, Tuomisto LE, Pietinalho A, Klaukka T, Erhola M, Kaila M, Nieminen MM, Kontula 
E and Laitinen LA. A 10 year asthma programme in Finland: major change for the better. 
Thorax 2006; 61(8):663–670.
Haahtela T, Valovirta E, Kauppi P, Tommila E, Saarinen K, von Hertzen L and Makela MJ. The 
Finnish Allergy Programme 2008–2018 – scientific rationale and practical implementation. 
Asia Pac Allergy 2012; 2(4):275–279.
Hakola R, Kauppi P, Leino T, Ojajarvi A, Pentti J, Oksanen T, Haahtela T, Kivimaki M and 
Vahtera J. Persistent asthma, comorbid conditions and the risk of work disability: a pros-
pective cohort study. Allergy 2011; 66(12):1598–1603.
Haldar P and Pavord ID. Noneosinophilic asthma: a distinct clinical and pathologic phenotype. 
J Allergy Clin Immunol 2007; 119(5):1043–1052; quiz 1053–1044.
Haldar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE, Wardlaw AJ and Green 
RH. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008; 
178(3):218–224.
Hansen CL, Baelum J, Skadhauge L, Thomsen G, Omland O, Thilsing T, Dahl S, Sigsgaard T 
and Sherson D. Consequences of asthma on job absenteeism and job retention. Scand J 
Public Health 2012; 40(4):377–384.
Hastie AT, Moore WC, Meyers DA, Vestal PL, Li H, Peters SP and Bleecker ER. Analyses of 
asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum 
granulocytes. J Allergy Clin Immunol 2010; 125(5):1028–1036 e1013.
Hedman J, Kaprio J, Poussa T and Nieminen MM. Prevalence of asthma, aspirin intolerance, 
nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int 
J Epidemiol 1999; 28(4):717–722.
Heinonen OP, Horsmanheimo M, Vohlonen I and Terho EO. Prevalence of allergic symptoms 
in rural and urban populations. Eur J Respir Dis Suppl 1987; 152:64–69.
Henneberger PK, Deprez RD, Asdigian N, Oliver LC, Derk S and Goe SK. Workplace exa-
cerbation of asthma symptoms: findings from a population-based study in Maine. Arch 
Environ Health 2003; 58(12):781–788.
Henneberger PK, Derk SJ, Sama SR, Boylstein RJ, Hoffman CD, Preusse PA, Rosiello RA and 
Milton DK. The frequency of workplace exacerbation among health maintenance organi-
sation members with asthma. Occup Environ Med 2006; 63(8):551–557.
Henneberger PK, Hoffman CD, Magid DJ and Lyons EE. Work-related exacerbation of asthma. 
Int J Occup Environ Health 2002; 8(4):291–296.
Henneberger PK, Mirabelli MC, Kogevinas M, Anto JM, Plana E, Dahlman-Hoglund A, Jarvis 
DL, Kromhout H, Lillienberg L, Norback D, Olivieri M, Radon K, Toren K, Urrutia I, 
Villani S and Zock JP. The occupational contribution to severe exacerbation of asthma. Eur 
Respir J 2010; 36(4):743–750.
114
references
Henneberger PK, Olin AC, Andersson E, Hagberg S and Toren K. The incidence of respiratory 
symptoms and diseases among pulp mill workers with peak exposures to ozone and other 
irritant gases. Chest 2005; 128(4):3028–3037.
Henneberger PK, Redlich CA, Callahan DB, Harber P, Lemiere C, Martin J, Tarlo SM, Van-
denplas O and Toren K. An official american thoracic society statement: work-exacerbated 
asthma. Am J Respir Crit Care Med 2011; 184(3):368–378.
Ho WC, Lin YS, Caffrey JL, Lin MH, Hsu HT, Myers L, Chen PC and Lin RS. Higher body 
mass index may induce asthma among adolescents with pre-asthmatic symptoms: a pros-
pective cohort study. BMC Public Health 2011; 11:542.
Holgate ST and Polosa R. The mechanisms, diagnosis, and management of severe asthma in 
adults. Lancet 2006; 368(9537):780–793.
Holm M, Omenaas E, Gislason T, Svanes C, Jogi R, Norrman E, Janson C and Toren K. Re-
mission of asthma: a prospective longitudinal study from northern Europe (RHINE study). 
Eur Respir J 2007; 30(1):62–65.
Ilmarinen J, Tuomi K and Klockars M. Changes in the work ability of active employees over an 
11-year period. Scand J Work Environ Health 1997; 23 Suppl 1:49–57.
in ‘t Veen JC, Beekman AJ, Bel EH and Sterk PJ. Recurrent exacerbations in severe asthma are 
associated with enhanced airway closure during stable episodes. Am J Respir Crit Care Med 
2000; 161(6):1902–1906.
Jaakkola JJ, Piipari R and Jaakkola MS. Occupation and asthma: a population-based incident 
case-control study. Am J Epidemiol 2003; 158(10):981–987.
Jacquemin B, Kauffmann F, Pin I, Le Moual N, Bousquet J, Gormand F, Just J, Nadif R, Pison C, 
Vervloet D, Kunzli N and Siroux V. Air pollution and asthma control in the Epidemiological 
study on the Genetics and Environment of Asthma. J Epidemiol Community Health 2011.
Jarvis D, Newson R, Lotvall J, Hastan D, Tomassen P, Keil T, Gjomarkaj M, Forsberg B, 
Gunnbjornsdottir M, Minov J, Brozek G, Dahlen SE, Toskala E, Kowalski ML, Olze H, 
Howarth P, Kramer U, Baelum J, Loureiro C, Kasper L, Bousquet PJ, Bousquet J, Bachert C, 
Fokkens W and Burney P. Asthma in adults and its association with chronic rhinosinusitis: 
the GA2LEN survey in Europe. Allergy 2011; 67(1):91–98.
Johnson A, Toelle BG, Yates D, Belousova E, Ng K, Corbett S and Marks G. Occupational 
asthma in New South Wales (NSW): a population-based study. Occup Med (Lond) 2006; 
56(4):258–262.
Johnson AR, Dimich-Ward HD, Manfreda J, Becklake MR, Ernst P, Sears MR, Bowie DM, 
Sweet L and Chan-Yeung M. Occupational asthma in adults in six Canadian communities. 
Am J Respir Crit Care Med 2000; 162(6):2058–2062.
Johnson D and Osborn LM. Cough variant asthma: a review of the clinical literature. J Asthma 
1991; 28(2):85–90.
Juniper EF, Kline PA, Vanzieleghem MA, Ramsdale EH, O’Byrne PM and Hargreave FE. Effect 
of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperres-
ponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis 
1990; 142(4):832–836.
115
references
Juniper EF, O’Byrne PM, Guyatt GH, Ferrie PJ and King DR. Development and validation of 
a questionnaire to measure asthma control. Eur Respir J 1999; 14(4):902–907.
Karjalainen A, Kurppa K, Martikainen R, Karjalainen J and Klaukka T. Exploration of asthma 
risk by occupation – extended analysis of an incidence study of the Finnish population. 
Scand J Work Environ Health 2002; 28(1):49–57.
Karjalainen A, Kurppa K, Martikainen R, Klaukka T and Karjalainen J. Work is related to a 
substantial portion of adult-onset asthma incidence in the Finnish population. Am J Respir 
Crit Care Med 2001; 164(4):565–568.
Karjalainen A, Kurppa K, Virtanen S, Keskinen H and Nordman H. Incidence of occupational 
asthma by occupation and industry in Finland. Am J Ind Med 2000; 37(5):451–458.
Karjalainen A, Martikainen R, Klaukka T, Saarinen K and Uitti J. Risk of asthma among Finnish 
patients with occupational rhinitis. Chest 2003; 123(1):283–288.
Karjalainen J. Exercise response in 404 young men with asthma: no evidence for a late asthmatic 
reaction. Thorax 1991; 46(2):100–104.
Karjalainen J, Lindqvist A and Laitinen LA. Seasonal variability of exercise-induced asthma 
especially outdoors. Effect of birch pollen allergy. Clin Exp Allergy 1989; 19(3):273–278.
Katz I, Moshe S, Sosna J, Baum GL, Fink G and Shemer J. The occurrence, recrudescence, and 
worsening of asthma in a population of young adults: impact of varying types of occupation. 
Chest 1999; 116(3):614–618.
Kauppi P, Salo P, Hakola R, Pentti J, Oksanen T, Kivimaki M, Vahtera J and Haahtela T. Allergic 
rhinitis alone or with asthma is associated with an increased risk of sickness absences. Respir 
Med 2010; 104(11):1654–1658.
Kennedy SM, Le Moual N, Choudat D and Kauffmann F. Development of an asthma specific 
job exposure matrix and its application in the epidemiological study of genetics and envi-
ronment in asthma (EGEA). Occup Environ Med 2000; 57(9):635–641.
Kilpelainen M, Terho EO, Helenius H and Koskenvuo M. Validation of a new questionnaire on 
asthma, allergic rhinitis, and conjunctivitis in young adults. Allergy 2001; 56(5):377–384.
Kivity S, Shochat Z, Bressler R, Wiener M and Lerman Y. The characteristics of bronchial asthma 
among a young adult population. Chest 1995; 108(1):24–27.
Kogevinas M, Anto JM, Soriano JB, Tobias A and Burney P. The risk of asthma attributable to 
occupational exposures. A population-based study in Spain. Spanish Group of the European 
Asthma Study. Am J Respir Crit Care Med 1996; 154(1):137–143.
Kogevinas M, Anto JM, Sunyer J, Tobias A, Kromhout H and Burney P. Occupational asthma 
in Europe and other industrialised areas: a population-based study. European Community 
Respiratory Health Survey Study Group. Lancet 1999; 353(9166):1750–1754.
Kogevinas M, Zock JP, Jarvis D, Kromhout H, Lillienberg L, Plana E, Radon K, Toren K, Alliksoo 
A, Benke G, Blanc PD, Dahlman-Hoglund A, D’Errico A, Hery M, Kennedy S, Kunzli N, 
Leynaert B, Mirabelli MC, Muniozguren N, Norback D, Olivieri M, Payo F, Villani S, van 
Sprundel M, Urrutia I, Wieslander G, Sunyer J and Anto JM. Exposure to substances in 
the workplace and new-onset asthma: an international prospective population-based study 
(ECRHS-II). Lancet 2007; 370(9584):336–341.
116
references
Kolnaar BG, Folgering H, van den Hoogen HJ and van Weel C. Asymptomatic bronchial 
hyperresponsiveness in adolescents and young adults. Eur Respir J 1997; 10(1):44–50.
Koskela HO, Hyvarinen L, Brannan JD, Chan HK and Anderson SD. Sensitivity and validity 
of three bronchial provocation tests to demonstrate the effect of inhaled corticosteroids in 
asthma. Chest 2003; 124(4):1341–1349.
Kotaniemi JT, Pallasaho P, Sovijarvi AR, Laitinen LA and Lundback B. Respiratory symptoms 
and asthma in relation to cold climate, inhaled allergens, and irritants: a comparison between 
northern and southern Finland. J Asthma 2002; 39(7):649–658.
Käsikirjoja 14 (Handbook 14). Helsinki SF, 1997, Ed. (1997). Tilastokeskus Ammattiluokitus 
(Classification of occupations).
Laforest L, Van Ganse E, Devouassoux G, Bousquet J, Chretin S, Bauguil G, Pacheco Y and 
Chamba G. Influence of patients’ characteristics and disease management on asthma control. 
J Allergy Clin Immunol 2006; 117(6):1404–1410.
Lai CK, Beasley R, Crane J, Foliaki S, Shah J and Weiland S. Global variation in the prevalence 
and severity of asthma symptoms: phase three of the International Study of Asthma and 
Allergies in Childhood (ISAAC). Thorax 2009; 64(6):476–483.
Laitinen LA. Histamine and metacholine challenge in the testing of bronchial reactivity. Scand 
J Respir Dis 1975; Suppl 86: 1–48.
Lange P, Scharling H, Ulrik CS and Vestbo J. Inhaled corticosteroids and decline of lung function 
in community residents with asthma. Thorax 2006; 61(2):100–104.
Latvala J, von Hertzen L, Lindholm H and Haahtela T. Trends in prevalence of asthma and allergy 
in Finnish young men: nationwide study, 1966–2003. Bmj 2005; 330(7501):1186–1187.
Le Moual N, Kauffmann F, Eisen EA and Kennedy SM. The healthy worker effect in asthma: 
work may cause asthma, but asthma may also influence work. Am J Respir Crit Care Med 
2008; 177(1):4–10.
Le Moual N, Kennedy SM and Kauffmann F. Occupational exposures and asthma in 14,000 
adults from the general population. Am J Epidemiol 2004; 160(11):1108–1116.
Le Moual N, Siroux V, Pin I, Kauffmann F and Kennedy SM. Asthma severity and exposure to 
occupational asthmogens. Am J Respir Crit Care Med 2005; 172(4):440–445.
Lehtimaki L, Kankaanranta H, Saarelainen S, Turjanmaa V and Moilanen E. Increased alveolar 
nitric oxide concentration in asthmatic patients with nocturnal symptoms. Eur Respir J 
2002; 20(4):841–845.
Lemiere C, Begin D, Camus M, Forget A, Boulet LP and Gerin M. Occupational risk fac-
tors associated with work-exacerbated asthma in Quebec. Occup Environ Med 2012; 
69(12):901–907.
Lemiere C, Boulet LP, Chaboillez S, Forget A, Chiry S, Villeneuve H, Prince P, Maghni K, 
Kennedy WA and Blais L. Work-exacerbated asthma and occupational asthma: Do they 
really differ? J Allergy Clin Immunol 2013; 131(3):704–710.
117
references
Lemiere C, Malo JL and Boutet M. Reactive airways dysfunction syndrome due to chlorine: 
sequential bronchial biopsies and functional assessment. Eur Respir J 1997; 10(1):241–244.
Levin MM. The two tests in the Rorschach. J Proj Tech 1953; 17(4):471–473.
Li CY and Sung FC. A review of the healthy worker effect in occupational epidemiology. Occup 
Med (Lond) 1999; 49(4):225–229.
Liard R, Leynaert B, Zureik M, Beguin FX and Neukirch F. Using Global Initiative for Asthma 
guidelines to assess asthma severity in populations. Eur Respir J 2000; 16(4):615–620.
Lillienberg L, Andersson E, Janson C, Dahlman-Hoglund A, Forsberg B, Holm M, Glslason 
T, Jogi R, Omenaas E, Schlunssen V, Sigsgaard T, Svanes C and Toren K. Occupational 
Exposure and New-onset Asthma in a Population-based Study in Northern Europe (RHI-
NE). Ann Occup Hyg 2012.
Limb SL, Brown KC, Wood RA, Wise RA, Eggleston PA, Tonascia J, Hamilton RG and Adkinson 
NF, Jr. Adult asthma severity in individuals with a history of childhood asthma. J Allergy 
Clin Immunol 2005; 115(1):61–66.
Lindstrom I, Malmberg P, Suojalehto H, Harju T, Kauppi P, Kilpelainen M, Lindqvist M, 
Nieminen EM, Nieminen E, Pallasaho P, Purokivi M, Sauni R, Tuomisto L and Jaakkola 
MS. Peak expiratory flow monitoring – the basis for diagnosing occupational asthma – 
guidelines by the Finnish Expert Group on Occupational Lung Diseases. Duodecim 2011; 
127(20):2194–2204.
Lotvall J, Ekerljung L, Ronmark EP, Wennergren G, Linden A, Ronmark E, Toren K and 
Lundback B. West Sweden Asthma Study: prevalence trends over the last 18 years argues 
no recent increase in asthma. Respir Res 2009; 10:94.
Malo JL and Chan-Yeung M. Agents causing occupational asthma. J Allergy Clin Immunol 
2009; 123(3):545–550.
Mancuso CA, Rincon M and Charlson ME. Adverse work outcomes and events attributed to 
asthma. Am J Ind Med 2003; 44(3):236–245.
Marcon A, Corsico A, Cazzoletti L, Bugiani M, Accordini S, Almar E, Cerveri I, Gislason D, 
Gulsvik A, Janson C, Jarvis D, Martinez-Moratalla J, Pin I and de Marco R. Body mass 
index, weight gain, and other determinants of lung function decline in adult asthma. J 
Allergy Clin Immunol 2009; 123(5):1069–1074, 1074 e1061–1064.
McKeever TM and Britton J. Diet and asthma. Am J Respir Crit Care Med 2004; 170(7):725–
729.
McLeish AC and Zvolensky MJ. Asthma and cigarette smoking: a review of the empirical lite-
rature. J Asthma 2010; 47(4):345–361.
Mendell MJ, Mirer AG, Cheung K, Tong M and Douwes J. Respiratory and allergic health effects 
of dampness, mold, and dampness-related agents: a review of the epidemiologic evidence. 
Environ Health Perspect 2011; 119(6):748–756.
118
references
Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van 
der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas 
D, Pedersen OF, Pellegrino R, Viegi G and Wanger J. Standardisation of spirometry. Eur 
Respir J 2005; 26(2):319–338.
Moore WC, Meyers DA, Wenzel SE, Teague WG, Li H, Li X, D’Agostino R, Jr., Castro M, 
Curran-Everett D, Fitzpatrick AM, Gaston B, Jarjour NN, Sorkness R, Calhoun WJ, Chung 
KF, Comhair SA, Dweik RA, Israel E, Peters SP, Busse WW, Erzurum SC and Bleecker ER. 
Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research 
Program. Am J Respir Crit Care Med 2010; 181(4):315–323.
Murgia N, Toren K, Kim JL and Andersson E. Risk factors for respiratory work disability in a 
cohort of pulp mill workers exposed to irritant gases. BMC Public Health 2011; 11:689.
Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ and Pendergraft 
TB. Development of the asthma control test: a survey for assessing asthma control. J Allergy 
Clin Immunol 2004; 113(1):59–65.
Nathel L, Malmberg P, Lundback B and Nygren A. Is asthma underestimated as a cause of sick 
leave? Respir Med 2000; 94(10):977–982.
Nathell L, Jensen I and Larsson K. High prevalence of obesity in asthmatic patients on sick 
leave. Respir Med 2002; 96(8):642–650.
Nicholson PJ, Cullinan P, Taylor AJ, Burge PS and Boyle C (2010). Occupational asthma: Pre-
vention, identification & management: Systematic review & recommendations. London, 
British Occupational Health Research Foundation.
Northridge ME. Public health methods – attributable risk as a link between causality and public 
health action. Am J Public Health 1995; 85(9):1202–1204.
Nurminen M and Karjalainen A. Epidemiologic estimate of the proportion of fatalities related 
to occupational factors in Finland. Scand J Work Environ Health 2001; 27(3):161–213.
Nygard CH, Eskelinen L, Suvanto S, Tuomi K and Ilmarinen J. Associations between functio-
nal capacity and work ability among elderly municipal employees. Scand J Work Environ 
Health 1991; 17 Suppl 1:122–127. 
O’Byrne PM, Pedersen S, Lamm CJ, Tan WC and Busse WW. Severe exacerbations and decline 
in lung function in asthma. Am J Respir Crit Care Med 2009a; 179(1):19–24.
O’Byrne PM, Lamm CJ, Busse WW, Tan WC and Pedersen S. The effects of inhaled budesonide 
on lung function in smokers and nonsmokers with mild persistent asthma. Chest 2009b; 
136(6):1514–1520.
Oksa P, Palo L, Saalo A, Jolanki R, Mäkinen I and Kauppinen T, Eds. (2009). Ammattitaudit 
ja ammattitautiepäilyt 2009. Helsinki, Työterveyslaitos.
Oksa P, Palo L, Saalo A, Jolanki R, Mäkinen I and Kauppinen T (2010). Ammattitaudit ja 
ammattitautiepäilyt 2010. Helsinki, Työterveyslaitos.
Olivieri M, Mirabelli MC, Plana E, Radon K, Anto JM, Bakke P, Benke G, D’Errico A, Hen-
neberger P, Kromhout H, Norback D, Toren K, van Sprundel M, Villani S, Wieslander 
G, Zock JP and Kogevinas M. Healthy hire effect, job selection and inhalation exposure 
among young adults with asthma. Eur Respir J 2010; 36(3):517–523.
119
references
Orriols R, Costa R, Albanell M, Alberti C, Castejon J, Monso E, Panades R, Rubira N and 
Zock JP. Reported occupational respiratory diseases in Catalonia. Occup Environ Med 
2006; 63(4):255–260.
Pallasaho P, Juusela M, Lindqvist A, Sovijarvi A, Lundback B and Ronmark E. Allergic rhino-
conjunctivitis doubles the risk for incident asthma – Results from a population study in 
Helsinki, Finland. Respir Med 2011; 105(10):1449–1456.
Pallasaho P, Lundback B, Laspa SL, Jonsson E, Kotaniemi J, Sovijarvi AR and Laitinen LA. 
Increasing prevalence of asthma but not of chronic bronchitis in Finland? Report from the 
FinEsS-Helsinki Study. Respir Med 1999; 93(11):798–809.
Panhuysen CI, Vonk JM, Koeter GH, Schouten JP, van Altena R, Bleecker ER and Postma DS. 
Adult patients may outgrow their asthma: a 25-year follow-up study. Am J Respir Crit Care 
Med 1997; 155(4):1267–1272.
Panizza JA, James AL, Ryan G, de Klerk N and Finucane KE. Mortality and airflow obstruction 
in asthma: a 17-year follow-up study. Intern Med J 2006; 36(12):773–780.
Pannett B, Coggon D and Acheson ED. A job-exposure matrix for use in population based 
studies in England and Wales. Br J Ind Med 1985; 42(11):777–783.
Paul G, Brehm JM, Alcorn JF, Holguin F, Aujla SJ and Celedon JC. Vitamin D and asthma. 
Am J Respir Crit Care Med 2012; 185(2):124–132.
Pavord ID. Asthma phenotypes. Semin Respir Crit Care Med 2012; 33(6):645–652.
Pearce N, Pekkanen J and Beasley R. How much asthma is really attributable to atopy? Thorax 
1999; 54(3):268–272.
Peat JK, Toelle BG, Marks GB and Mellis CM. Continuing the debate about measuring asthma 
in population studies. Thorax 2001; 56(5):406–411.
Peat JK, Woolcock AJ and Cullen K. Rate of decline of lung function in subjects with asthma. 
Eur J Respir Dis 1987; 70(3):171–179.
Pekkanen J and Pearce N. Defining asthma in epidemiological studies. Eur Respir J 1999; 
14(4):951–957.
Peters SP, Jones CA, Haselkorn T, Mink DR, Valacer DJ and Weiss ST. Real-world Evaluation 
of Asthma Control and Treatment (REACT): findings from a national Web-based survey. 
J Allergy Clin Immunol 2007; 119(6):1454–1461.
Phelan PD, Robertson CF and Olinsky A. The Melbourne Asthma Study: 1964–1999. J Allergy 
Clin Immunol 2002; 109(2):189–194.
Piipari R, Jaakkola JJ, Jaakkola N and Jaakkola MS. Smoking and asthma in adults. Eur Respir 
J 2004; 24(5):734–739.
Piipari R and Keskinen H. Agents causing occupational asthma in Finland in 1986–2002: cow 
epithelium bypassed by moulds from moisture-damaged buildings. Clin Exp Allergy 2005; 
35(12):1632–1637.
Porpodis K, Papakosta D, Manika K, Kontakiotis T, Gaga M, Sichletidis L and Gioulekas D. 
Long-term prognosis of asthma is good – a 12-year follow-up study. Influence of treatment. 
J Asthma 2009; 46(6):625–631.
120
references
Porsbjerg C, Brannan JD, Anderson SD and Backer V. Relationship between airway responsi-
veness to mannitol and to methacholine and markers of airway inflammation, peak flow 
variability and quality of life in asthma patients. Clin Exp Allergy 2008; 38(1):43–50.
Quinlan PJ, Earnest G, Eisner MD, Yelin EH, Katz PP, Balmes JR and Blanc PD. Performance 
of self-reported occupational exposure compared to a job-exposure matrix approach in 
asthma and chronic rhinitis. Occup Environ Med 2009; 66(3):154–160.
Rabe KF, Adachi M, Lai CK, Soriano JB, Vermeire PA, Weiss KB and Weiss ST. Worldwide 
severity and control of asthma in children and adults: the global asthma insights and reality 
surveys. J Allergy Clin Immunol 2004; 114(1):40–47.
Raherison C, Janson C, Jarvis D, Burney P, Cazzoletti L, de Marco R, Neukirch F and Leynaert 
B. Evolution of asthma severity in a cohort of young adults: is there any gender difference? 
PLoS One 2009; 4(9):e7146.
Rasmussen F, Taylor DR, Flannery EM, Cowan JO, Greene JM, Herbison GP and Sears MR. 
Risk factors for airway remodeling in asthma manifested by a low postbronchodilator FEV1/
vital capacity ratio: a longitudinal population study from childhood to adulthood. Am J 
Respir Crit Care Med 2002; 165(11):1480–1488.
Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, Casale TB, Chanez P, 
Enright PL, Gibson PG, de Jongste JC, Kerstjens HA, Lazarus SC, Levy ML, O’Byrne PM, 
Partridge MR, Pavord ID, Sears MR, Sterk PJ, Stoloff SW, Sullivan SD, Szefler SJ, Thomas 
MD and Wenzel SE. An official American Thoracic Society/European Respiratory Society 
statement: asthma control and exacerbations: standardizing endpoints for clinical asthma 
trials and clinical practice. Am J Respir Crit Care Med 2009; 180(1):59–99.
Ronchetti R, Indinnimeo L, Bonci E, Corrias A, Evans D, Hindi-Alexander M, Midulla F, Pulejo 
R and Villa MP. Asthma self-management programmes in a population of Italian children: 
a multicentric study. Italian Study Group on Asthma Self-Management Programmes. Eur 
Respir J 1997; 10(6):1248–1253.
Ronmark E, Jonsson E and Lundback B. Remission of asthma in the middle aged and elder-
ly: report from the Obstructive Lung Disease in Northern Sweden study. Thorax 1999; 
54(7):611–613.
Ronmark E, Lindberg A, Watson L and Lundback B. Outcome and severity of adult onset 
asthma – report from the obstructive lung disease in northern Sweden studies (OLIN). 
Respir Med 2007; 101(11):2370–2377.
Ronmark EP, Ekerljung L, Lotvall J, Toren K, Ronmark E and Lundback B. Large scale ques-
tionnaire survey on respiratory health in Sweden: effects of late- and non-response. Respir 
Med 2009; 103(12):1807–1815.
Rosenthal LA, Avila PC, Heymann PW, Martin RJ, Miller EK, Papadopoulos NG, Peebles RS, 
Jr. and Gern JE. Viral respiratory tract infections and asthma: the course ahead. J Allergy 
Clin Immunol 2010; 125(6):1212–1217.
Rouhos A, Ekroos H, Karjalainen J, Sarna S and Sovijarvi AR. Exhaled nitric oxide and exercise-
induced bronchoconstriction in young male conscripts: association only in atopics. Allergy 
2005; 60(12):1493–1498.
121
references
Saarinen K, Karjalainen A, Martikainen R, Uitti J, Tammilehto L, Klaukka T and Kurppa K. 
Prevalence of work-aggravated symptoms in clinically established asthma. Eur Respir J 
2003; 22(2):305–309.
Schatz M, Sorkness CA, Li JT, Marcus P, Murray JJ, Nathan RA, Kosinski M, Pendergraft TB 
and Jhingran P. Asthma Control Test: reliability, validity, and responsiveness in patients not 
previously followed by asthma specialists. J Allergy Clin Immunol 2006; 117(3):549–556.
Schaub B and von Mutius E. Obesity and asthma, what are the links? Curr Opin Allergy Clin 
Immunol 2005; 5(2):185–193.
Schleich FN, Manise M, Sele J, Henket M, Seidel L and Louis R. Distribution of sputum cel-
lular phenotype in a large asthma cohort: predicting factors for eosinophilic vs neutrophilic 
inflammation. BMC Pulm Med 2013; 13:11.
Sears MR, Burrows B, Flannery EM, Herbison GP, Hewitt CJ and Holdaway MD. Relation 
between airway responsiveness and serum IgE in children with asthma and in apparently 
normal children. N Engl J Med 1991; 325(15):1067–1071.
Sears MR, Greene JM, Willan AR, Wiecek EM, Taylor DR, Flannery EM, Cowan JO, Herbison 
GP, Silva PA and Poulton R. A longitudinal, population-based, cohort study of childhood 
asthma followed to adulthood. N Engl J Med 2003; 349(15):1414–1422.
Silverstein MD, Reed CE, O’Connell EJ, Melton LJ, 3rd, O’Fallon WM and Yunginger JW. 
Long-term survival of a cohort of community residents with asthma. N Engl J Med 1994; 
331(23):1537–1541.
Simpson JL, Powell H, Boyle MJ, Scott RJ and Gibson PG. Clarithromycin targets neut-
rophilic airway inflammation in refractory asthma. Am J Respir Crit Care Med 2008; 
177(2):148–155.
Sin DD and Sutherland ER. Obesity and the lung: 4. Obesity and asthma. Thorax 2008; 
63(11):1018–1023.
Siroux V, Basagana X, Boudier A, Pin I, Garcia-Aymerich J, Vesin A, Slama R, Jarvis D, Anto 
JM, Kauffmann F and Sunyer J. Identifying adult asthma phenotypes using a clustering 
approach. Eur Respir J 2011; 38(2):310–317.
Siroux V, Boudier A, Bousquet J, Bresson JL, Cracowski JL, Ferran J, Gormand F, Just J, Le 
Moual N, Morange S, Nadif R, Oryszczyn MP, Pison C, Scheinmann P, Varraso R, Vervloet 
D, Pin I and Kauffmann F. Phenotypic determinants of uncontrolled asthma. J Allergy Clin 
Immunol 2009; 124(4):681–687.
Smith AD, Cowan JO, Brassett KP, Herbison GP and Taylor DR. Use of exhaled nitric oxide me-
asurements to guide treatment in chronic asthma. N Engl J Med 2005; 352(21):2163–2173.
Sorkness RL, Bleecker ER, Busse WW, Calhoun WJ, Castro M, Chung KF, Curran-Everett D, 
Erzurum SC, Gaston BM, Israel E, Jarjour NN, Moore WC, Peters SP, Teague WG and 
Wenzel SE. Lung function in adults with stable but severe asthma: air trapping and incomp-
lete reversal of obstruction with bronchodilation. J Appl Physiol 2008; 104(2):394–403.
Spahn JD and Covar R. Clinical assessment of asthma progression in children and adults. J 
Allergy Clin Immunol 2008; 121(3):548–557; quiz 558–549.
122
references
Steenland K and Armstrong B. An overview of methods for calculating the burden of disease 
due to specific risk factors. Epidemiology 2006; 17(5):512–519.
Sterk PJ, Fabbri LM, Quanjer PH, Cockcroft DW, O’Byrne PM, Anderson SD, Juniper EF 
and Malo JL. Airway responsiveness. Standardized challenge testing with pharmacological, 
physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung 
Function Tests, European Community for Steel and Coal. Official Statement of the European 
Respiratory Society. Eur Respir J Suppl 1993; 16:53–83.
Strachan DP, Butland BK and Anderson HR. Incidence and prognosis of asthma and whee-
zing illness from early childhood to age 33 in a national British cohort. Bmj 1996; 
312(7040):1195–1199.
Strachan DP and Cook DG. Health effects of passive smoking. 6. Parental smoking and childhood 
asthma: longitudinal and case-control studies. Thorax 1998; 53(3):204–212.
Suojalehto H, Malmberg P, Lindstrom I, Harju T, Kauppi P, Kilpelainen M, Lindqvist M, Nie-
minen EM, Nieminen E, Pallasaho P, Purokivi M, Sauni R, Tuomisto L and Jaakkola MS. 
Specific challenge tests in occupational asthma – guidelines by the Finnish Expert Group 
on Occupational Lung Diseases. Duodecim 2011; 127(20):2205–2214.
Tarlo SM, Balmes J, Balkissoon R, Beach J, Beckett W, Bernstein D, Blanc PD, Brooks SM, 
Cowl CT, Daroowalla F, Harber P, Lemiere C, Liss GM, Pacheco KA, Redlich CA, Rowe 
B and Heitzer J. Diagnosis and management of work-related asthma: American College Of 
Chest Physicians Consensus Statement. Chest 2008; 134(3 Suppl):1S–41S.
Tarlo SM, Liss G, Corey P and Broder I. A workers’ compensation claim population for occu-
pational asthma. Comparison of subgroups. Chest 1995; 107(3):634–641.
Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, Casale TB, Chanez P, Enright 
PL, Gibson PG, de Jongste JC, Kerstjens HA, Lazarus SC, Levy ML, O’Byrne PM, Partridge 
MR, Pavord ID, Sears MR, Sterk PJ, Stoloff SW, Szefler SJ, Sullivan SD, Thomas MD, 
Wenzel SE and Reddel HK. A new perspective on concepts of asthma severity and control. 
Eur Respir J 2008a; 32(3):545–554
Taylor B, Mannino D, Brown C, Crocker D, Twum-Baah N and Holguin F. Body mass index 
and asthma severity in the National Asthma Survey. Thorax 2008b; 63(1):14–20.
Taylor DR, Cowan JO, Greene JM, Willan AR and Sears MR. Asthma in remission: can relapse 
in early adulthood be predicted at 18 years of age? Chest 2005; 127(3):845–850.
ten Brinke A, Zwinderman AH, Sterk PJ, Rabe KF and Bel EH. Factors associated with persistent 
airflow limitation in severe asthma. Am J Respir Crit Care Med 2001; 164(5):744–748.
Thaon I, Wild P, Mouchot L, Monfort C, Touranchet A, Kreutz G, Derriennic F and Paris C. 
Long-term occupational consequences of asthma in a large French cohort of male workers 
followed up for 5 years. Am J Ind Med 2008; 51(5):317–323.
Thomsen SF, Ulrik CS, Kyvik KO, Larsen K, Skadhauge LR, Steffensen I and Backer V. The 
incidence of asthma in young adults. Chest 2005; 127(6):1928–1934.
Thomsen SF, Ulrik CS, Kyvik KO, Larsen K, Skadhauge LR, Steffensen IE, Duffy DL and 
Backer V. Risk factors for asthma in young adults: a co-twin control study. Allergy 2006; 
61(2):229–233.
123
references
Tobacco dependence and cessation (online). Current Care guideline. Working group set up by 
the Finnish Medical Society Duodecim and the Finnish Association for General Practice. 
Helsinki: Finnish Medical Society Duodecim, 2012 (referred 19 January, 2012). Available 
online at: www.kaypahoito.fi
Toelle BG, Peat JK, Salome CM, Mellis CM and Woolcock AJ. Toward a definition of asthma 
for epidemiology. Am Rev Respir Dis 1992; 146(3):633–637.
Toelle BG, Xuan W, Peat JK and Marks GB. Childhood factors that predict asthma in young 
adulthood. Eur Respir J 2004; 23(1):66–70.
Toren K. Self reported rate of occupational asthma in Sweden 1990–2. Occup Environ Med 
1996; 53(11):757–761.
Toren K and Blanc PD. Asthma caused by occupational exposures is common – a systematic 
analysis of estimates of the population-attributable fraction. BMC Pulm Med 2009a; 9:7.
Toren K, Brisman J and Jarvholm B. Asthma and asthma-like symptoms in adults assessed by 
questionnaires. A literature review. Chest 1993; 104(2):600–608.
Toren K, Ekerljung L, Kim JL, Hillstrom J, Wennergren G, Ronmark E, Lotvall J and Lundback 
B. Adult-onset asthma in west Sweden – incidence, sex differences and impact of occupational 
exposures. Respir Med 2011; 105(11):1622–1628.
Toren K and Hermansson BA. Incidence rate of adult-onset asthma in relation to age, sex, atopy 
and smoking: a Swedish population-based study of 15813 adults. Int J Tuberc Lung Dis 
1999a; 3(3):192–197.
Toren K, Jarvholm B, Brisman J, Hagberg S, Hermansson BA and Lillienberg L. Adult-onset 
asthma and occupational exposures. Scand J Work Environ Health 1999b; 25(5):430–435.
Toren K, Zock JP, Kogevinas M, Plana E, Sunyer J, Radon K, Jarvis D, Kromhout H, d’Errico 
A, Payo F, Anto JM and Blanc PD. An international prospective general population-based 
study of respiratory work disability. Thorax 2009b; 64(4):339–344.
Tuomi K, Ilmarinen J, Jahkola M, Katajarinne L, Tulkki A (2006). Work Ability Index Helsinki, 
Finnish Institute of Occupational Health.
Ulrik CS. Outcome of asthma: longitudinal changes in lung function. Eur Respir J 1999; 
13(4):904–918.
Ulrik CS and Lange P. Decline of lung function in adults with bronchial asthma. Am J Respir 
Crit Care Med 1994; 150(3):629–634.
van den Toorn LM, Overbeek SE, de Jongste JC, Leman K, Hoogsteden HC and Prins JB. 
Airway inflammation is present during clinical remission of atopic asthma. Am J Respir 
Crit Care Med 2001; 164(11):2107–2113.
van den Toorn LM, Prins JB, Overbeek SE, Hoogsteden HC and de Jongste JC. Adolescents in 
clinical remission of atopic asthma have elevated exhaled nitric oxide levels and bronchial 
hyperresponsiveness. Am J Respir Crit Care Med 2000; 162(3 Pt 1):953–957.
van der Wiel E, ten Hacken NH, Postma DS and van den Berge M. Small-airways dysfunction 
associates with respiratory symptoms and clinical features of asthma: a systematic review. J 
Allergy Clin Immunol 2013; 131(3):646–657.
124
references
van Veen IH, Ten Brinke A, Sterk PJ, Sont JK, Gauw SA, Rabe KF and Bel EH. Exhaled ni-
tric oxide predicts lung function decline in difficult-to-treat asthma. Eur Respir J 2008; 
32(2):344–349.
Vandenplas O, D’Alpaos V, Evrard G and Jamart J. Incidence of severe asthmatic reactions after 
challenge exposure to occupational agents. Chest 2012.
Vandenplas O, Van Brussel P, D’Alpaos V, Wattiez M, Jamart J and Thimpont J. Rhinitis in 
subjects with work-exacerbated asthma. Respir Med 2010; 104(4):497–503.
Weatherall M, Travers J, Shirtcliffe PM, Marsh SE, Williams MV, Nowitz MR, Aldington S 
and Beasley R. Distinct clinical phenotypes of airways disease defined by cluster analysis. 
Eur Respir J 2009; 34(4):812–818.
Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet 2006; 368(9537):804–
813.
Viljanen A. Reference values for spirometric, pulmonary diffuusing capacity and body plethys-
mographic studies. Scand J Clin Invest 1982; 42(Suppl.159):1–50.
Willemsen G, van Beijsterveldt TC, van Baal CG, Postma D and Boomsma DI. Heritability of 
self-reported asthma and allergy: a study in adult Dutch twins, siblings and parents. Twin 
Res Hum Genet 2008; 11(2):132–142.
Virtanen M, Kivimaki M, Vahtera J, Elovainio M, Sund R, Virtanen P and Ferrie JE. Sickness 
absence as a risk factor for job termination, unemployment, and disability pension among 
temporary and permanent employees. Occup Environ Med 2006; 63(3):212–217.
Withers NJ, Low L, Holgate ST and Clough JB. The natural history of respiratory symptoms 
in a cohort of adolescents. Am J Respir Crit Care Med 1998; 158(2):352–357.
Vollmer WM, Markson LE, O’Connor E, Sanocki LL, Fitterman L, Berger M and Buist AS. 
Association of asthma control with health care utilization and quality of life. Am J Respir 
Crit Care Med 1999; 160(5 Pt 1):1647–1652.
Vonk JM, Jongepier H, Panhuysen CI, Schouten JP, Bleecker ER and Postma DS. Risk factors 
associated with the presence of irreversible airflow limitation and reduced transfer coefficient 
in patients with asthma after 26 years of follow up. Thorax 2003; 58(4):322–327.
Vonk JM, Postma DS, Boezen HM, Grol MH, Schouten JP, Koeter GH and Gerritsen J. 
Childhood factors associated with asthma remission after 30 year follow up. Thorax 2004; 
59(11):925–929.
Wu AC, Tantisira K, Li L, Fuhlbrigge AL, Weiss ST and Litonjua A. Effect of vitamin D and 
inhaled corticosteroid treatment on lung function in children. Am J Respir Crit Care Med 
2012; 186(6):508–513.
Yelin E, Katz P, Balmes J, Trupin L, Earnest G, Eisner M and Blanc P. Work life of persons with 
asthma, rhinitis, and COPD: a study using a national, population-based sample. J Occup 
Med Toxicol 2006; 1:2.
Zureik M, Neukirch C, Leynaert B, Liard R, Bousquet J and Neukirch F. Sensitisation to airborne 
moulds and severity of asthma: cross sectional study from European Community respiratory 
health survey. Bmj 2002; 325(7361):411–414.

Men with asthma since youth 
– Prognosis, impact of work and effect on 
work ability
People and Work
Research Reports 99
Irmeli Lindström
  M
en w
ith asthm
a since youth 
Irm
eli Lindström
 
Asthma is an increasing health problem among the working age 
population and may already start at a young age. The aim was 
to study the asthma prognosis and the work ability of men with 
asthma since youth.
We used the Finnish Defence Force registers to select the study 
populations. Military aggravated asthma had a good 2-year and 
20-year prognosis. Both mild and more severe asthma at the age 
of around 20 seems to be associated with reduced work ability 
among middle-aged men. Furthermore, current occupational ex-
posure may be associated with asthma exacerbations among men 
with relatively severe asthma in youth. 
Health care providers should therefore carefully follow men with 
asthma that began in youth, support their work ability and pay 
close attention to their work environment.
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Erratum: 
 
 
On page 13 on line 2 the word incidence should 
be replaced with the word prevalence. 
 
